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Pyroptosis is a form of lytic cell death occurring downstream of inflammasome 
activation. Pattern recognition receptors from the NOD-like and AIM2-like families 
and Pyrin sense the cytosol of macrophages, monocytes, neutrophils, dendritic cells 
and other myeloid cell types and epithelial cells for danger- and pathogen-associated 
molecular patterns. Once activated, these receptors assemble in an ASC-dependent 
or -independent manner to form the inflammasome platform. Caspase-1 is produced 
in the cell as a zymogen, and recruitment to the inflammasome allows its proximity-
induced autoactivation. Active caspase-1 leads to pyroptotic cell death. Pyroptosis 
can also be executed by caspase-11, which is activated through the non-canonical 
inflammasome. Both caspase-1 and caspase-11 pathways converge at cleavage of 
GSDMD, the executor of cell permeabilization during pyroptosis. However, 
canonical and non-canonical inflammasomes differentially control cytokine 
processing. Active caspase-1 also cleaves and activates the pro-cytokines IL1β and 
IL18, while caspase-11 relies on downstream activation of caspase-1 to promote 
cytokine maturation.  
Pyroptotic cell death and lysis have been increasingly associated with the release of 
IL1β and IL18, while the pyroptotic corpse has been shown to contain intracellular 
pathogens, facilitating clearance by infiltrating neutrophils. Indeed, pyroptosis has 
been shown to mediate clearance of a variety of intracellular pathogens, but overt cell 
death and cytokine release also plays a role in autoinflammatory diseases. While the 
studies on the execution of cell lysis during pyroptosis have gained track during the 
past years, the organellar and biochemical mechanisms occuring during cell death 
execution are still undefined. Therefore, the current thesis aimed at describing the 
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organellar events happening during pyroptosis and defining the biochemical 
characteristics of this cell death.  
Through a single-cell based, live-cell imaging analysis of pyroptosis induction by the 
NLRC4, NLRP1b and non-canonical inflammasomes, we defined a set of organellar 
changes preceding plasma membrane permeabilization. Ionic fluxes, cellular 
swelling, mitochondrial and lysosomal damage were shared between these 
inflammasomes, demonstrating they are common pyroptotic-associated events. 
Furthermore, these observations suggested that a gradual increase in membrane 
permeabilization is the mechanism behind GSDMD-induced pyroptosis. Our 
biochemical analysis of NLRC4 and NLRP1b-mediated dying macrophages revealed 
activation of caspase-3 and -7, with detection of DEVDase activity and cleavage of 
ROCKI, Bid and p23. These data suggest that pyroptosis comprises a caspase-3/-7 
demolition program, previously associated only to apoptosis. In line with this, 
removal of GSDMD protein or its function after inflammasome triggering caused cell 
death associated with shrinkage and blebbing, typical of an apoptotic program. This 
phenotype was independent of the ASC speck, previously described to mediate 
caspase-8 activation and apoptosis in the absence of caspase-1. In the last part of the 
thesis, we screened a set pharmacological inhibitors for their ability to promote cell 
death and inflammasome activation. We demonstrated that inhibition of PRCP by 
Compound 8o leads to fast cell death. This was accompanied by IL1β release through 
the NLRP3 inflammasome. On the other hand, DPP8/DPP9 inhibition by Val-boroPro 
and 1G244 led to pyroptosis and IL1β release in mouse macrophages containing the 
129-associated allele of Nlrp1b. Macrophages lacking this allele still responded to 
1G244 and Val-boroPro, albeit with less intensity.  
This thesis defined the organellar morphological changes associated to pyroptosis 
and identified a gradual increase in membrane permeability as the mechanism of cell 
lysis. We also identified a caspase-3/-7 signature in pyroptotic cells, downstream of 
caspase-1 activation. Furthermore, we defined two groups of inhibitors for 






Pyroptose is een vorm van lytische celdood die optreedt na activatie van de 
inflammasoom signalisatie pathway. Receptoren die behoren tot de NOD-like en 
AIM2-like families alsook Pyrine surveilleren het cytosol van macrofagen en 
epitheelcellen, om zo signalen te detecteren die wijzen op niet-infectieus gevaar of de 
aanwezigheid van pathogenen. Eenmaal geactiveerd, assembleren deze receptoren 
op een ASC-afhankelijke of -onafhankelijke manier om het inflammasoom-platform 
te vormen. Caspase-1 wordt in de cel geproduceerd als een zymogeen, maar 
rekrutering door het inflammasoom maakt nabijheid-geïnduceerde autoactivatie 
mogelijk, waarbij actief caspase-1 leidt tot pyroptotische celdood. Pyroptose kan 
echter ook worden uitgevoerd door caspase-11, dat geactiveerd wordt door het niet-
canonieke inflammasoom. Zowel caspase-1- als caspase-11-gemedieerde signalisatie 
convergeren bij de verknipping van GSDMD, het eiwit verantwoordelijk voor 
celpermeabilisatie tijdens pyroptose. Beide caspasen divergeren echter op het niveau 
van cytokine maturatie. Actief caspase-1 verknipt en activeert de pro-cytokines IL1β 
en IL18, terwijl caspase-11 afhankelijk is van downstream activering van caspase-1 
om cytokine-maturatie te bevorderen. 
Pyroptotische celdood en lyse worden in toenemende mate geassocieerd met 
vrijstelling van IL1β en IL18, verder is echter ook aangetoond dat de celresten van 
pyroptotische cellen intracellulaire pathogenen bevat, wat klaring door infiltrerende 
neutrofielen vergemakkelijkt. Inderdaad, er is aangetoond dat pyroptose de klaring 
van een verscheidenheid aan intracellulaire pathogenen medieert, echter massale 
celdood en cytokine-vrijstelling spelen ook een belangrijke nefaste rol bij auto-
inflammatoire aandoeningen. Hoewel er de afgelopen jaren meer en meer studies 
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zijn gedaan naar de processen die aan de basis liggen van cel lyse tijdens pyroptose, 
zijn de biochemische mechanismen die plaatsvinden tijdens de uitvoering van 
celdood nog steeds niet gedefinieerd, alsook over de betrokkenheid van specifieke 
organellen is er nog veel onduidelijkheid. Daarom was het huidige proefschrift 
gericht op het beschrijven van de gebeurtenissen die plaatsvinden in specifieke 
organellen tijdens pyroptose en het definiëren van de biochemische kenmerken van 
deze pro-inflammatoire vorm van celdood.  
Door gebruik te maken van een single-cell benadering, en via live-imaging analyse 
van pyroptose geïnduceerd door de NLRC4, NLRP1b en niet-canonieke 
inflammasomen, hebben we een aantal organellaire veranderingen gedefinieerd die 
voorafgaan aan plasmamembraan permeabilisatie. Fluxen van ionen, cellulaire 
zwelling, mitochondriale en lysosomale schade werden teruggevonden na activatie 
van de verschillende inflammasomen, wat aantoont dat dit gebeurtenissen zijn die 
gelinkt zijn aan pyroptose in het algemeen. Bovendien suggereerden deze 
waarnemingen dat een geleidelijke toename in membraanpermeabilisatie het 
mechanisme is achter GSDMD-geïnduceerde pyroptose. Onze biochemische analyse 
van stervende macrofagen na activatie van het NLRC4 of NLRP1b inflammasoom 
onthulde een caspase-3/-7-handtekening, met DEVDase-activiteit en verknipping van 
ROCKI, Bid en p23. Deze bevindingen suggereren dat pyroptose een caspase-3/-7 
programma omvat, iets dat normaal gezien geassocieerd wordt met apoptose. In 
overeenstemming met onze biochemischie bevindingen konden we een apoptotisch 
fenotype waarnemen na het verwijderen van het GSDMD-eiwit of de inactivatie van 
de functie ervan. Dit fenotype was onafhankelijk van de ASC-speck, een fenomeen 
dat eerder beschreven werd om caspase-8-activering en apoptose te mediëren in de 
afwezigheid van caspase-1. Tot slot, in het laatste deel van het proefschrift, screenden 
we een aantal inhibitoren op hun vermogen om celdood en inflammasoom-
activering te bevorderen. We hebben aangetoond dat remming van PRCP door 
Compound 8o leidt tot snelle celdood. Dit ging gepaard met IL1β-vrijstelling via het 
NLRP3-inflammasoom. Aan de andere kant leidde DPP8/DPP9-remming door Val-
boroPro en 1G244 tot pyroptose en IL1β-vrijstelling in muizenmacrofagen die het 
129-geassocieerde allel van Nlrp1b bevatten. Macrofagen zonder dit allel reageerden 
nog steeds op 1G244 en Val-boroPro, zij het in beperktere mate.  
De huidige thesis definieerde dus specifieke morfologische veranderingen in 
organellen geassocieerd met pyroptose en identificeerde een geleidelijke toename in 
membraanpermeabiliteit als het mechanisme van cel lyse. Verder hebben we ook een 
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caspase-3/-7-handtekening geïdentificeerd in pyroptotische cellen, iets dat 
plaatsvindt na activering van caspase-1. Verder definieerden we twee groepen 
inhibitoren van dipeptidasen die in staat zijn om inflammasoom-activering en IL1β-
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 1. Introduction 
Studies into regulated forms of cell death started with observations of apoptosis 
during development. Apoptotic cell death was defined as a highly regulated cellular 
process through which cells pack their contents into apoptotic bodies for efficient 
clearance, avoiding spillage of intracellular contents. This concept lead to the 
hypothesis that lysis of a cell was always an uncontrolled mechanism, related to an 
accidental cell death. However, more recent understanding of the tumor necrosis 
factor (TNF) receptor signaling pathway, and its ability to induce cell death in the 
absence of caspase activity, lead to the first description of a lytic regulated form of 
cell death, necroptosis. This allowed the cell death field to recognize that regulated 
cell death can also be lytic and potentially promote immune activation. The field of 
regulated necrosis grew and widened the scope of cell death to pathways such as 
parthanatos, cyclophilin D (CYPD)-regulated cell death, ferroptosis, NETosis and 
pyroptosis. Cell death plays a significant role during pathogen invasion by a variety 
of mechanisms. Dying of a cell allows the end of a pathogenic replication niche, 
while dead cell corpses or their derived molecules can trap pathogens to avoid 
spread. Furthermore, cell death accounts for the release of signaling molecules. 
However, cell death can be hijacked by the pathogen in order to aid its 
replication/life cycle, and extensive cell death accounts for tissue damage and 
underlies the pathology of some infectious and autoinflammatory diseases. 
Therefore, a better understanding of the cell death pathways is vital in the generation 
of new targets for infectious and autoinflammatory disorders. In this line, pyroptosis 
is unique as it shares features with both apoptosis and necroptosis. Furthermore, its 
close association to pathogen clearance and cytokine release has boosted the interest 
of this form of regulated cell death and its potential regulation. The current thesis 
focuses in the cell death mechanisms occurring downstream of pathogen and danger 
sensing in macrophages by inflammasomes. This introduction will focus on a 
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description of the best described forms of regulated cell death, namely apoptosis, 
necroptosis and netosis, ending with a focus in inflammasome-mediated cell death. 
1.1. Apoptosis 
Apoptosis is the prototype pathway of regulated cell death. Its name was first coined 
in 1972, in order to describe a cell dismantling process happening during 
development, with shrinkage of the cell body and nuclear condensation1. 
Apoptosis plays a role in development and homeostasis of multicellular organisms. 
Evidence that impairment of the apoptotic signaling alters immune homeostasis is 
seen in patients with autoimmune lymphoproliferative syndrome (ALPS)2. A 
germline mutation in the first apoptosis signal (Fas) gene, an apoptosis-inducing 
receptor, is the cause of 70% of the cases of ALPS, with the most common disease 
presentations being lymphadenopathy, splenomegaly, and potentially autoimmune 
complications in non immune organs. This autoimmune phenotype is recapitulated 
in mice carrying loss of function mutations at Fas or at Bcl2-interacting mediator of cell 
death (BIM) loci3,4, which encode pro-apoptotic proteins, and the clinical symptoms 
are associated to a low ability of apoptosis induction in immune cells5. 
Apoptotic control of the lymphocyte population and maintenance of their 
homeostasis is done by both induction of apoptosis of auto-reactive T lymphocytes 
and killing of T and B cells to return to the basal level after clonal expansion5. 
Apoptosis also acts as an effector response of the immune system, performed by 
cytotoxic T cells and natural killer cells. These rely on the death receptor Fas, 
together with the perforin system, to clear virus-infected target cells6,7. In addition, 
most cells of the immune system can be triggered to express the cytokine TNF-
related apoptosis-inducing ligand (TRAIL), an apoptosis inducer, as a soluble or 
membrane-bound protein8,9, in order to aid in clearance of tumor cells. Therefore, 
many of the immune effector functions can be understood by elucidating apoptotic 
signaling pathways and their regulation. 
1.1.1. Caspases 
Early studies on the apoptotic cell death pathway have distinguished a family of 
cysteine proteases, the caspases, as the responsible effectors for its signaling and 
execution10. Homologous caspase genes can be found throughout metazoans, where 
they regulate cell death and inflammation11. All caspases mediate cleavage of 
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substrates at an Aspartate and utilize the four amino acids – numbered as P4-P2 – 
upstream of the cleavage site for substrate recognition12. Caspases are produced in 
the cell as zymogens and are molecularly organized as prodomains plus a p20 and 
p10 subunits, which guard the catalytic activity. 
Caspases have been historically subdivided according to their cellular function as 
either apoptotic or inflammatory caspases13. In this context, human caspase-1, -4, -5 
and -12 are categorized as inflammatory caspases. Growing evidence supports that 
both human caspases -4 and -5 perform similar functions as murine caspase-11 and 
can be considered its homologue14-18. Human caspase-8, -9, -10, -3, -6 and -7 have 
been firstly implicated in the induction and execution of apoptosis, hence are 
referred to as apoptotic caspases13. However, recent implication of caspase-8 in the 
inhibition of necroptosis and, most importantly, in regulation of nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-kB) and inflammatory signaling 
contests its “apoptotic” classification19. Therefore, while this classification of caspases 
describes their most common – or canonical – functions, it poses challenges with the 
new understandings of caspases signaling cascades and its relationship to 
inflammation. 
In this sense, an alternative method for subdivision of caspases regards the nature of 
their prodomain20. As the length of the caspase prodomain determines its mode of 
activation, this classification also reveals the upstream and downstream players in a 
signaling cascade, and therefore is closely related to a functional role. Initiator 
caspases comprise the human caspase-1, -2, -4, -5, -8, -9, -10, -12 and -14 and murine 
caspase-11, which have long prodomains containing an oligomerization domain. 
These oligomerization domains belong to the superfamily of death domains (DD), 
and share a six-helical bundle in their structure21. DDs are present in many proteins 
to mediate protein-protein interaction, mostly in a homotypic manner. Caspase-1, -2 -
9 and -12 have a caspase activation and recruitment domain (CARD) domain (Figure 
1). Caspase-1, -2 and -9 interact with a CARD in apoptosis-associated speck-like 
protein containing CARD (ASC)22, RIP associated ICH-1/CED-3 homologous protein 
with a death domain (RAIDD)23 or apoptotic protease activating factor 1 (Apaf-1)24, 
while an interactor for caspase-12 remains elusive. Interestingly, human caspases -4, -
5 and murine caspase-11 also have a CARD domain, but in this scenario the death 
domain is used for intracellular lipopolysaccharide (LPS) sensing and self 
oligomerization25. Caspase-8 and -10 have two death effector domain (DED) domains 
in tandem, which mediates interaction with the DED on Fas-associated protein with 
death domain (FADD)26-28. It is known that oligomerization of initiator caspases in a 
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higher macromolecule complex, their dimerization, conformational changes and 
autoprocessing are all steps that play a role for full activation of the protease29-31. 
However, the exact molecular requirements for each of these steps in the activation 
process are still debated. As a general mechanism, caspase autoproteolysis lead by 
dimerization releases the active p20 and p10 domains which organize themselves 
into an heterotetramer and locks the caspase in an activated state20. However, for 
caspase-9, as an example, the catalytic activity of the p20/p10 heterotetramer is 
several folds higher when associated to the complex with Apaf-1 than when soluble, 
suggesting the active enzyme remains trapped in the complex32. Furthermore, 
mutations on caspase-1 hampering its autocleavage demonstrated that full length 
caspase-1 is able to mediate cell death, but not to efficiently process interleukin(IL)-
1β, its canonical substrate33. Similarly, caspase-8 bears pro-survival activity while in 
its unprocessed form34-36. For both caspase-1 and caspase-8, their full-length activity 
seems to be restricted to local or high affinity substrates. Both maintenance of highly 
active caspases in a complex, as for caspase-9, or of the full-length protein with 
partial activity, as for caspase-8 and -1, suggests that caspases can have their activity 
regulated in some instances through local substrate availability. 
 
Figure 1. Caspases present in human (H) and mouse (M) systems. Initiator caspases have interacting 
domains from the DD family, represented by either CARD or DED, used for either sensing and self-
oligomerization (hcaspase-4, -5 and mcaspase-11) or for recruitment to macromolecular complexes (caspase-1, 
-2, -9, -8, -10). An interactor for caspase-12, here shown on its long form (L), is still unknown. Executioner 
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The other group of caspases, the executioners caspase-3, -6 and -7, have a short 
prodomain and rely on cleavage for activation13 (Figure 1). Maturation of executioner 
caspases is done by either an initiator caspase or other protease during a signaling 
pathway. 
Initiation of apoptosis is mostly understood via either an intrinsic pathway, initiated 
at the mitochondria, or an extrinsic pathway, initiated through death receptors at the 
plasma membrane. These two signaling mechanisms are further outlined below. 
1.1.2. Extrinsic pathway 
The extrinsic pathway links extracellular signaling to initiation of apoptosis through 
engagement of members of the TNF receptor (TNFR) superfamily located at the 
plasma membrane37. Within these, the death receptors (DR) share an extracellular 
domain rich in cysteines and a cytoplasmic tail containing a DD, essential for 
recruitment of apoptotic factors and downstream signaling. DR signaling culminates 
in the formation of a macromolecular complex, the death inducing signalling 
complex (DISC), through engagement of FADD and caspase-821. FADD recruitment 
to the DR – or its complex – is mediated by its DD domain38. This homotypic 
interaction causes conformational changes in FADD, exposing its DED domain for 
recruitment of procaspase-8. Tandem interactions of procaspase-8 DED domains 
precipitate the formation of a filament structure, where catalytic domains dimerize 
and allow proximity-induced autoactivation38,39. The active caspase-8 is released from 
the DISC as a p18/p10 heterotetramer and cleaves procaspase-3, -7 and -6, activating 
these procaspases37. Presence or absence of cellular FLICE-like inhibitory protein 
(cFLIP) at the DISC further regulates caspase-8 activity, dictating if a cell undergoes 
apoptosis or survives after death receptor engagement38,39. 
The DR Fas and TRAIL receptor (TRAILR)1/2 are normally expressed at the plasma 
membrane as trimers40. Association of these receptors with their cognate ligands, Fas 
ligand (FasL) and TRAIL respectively, induces conformational changes in their 
cytoplasmic tail which allows direct recruitment of FADD for DISC formation and 
downstream apoptotic signaling37.  
Activation of caspase-8 through the DR TNFR1, though, involves more steps for 
DISC formation40. Ligation of TNF-α to TNFR1 primarily leads to the formation of a 
membrane-bound complex, complex I, with the recruitment of TNFR1-associated 
death domain protein (TRADD), receptor-interacting serine/threonine-protein kinase 
(RIPK)1, TNF receptor-associated factor (TRAF) 2, cellular inhibitor of apoptosis 
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(cIAP) 1/2 and linear ubiquitin chain assembly complex (LUBAC) complex41-43. Once 
in complex I, cIAP1/2 and LUBAC attach ubiquitin-chains to (mostly) RIPK1, which 
serve as scaffold for recruitment of transforming growth factor beta-activated kinase 
1 (TAK1)/ TAK1-binding protein (TAB) 2/TAB3 and inhibitor of nuclear factor 
kappa-B kinase (IKK)a/b/NF-κB essential modulator (NEMO)43. Therefore, signaling 
through TNFR1 normally leads to mitogen-activated protein kinase (MAPK) and NF-
kB-dependent survival signaling and cytokine production19 (Figure 2). Nonetheless, 
several scenarios can deviate from the initial pro-survival effect of TNFR1 
stimulation. First, continued signaling on TNFR1 eventually leads to the release of 
RIPK1 from complex I, which act as a seed to assemble a cytosolic platform, complex 
IIa or ripoptosome, containing RIPK1, FADD and caspase-842. In presence of a 
functional NF-κB response, complex IIa also contains cFLIP, which forms an 
heterotetramer with caspase-8 to promote cell survival19. However, under low levels 
of cFLIP, procaspase-8 homooligomerization at complex IIa drives its activation and 
initiation of apoptosis. The apoptotic response triggered by complex IIa can also be 
regulated by RIPK1 ubiquitination status44. Deubiquitination of RIPK1 by either 
ubiquitin carboxyl-terminal hydrolase CYLD (CYLD) or TNF alpha-induced protein 
3 (A20) promotes RIPK1 dissociation from complex I, favoring complex IIa 
assembly45,46 (Figure 2). Both CYLD and A20 are also transcriptionally regulated by 
NF-κB, and therefore represent a negative feedback control to hamper TNR1-
mediated transcription. RIPK1 – and the cell death downstream – can also be 
regulated by phosphorylation. MAP kinase-activated protein kinase 2 (MK2) 
activation after TNFR1 signaling leads to phosphorylation of the cytosolic pool of 
RIPK1 and its incorporation into TNFR1 signaling limits cell death induction47,48. 
Further, IKKa/b can also phosphorylate RIPK1, preventing its signaling to cell 
death49. 
The extrinsic apoptotic pathway is tightly controlled by an efficient NF-κB response 
through the means of cFLIP transcription. cFLIP is a homologue of caspase-8, but it is 
either expressed as a short form (cFLIPs) bearing only the tandem DED domains, or 
as a long form (cFLIPL) with a high homologue sequence to procaspase-8, but 
harboring mutations which hampers its catalytic activity19. Both isoforms of cFLIP 
are recruited to the death receptor signaling complex through interaction with 
procaspase-8 by means of DED/DED assemblies38,39. cFLIPs is a well-defined inhibitor 
of procaspase-8 activation and has been proposed to avoid procaspase-8 
homodimerization and autoactivation by preventing procaspase-8 homodimerization 
at the filament by direct or indirect means39. Furthermore, overexpression studies 
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have demonstrated that at high concentrations, cFLIPS can act as a cap at the 
filament, preventing its further elongation38. At high concentrations as in 
overexpression studies, cFLIPL can also have an inhibitory function of caspase-8 
activity by competing with it for the filament38. However, the physiological role of 
cFLIPL seems to be of an activator of procaspase-834. Heteroligomerization of cFLIPL 
and procaspase-8 at the DISC induces conformational changes in caspase-8 which 
allows its activation without cleavage36. This local active caspase-8 cleaves RIPK1 and 
RIPK3, also at the complex, preventing these kinases to continue cell death signaling 
to necroptosis35,50. Active caspase-8 also generates a p43 cFLIPL form, which regulates 
NF-κB and ERK signaling pathways downstream51. Therefore, low and local caspase-
8 activity is associated to survival. Additionally, once cFLIPL p43 fragment leaves the 
complex, caspase-8 loses its activity38, further ensuring a survival commitment of the 
cell.  
Finally, absence or low levels of both cFLIPS and cFLIPL allow homodimerization of 
procaspase-8 at the DISC filament, self-activation and gain of full activity38,39. The 
p18/p10 heterotetramer leaves the DISC complex to cleave its cytoplasmic substrates, 
procaspase-3, -7 and -8. As the survival role for caspase-8 activity is a growing 
understanding, it would be interesting to understand whether these signaling 
pathways are a constant mechanism happening inside the cell or whether they are 
signaling-induced. 
1.1.3. Intrinsic pathway 
The intrinsic apoptotic pathway unifies a plethora of intracellular stresses into a 
signaling cascade initiated at the mitochondria. The convergence of signals such as 
DNA damage, cytoskeleton perturbations, endoplasmic reticulum (ER) stress, mitotic 
stress and withdrawal of growth hormone to the mitochondria is performed by a 
group of proteins from the B-cell lymphoma-2 (Bcl-2) family52. 
Bcl-2 proteins have between one and four Bcl-2-homology (BH) domains, and control 
apoptosis initiation by promoting or avoiding the release of proapoptotic factors 
from the intermembrane mitochondrial space (IMM)53. The Bcl-2 family can be 
further subdivided into three subfamilies, according to their function in the apoptotic 
cascade. The pro-apoptotic Bcl-2 proteins, Bcl-2 homologous antagonist killer (Bak), 
Bcl-2-associated X protein (Bax) and Bcl-2 related ovarian killer (Bok) have four BH 
domains and a transmembrane domain used for integration to organellar 
membranes20. These three proteins are able to directly cause mitochondrial outer 
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membrane permeabilization (MOMP) by permeabilizing the outer mitochondrial 
membrane (OMM) to allow passage of proteins of even 100 kDa53. The other two Bcl-
2 subfamilies comprise proteins that regulate the function of Bax, Bak and Bok. In 
one hand, anti-apoptotic proteins Bcl-extra large (Bcl-XL), induced myeloid leukemia 
cell differentiation protein Mcl-1 (MCL-1), Bcl-2, Bcl-2-like protein 2 (Bcl-w) and Bcl-
2-related protein A1 (A1) hinder Bax/Bak – and potentially Bok – pore formation at 
the OMM53. On the other hand, Bax/Bak can be activated by BH3-only proteins, the 
third subfamily, represented by BH3-interacting domain death agonist (Bid), Noxa, 
p53 up-regulated modulator of apoptosis (Puma), Bcl2-associated agonist of cell 
death (Bad), Bcl-2-interacting killer (Bik), activator of apoptosis harakiri (Hrk), Bim 
and Bcl-2-modifying factor (Bmf)52. 
BH3-only proteins represent the most apical Bcl-2 proteins in a signaling pathway 
and therefore lie at the crossroads between cellular stress and apoptotic signaling. As 
such, PUMA and Noxa have their protein levels regulated by p53, thereby linking 
DNA damage to intrinsic apoptosis54. On the other hand, augmented levels of BIM 
lead to apoptotic initiation after cytokine deprivation or cross-linking of B and T cell 
receptors52. Further, Bid interconnects the extrinsic and intrinsic apoptotic pathways, 
once it is cleaved by caspase-8, generating its truncated and active version, tBid55,56. 
These BH3-only proteins can directly engage the pro-apoptotic Bcl-2 proteins, Bax 
and Bak, to promote conformational changes essential for their activation. However, 
they also sequester different sets of Bcl-2 anti-apoptotic proteins to sensitize cells to 
the apoptotic stimuli52. Direct interaction between Bcl-2 family members leads to a 
complex signaling network that dictates cell fate after stress, by finally controlling 
MOMP occurrence. 
Each of the pro-apoptotic Bcl-2 family members, the final controllers of MOMP, is 
subject to regulation through a specific mechanism, representing their distinct roles 
in apoptosis initiation. Though a low level of Bak shuttles between the OMM and 
cytosol, the high hydrophobicity of its tail anchor favors this dynamics towards the 
OMM57, where interaction with the anti-apoptotic Bcl-2 members Bcl-XL and MCL-1 
keeps Bak in an inactive state58. A transient interaction of Bak with an activating 
BH3-only protein – and the conformational changes induced thereof –, allows Bak 
homodimerization through mutual insertion of BH3-domains in the partner’s 
groove59. Further oligomerization of these BH3:groove dimers causes reorganization 
of the OMM and eventually leads to the formation of a proteolipidic pore, 
responsible for the MOMP60. 
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Bax undergoes a similar activation procedure, with priming by a BH3-only protein 
causing conformational changes leading to the BH3:groove dimer and pore 
assembly60,61. However, Bax counts on the control of its intracellular localization as an 
extra step for activation. Bax is shuttled from the OMM to the cytosol very efficiently 
by Bcl-XL; thus, it is mainly found in the cytosol62,63. Stress signals cause BH3-only 
proteins to sequester anti-apoptotic Bcl-2 members, which stops Bax 
retrotranslocation and allows its accumulation at the OMM62. Though this is not 
enough for activation, accumulation of Bax at the OMM is the first step in apoptotic 
sensitization. 
A similar role for accumulation at the OMM has also been suggested to control the 
activity of Bok. However, in this case, mere accumulation of Bok protein level could 
suffice for oligomerization and MOMP, which would be insensitive to regulation by 
anti-apoptotic Bcl-2 family members64. While overt ER-stress was proposed as one of 
the pathways for building up Bok protein level64, ovarian carcinoma cells have been 
also shown to be prone to Bok-mediated apoptosis through other intrinsic triggers65. 
Remarkably, though dimers of Bax and Bak can associate for final pore formation, 
Bok, Bak and Bax can induce MOMP by themselves, and single knockout of these 
proteins is insufficient to protect cells to intrinsic apoptotic stimuli52. However, 
developmental intrinsic apoptosis has been shown to strongly rely on Bax/Bak, as 
double knockout mice die prematurely, with accumulation of cells in diverse organs 
and failure to remove interdigital membranes66. So far, a developmental role of Bok 
has only been shown in clearance of follicles when in a Bax deficient background67, 
though further understanding the role of this Bcl-2 member in apoptosis initiation 
might highlight other developmental functions. 
Finally, MOMP allows the release of several apoptogenic factors in the cytosol, such 
as cytochrome c, second mitochondria-derived activator of caspase (SMAC)/ direct 
IAP-binding protein with low pI (DIABLO) and high temperature requirement 
protein A2 (Htr2)68. Cytochrome c normally resides in the IMM, where it participates 
in the cascade of adenosine triphosphate (ATP) production21. Once released in the 
cytosol, cytochrome c interacts with Apaf-1, allowing its oligomerization dependent 
on (d)ATP69. This macromolecular structure formed by cytochrome c and Apaf-1 is 
called the Apoptosome21. Through CARD-CARD interactions between Apaf-1 and 
pro-caspase-9, this caspase is recruited to the Apoptosome, where it undergoes 
dimerization and activation. Active caspase-9, then, cleaves caspase-3/-7/-6 to execute 
apoptosis. SMAC/DIABLO70,71 and Hrt272, also released during MOMP, act 
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downstream on the signaling pathway, inhibiting IAPs to allow efficient caspase 
activation and apoptosis execution, as commented further below. 
1.1.4. Execution phase of apoptosis and clearance 
Extrinsic and intrinsic apoptotic signaling pathways converge at the level of 
activation of the executioners’ caspases, by proteolytic cleavage of procaspase-3, -7 
and -6 by caspase-8 and caspase-973. Interestingly, despite efficient cleavage of 
procasase-3 and -7 by caspase-8, signaling through the extrinsic apoptotic pathway is 
not sufficient to promote apoptosis in certain cell types. In the so-called type II cells, 
distinctively represented by hepatocytes, intrinsic and extrinsic pathways act in a 
concerted way to determine apoptotic cell death74. The connection between the two 
pathways happens at the level of caspase-8, which cleaves the Bcl-2 protein BID, 
leading to its active truncated version, tBID55,56. At the mitochondria, tBID sequesters 
Bcl2 and allows Bax/Bak pore formation56. Mitochondrial release of SMAC/DIABLO 
and its inhibition of X-linked IAP (XIAP) are essential for caspase-3 and -7 to acquire 
full activity and induce cell death75. XIAP is a cytosolic protein, part of the IAP family 
containing three tandem baculovirus IAP repeat (BIR) domains. XIAP interacts with 
active caspase-3 and -7, inhibiting their catalytic pocket and downstream apoptosis76. 
Therefore, type II cells are defined by their high levels of XIAP75. Interestingly, 
though cytochrome c, Apaf-1 and caspase-9 aid in the downstream signaling for 
apoptosis, the mitochondrial signaling to apoptosis after DR engagement in type II 
cells does not rely on them. In fact, knockout of XIAP in hepatocytes is sufficient to 
reestablish their ability to undergo DR-induced cell death without mitochondrial 
signaling75. In marked contrast to type II cells, type I cells, such as lymphocytes, are 
efficient in undergoing DR-dependent cell death in the absence of mitochondrial 
signaling, given their low level of XIAP. Regulation of apoptosis by type I and type II 
cells interestingly exemplifies how basal cellular protein regulation determines cell 
fate. 
Finally, cleavage of substrates by caspase-3, -7 and -6 determines the apoptotic 
phenotypic characteristics of cell demise20. More than 1000 substrates for executioner 
caspases have been described to this date, demonstrating the complexity of the 
apoptotic program. Morphologically, shrinkage and cell rounding are some of the 
bona fide features of apoptosis implemented by executioner caspases20. Cleavage of 
gelsolin by caspase-3 produces an active n-terminal fragment, able to promote 
polymerized actin to dissociate independently of Ca2+77. The consequent disruption of 
Introduction 11 
 
the actin structure causes apoptotic cell rounding. Caspase-3 and -7 also cleave and 
activate Rho-associated protein kinase 1 (ROCKI) by removal of its auto-inhibitory c-
terminal domain78-80. Active ROCKI phosphorylates myosin light chain (MLC), 
increasing contraction of the actomyosin system and causing membrane blebbing, 
another apoptotic defining feature. 
Apoptosis is classically defined as a silent form of cell death, since the plasma 
membrane structure is not compromised during its execution73. Cell rounding, 
blebbing of the plasma membrane and packaging of the intracellular contents into 
apoptotic bodies help in a fast clearance by neighboring cells. Furthermore, an 
important characteristic of apoptotic cells is the early exposure of phosphatidylserine 
(PS) in the external face of the plasma membrane bilayer81. In healthy cells, 
transmembrane proteins called flippases actively keep PS in the inner leaflet of the 
plasma membrane. However, caspase-3 cleaves and inactivates flippases, while also 
constitutively activating scramblases, to promote fast and irreversible loss of lipid 
asymmetry and exposure of PS in early apoptotic cells82. PS is an efficient signal for 
phagocytosis and, in combination with the rounded and packaged cell body, 
promotes rapid uptake and clearance of apoptotic cells81, further supporting its 
immunologically silent role. 
Nuclear structure and DNA integrity are also compromised in apoptosis by activity 
of executioner caspases20. Active caspase-3 and -6 cleave laminins, disrupting the 
nuclear envelope83, and lead to DNA fragmentation through cleavage of the inhibitor 
of caspase-activated DNAse (ICAD)84. Proteasomal degradation of ICAD releases its 
partner, the caspase-activated DNAse (CAD), which translocates to the nucleus 
where it cleaves the DNA in internucleossomal regions84. 
The enzyme poly(ADP)ribose polymerase 1 (PARP1) plays important roles in DNA 
damage repair and its regulation is essential for the progress of programmed cell 
death85. PARP1 is recruited to DNA damage where it catalyses the polymerization of 
ADP-ribose and bridges the recruitment of DNA-repair factors. However, poly(ADP) 
ribose synthesis happens at great expense of the intracellular stores of NAD+ and 
ATP. In apoptosis, PARP1 is readily cleaved by caspases -3 and -7, rendering it 
inactive, in order to maintain intracellular levels of ATP to execute the apoptotic 
program83. 
Caspase-3 seems to be the most efficient executioner caspase in cleavage of apoptotic 
substrates on the studied mechanisms so far83. This is further confirmed on the 
severity of phenotype observed in mice lacking caspase-3, which suffer either from 
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perinatal lethality or mild phenotypic impairments, depending on their genetic 
background86. Contrastingly, Caspase-7-/- and Caspase-6-/- knockout mice develop 
normally87,88. Further, while the presentation of the apoptotic pathway follows a 
linear signaling pathway, the physiological pathway might be more complex, with 
feedback loops and compensatory mechanisms playing a role in the activation of 
caspases88,89.  
Interestingly, in a screening for inhibitors of caspases based on tetrapeptidic 
sequences, DEVD has been shown to be a major consensus sequence for both 
caspase-3 and -790, suggesting that these caspases would have overlapping roles. 
Indeed, absence of both caspases in mice leads to early embryonic lethality87. 
However, while in most systems caspase-3 and caspase-7 seem to indeed overlap, 
analysis of their substrates suggests that caspase-7 might need the recognition of 
longer peptide stretches despite the P1-P4 consensus sequence in physiological 
substrates91,92. Furthermore, attempts to understand the differential roles of 
executioner caspases have demonstrated that there might be indeed preferentiality in 
substrate according to the executioner caspase. For example, the cochaperone p23 has 
been shown to be a preferential substrate of caspase-7, while gelsolin seem to be 
specifically cleaved by caspase-379. This suggests that the embryonic lethality seen in 
Caspase-3-/-Caspase-7-/- double knockout mouse could also be related to 
complementary functions of these caspases in development, possibly affecting 
different cell types. 
In the human body, as millions of cells die each day without triggering a constant 
immune response93, it confirms that immune suppression is indeed the default 
mechanism to apoptotic clearance. The activity of caspases seems to be an essential 
step for eliciting a local immune suppression. First, executioner caspases control PS 
exposure, which is a potent signal for efferocytosis. Highlighting that PS exposure is 
a sufficient signal for uptake, liposomes with PS exposed are readily taken up by 
neighboring cells93. Secondly, caspases may act in a cell intrinsic manner to prevent 
immune triggering initiated during apoptosis. For example, later stages of Bax/Bak 
mitochondrial channels allow herniation of inner mitochondrial membrane and 
release of mitochondrial DNA for intracellular sensing by the cyclic GMP-AMP 
synthase (cGAS) - stimulator of interferon genes protein (STING) pathway94. This 
response only happens in a caspase-independent setting and promotes 
interferon(IFN)β secretion and an anti-viral signature on the triggered cell95,96. While 
it is still unclear how exactly caspases prevent cGAS-signaling and IFNβ release, it is 
tempting to speculate either that their direct cleavage of a mediator is responsible for 
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dampening inflammation or that their fast activity terminates storages of 
intracellular signaling platforms. Further, immune silencing during apoptosis is also 
a cell-extrinsic event. In homeostatic conditions, uptake of apoptotic cells elicits the 
release of the immunosuppressant cytokines IL10 and transforming growth 
factor(TGF)β from the phagocyte97.  
Though immunosuppression is the norm after apoptotic uptake, apoptotic cells can 
also mediate inflammatory response in conditions of infections. Concomitant 
stimulation of dendritic cells (DC) with Toll-like receptor (TLR) ligands and 
apoptotic corpses causes additional secretion of IL6 and IL23 by the DC98. The 
combination of IL6, IL23 and TGFβ promotes differentiation and expansion of the 
highly inflammatory Th17 CD4 T helper cells. As a result, conditioned media from 
DCs that had been co-stimulated with TLR agonists and apoptotic cells promoted the 
polarization of naïve CD4 T cells to Th17 profile, while conditioned media of DCs 
that were fed only apoptotic cells promoted a Treg phenotype98. Thus, addressing the 
role of cell death in the context of pathogen invasion seems imperative to fully 
understand the immune response elicited. 
1.2. Regulated necrosis 
Initial descriptions of necrotic cell death focused on the fact that this cell demise 
terminates on release of intracellular content, as in marked contrast to apoptotic cell 
death. For 30 years it was largely assumed that apoptotic cell death was the only 
form of regulated cell death, while necrosis largely represented an accidental death99. 
Studies on the roles of TNF-α have, however, majorly contributed to debunk this 
concept. Discovered in the 1980s, TNF-α took its name from the necrotic activity it 
could cause in tumour cells100. Interestingly, in 2008, Degterev and colleagues 
described a drug, Necrostatin-1 (Nec-1), which could inhibit TNF-α toxicity, therefore 
defining that a necrotic death could be regulated101. Soon after, the kinase activity of 
RIPK1 was described to be the target of Nec-1 inhibition102, initiating the studies into 
necroptotic cell death mechanisms and further establishing this as a regulated form 
of cell death. 
1.2.1. Necroptosis 
Necroptosis can be defined as a necrotic cell death which relies on mixed lineage 
kinase domain-like protein (MLKL)103. TNFR1, Fas, TRAILR, TLRs, IFNγR and Z-
DNA-binding protein 1 (ZBP1)/DAI were demonstrated to lead to necroptotic 
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signaling downstream when engaged in absence of caspase activity99. Though these 
lead to similar initiation and regulation of necroptosis, TNFR1 activation is the 
prototypical necroptotic signaling pathway, and thus the example used herein. 
As described earlier, a cell can execute multiple downstream decisions upon 
engagement of the TNFR1 by TNFα. First, NF-κB and MAP kinase kinase (MKK)-
dependent survival responses are initiated on the establishment of the membrane-
bound complex I and RIPK1 ubiquitination42,43. Disengagement of RIPK1 from the 
membrane-bound complex forms the cytosolic structure called complex II (Figure 2). 
In presence of NF-κB signaling levels sufficient to upregulate cFLIPL, this protein is 
incorporated to complex IIa, and the cFLIPL/caspase-8 heterotetramer cleaves RIPK1 
and RIPK3 also at the complex, maintaining the survival signal19. Absence of NF-κB 
signaling and cFLIPL upregulation leads to accumulation of caspase-8 at complex IIa 
and induction of apoptosis. On the opposite side of the spectrum, in absence of 
caspase-8 on protein level or its catalytic inhibition, RIPK1 and RIPK3 are no longer 
inhibited, and their association through their RIP homotypic interaction motif 
(RHIM) domains in complex IIb, or necrosome, promotes their phosphorylation104. 
MLKL is recruited to complex IIb and phosphorylated by RIPK3105, which induces 
conformational changes that exposes its 4-helical bundle domain, with high affinity 
for membranes106,107. Oligomerization of MLKL and its association with 
phosphatidylinositol’s at the plasma membrane are essential steps for necroptosis106-
108. 
 
Figure 2. Multiple signaling pathways are possible downstream of TNFR1. Engagement of TNFR1 leads 
































allows the recruitment of NEMO/IKKα/β and TAK1/TAB2/TAB3 for a survival signal and cytokine 
production. Release of RIPK1 from complex I can be modulated by deubiquitination by CYLD and A20, and 
promotes the formation of a cytosolic complex II. Presence of cFLIPL at complex IIa determined whether the 
outcome of its signaling is to maintain survival or induce caspase-8-dependent apoptosis. Absence of caspase-
8 or its inhibition allows the formation of complex IIb, where RIPK3 recruits MLKL and phosphorylates it. 
Phosphorylated MLKL translocates to the plasma membrane and mediates necroptosis. 
Whereas the indispensable role of MLKL in necroptosis execution in well defined, 
the molecular mechanisms responsible for cell lysis are still not fully elucidated. The 
role of diverse ion influxes have been contested on necroptotic cell death107,109-111 and 
in some cells MLKL seem to rely on plasma membrane-associated channels to 
terminally execute lysis108. Conversely, cell rounding has been widely described as a 
morphological feature of necroptosis in diverse cell lines, happening downstream of 
MLKL111,112. Furthermore, mitochondrial hyperpolarization and reactive oxygen 
species (ROS) production have been shown to anticipate plasma membrane lysis 
during necroptosis of mouse fibroblast cells, L929112. Interestingly, despite 
canonically being associated to apoptosis, loss of membrane asymmetry and PS 
translocation to the outer leaflet is an event downstream of MLKL activation; 
nonetheless it precedes membrane permeabilization113,114. Furthermore, cells 
undergoing necroptosis shed damaged pieces of membrane as vesicles containing PS 
at the extracellular side113,114, thereby delaying fatal plasma membrane commitment 
and promoting uptake by neighbouring cells. This self-repair mechanism relies on 
the activation of MLKL and its association to proteins of the endosomal sorting 
complexes required for transport (ESCRT) machinery113,115. Since this phenomenon 
has been implicated in allowing an efficient NF-κB response113, it would be 
interesting to evaluate the possible consequences of lack of the ESCRT components in 
in vivo disease models.  
Fas and TRAILR lead to similar initiation and regulation of necroptosis as in the 
context of TNFR199. However, IFNγR seems to rely on signal transducer and 
activator of transcription 1 (STAT1) for necroptosis induction99 and TLR3 and TLR4 
recruit RIPK3 based on TIR-domain-containing adapter-inducing interferon-β (TRIF) 
signaling downstream116. 
1.2.1.1. Necroptosis in development and immunity 
A developmental role for necroptosis was further pursued in studies with knockout 
mice for its main players. Of note, the ability to undergo necroptosis is not essential 
for development, as RIPK3-/- and MLKL-/- single knockouts develop normally and 
show no spontaneous phenotype117,118. However, absence of RIPK3 rescues the 
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lethality observed in Caspase-8-/- and allows fully development to adulthood119,120. 
Caspase-8-/- mice have long been recognized to succumb around embryonic stage 
E10.5 given their inability to vascularize the yolk salc121. The survival of RIPK3-/- 
Caspase-8-/- double knockouts reveals that the ability of this caspase in blocking 
necroptosis is essential for fully embryonic development. Of note, consistent with the 
role of caspase-8 in inhibiting RIPK3 when in a heterocomplex with cFLIP, transgenic 
mice bearing the uncleavable mutant caspase-8 are viable, while their thymocytes are 
protected from toxicity of Fas injection122. 
Contrasting RIPK3-/- and MLKL-/- mice, lack of RIPK1 reveals a lethal phenotype and 
mice die right after birth by an overt systemic inflammation, suggesting RIPK1 has a 
physiological role of dampening inflammation123. Notably, mice bearing either the 
D138N or K45A mutations on RIPK1 express catalytic mutant proteins but are viable 
and survive to adulthood with no reported spontaneous phenotype124,125. Thus, the 
autoinflammatory phenotype observed in RIPK1-/- mice is due to lack of the scaffold 
function of RIPK1. Given the requirement for the kinase activity of RIPK1 in 
necroptosis induction, this further supports that necroptosis is not essential during 
development. 
RIPK1-/- mice die mostly by consequences of skin and intestinal impairments123,126. 
Each affected compartment on RIPK1-/- mice correlates with the dual role of RIPK1 in 
controlling caspase-8 and RIPK3, and a full protection is observed in RIPK1-/-RIPK3-/-
Caspase-8-/- triple knockout mice123,126.  
The intestinal effects of the lack of RIPK1 seem to be associated to overt caspase-8-
mediated apoptosis induction of epithelial cells127,128. Commitment of the intestinal 
barrier, translocation of bacteria, myeloid differentiation primary response 88 
(MyD88) and TNFR signaling were all shown to play a role in theses’ mice inability 
to thrive123,127,128, and absence of RIPK3 could not rescue the absence of RIPK1127,128. 
On the other hand, the skin abnormalities of RIPK1-/- mice are prevented by lack of 
RIPK3 or MLKL128-130. While this firmly establishes that necroptosis is the main driver 
of the skin inflammation observed in these mice, it also surprisingly reveals that 
RIPK1 can in fact act as an inhibitor of necroptosis. Indeed, absence of RIPK1 seems 
to unleash the necroptotic ability of ZBP1. While absence of ZBP1 delays the 
necroptotic phenotype in the skin of the mice, RIPK3 or MLKL completely rescues 
them, indicating that RIPK1 also prevents other necroptotic signaling from occurring 
besides ZBP1129. In fact, dual deletion of TRIFF and ZBP1 phenocopies RIPK3 
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deletion, indicating both proteins can engage RIPK3-necroptotic signaling in the 
absence of RIPK1130.  
ZBP1 contains two DNA/RNA sensing domains in tandem and two RHIM domains, 
used in the RHIM/RHIM interaction with RIPK3130,131. Besides its role in 
development, ZBP1 also functions during viral detection, though also in a still 
elusive mechanism. ZBP1 is required for cell death induction of macrophages during 
influenza A viral infection132. Furthermore, murine cytomegalovirus (MCMV) 
bypasses host defenses by expressing a RHIM interacting protein, vIRA, which 
impairs the association between ZBP1 and RIPK3131. MCMV lacking vIRA induces 
inflammation in WT animals, in a ZBP1-dependent manner131,133. 
Remarkably, an Escherichia coli effector, EpsL, was demonstrated to degrade RIPK1, 
RIPK3, TRIF and ZBP1, thereby preventing necroptotic signaling in vitro134. 
Furthermore, Citrobacter rodentium lacking the EpsL effector are less efficient in 
colonizing murine intestines134. Thus, targeting the necroptotic pathway might be an 
evasion mechanism shared between viruses and bacteria. Further suggesting a role 
for necroptosis in immune response, inhibition of necroptosis during in vivo infection 
by Staphyloccocus aureus worsens pathology135. Necroptotic signaling as an immune 
response is also indicated by the ability of TLR4 and TLR3 to lead to TRIF-mediated 
RIPK3 activation and cell death in conditions of caspase inhibition116. It is still to be 
determined whether caspase inactivation happens physiologically, and in which 
conditions. Overall, understanding particularly which cells are targeted and what are 
the immunological consequences of necroptosis induction would aid in the further 
characterization of the role of necroptosis in infection models. 
1.2.2. Emerging pathways of regulated necrosis 
Other forms of regulated necrosis which do not rely on RIPK3 and RIPK1 activities 
have been described. While parthanatos and CYPD-dependent regulated necrosis kill 
by depletion of the intracellular levels of NAD+, ferroptosis is a mechanism in which 
excessive intracellular iron leads to lipid peroxidation and cell death99. Further 
understanding of their potential participation in immunity and host-pathogen 
interaction is still to be reached. 
Neutrophils, and their cell death by NETosis, though, have a clear role in pathogen 
clearance136. Neutrophils are one of the first immune cells to reach a challenge site, 
and their effector responses to pathogens relies on release of intracellular granules, 
phagocytosis, cytokine release and release of neutrophil extracellular traps (NET). 
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These traps are composed by DNA, histones and neutrophilic proteases137. NETs 
have been demonstrated to selectively trap large pathogens to avoid microbial 
spread and help clearance138. Furthermore, recently they have been shown to also act 
as scaffold for the neutrophilic proteases cathepsin G and elastase to act on 
extracellular cytokine processing139. NET formation relies mainly in the activity of 
neutrophil elastase (NE)140. Once a neutrophil starts to degranulate, its DNA 
decondenses and is released in the cytoplasm, where it binds to granular proteins. 
The DNA, together with histones and granular proteins are finally released 
extracellularly. So far, ROS production is the most upstream player identified in NET 
formation, and it activates myeloperoxidase (MPO) to induce degranulation140. MPO 
then releases NE, which translocates to the nucleus where it degrades histones to 
promote DNA decondensation. MPO and other granular proteins aid in DNA 
decondensation but inhibiting NE activity is sufficient to prevent NET formation140, 
demonstrating its key role in the process.  
While many reports have shown NET occurring during neutrophilic cell death, 
termed NETosis, there has been descriptions of phagocytic activity of a neutrophil 
after it has shed a NET137. Further, a report has implicated an upstream necroptotic 
signaling pathway to NET formation141. Further research is needed to uncover 
whether NET formation lies at the downstream signaling pathway of other lytic 
forms of cell death, and it might represent a common response of neutrophil to lytic 




1.3. Cell death and the inflammasomes 
1.3.1. Cell death initiated at the inflammasome 
complex 
 
Section 1.3.1.  is modified from the review: de Vasconcelos, N.M., Van 
Opdenbosch, N.; Lamkanfi, M. 2016. Inflammasomes as polyvalent cell 




Inflammasomes are multi-protein platforms that are organized in the cytosol to cope 
with pathogens and cellular stress. The pattern-recognition receptors NLRP1, 
NLRP3, NLRC4, AIM2 and Pyrin all assemble canonical platforms for caspase-1 
activation, while caspase-11-dependent inflammasomes respond to intracellular 
Gram-negative pathogens. Inflammasomes are chiefly known for their roles in 
maturation and secretion of the inflammatory cytokines IL1β and IL18, but they can 
also induce regulated cell death. Activation of caspases -1 and -11 in myeloid cells 
can trigger pyroptosis, a lytic and inflammatory cell death mode. Pyroptosis has been 
implicated in secretion of IL1β, IL18 and intracellular alarmins. Akin to these factors, 
it may have beneficial roles in controlling pathogen replication, but become 
detrimental in the context of chronic autoinflammatory diseases. Inflammasomes are 
increasingly implicated in induction of additional regulated cell death modes such as 
pyronecrosis and apoptosis. In this review, we overview recent advances in 
inflammasome-associated cell death research, illustrating the polyvalent roles of 




1.3.1.2. Canonical and non-canonical inflammasome 
platforms 
Inflammasomes are cytosolic multiprotein complexes that are assembled when the 
cell encounters pathogens, toxins, crystals and a diversity of other agents that may 
harm the host142,143. These potentially cytotoxic agents or the ensuing cellular stress 
are monitored by a set of intracellular pattern recognition receptors (PRRs) that auto-
oligomerize and recruit additional inflammasome components. Similar to the death-
inducing signaling complexes that activate the apoptotic initiator caspases -8 and -
10144, and the caspase-9-activating apoptosome145, oligomerization of inactive 
procaspase-1 zymogens in inflammasomes results in the proximity-induced 
autoactivation of the protease142. The CARD- and pyrin domain (PYD)-containing 
adaptor protein ASC bridges the recruitment of procaspase-1, although 
inflammasomes of CARD-containing PRRs may also recruit the inflammatory 
protease directly33,146,147. Once active, caspase-1 matures and releases the pleiotropic 
inflammatory cytokines IL1β and IL18, thereby contributing importantly to 
inflammatory and immune responses148. Caspase-1 also induces pyroptosis, a lytic 
regulated cell death mode of myeloid cells that is emerging as a critical host defense 
mechanism against microbial pathogens149. On the other hand, excessive and 
unwarranted pyroptosis induction is linked to autoinflammatory disease 150-153. Also, 
activation of murine caspase-11 and its human orthologs caspases -4 and -5 in the 
non-canonical inflammasome pathway induces pyroptosis14,15,154. Furthermore, 
inflammasome-induced cell death responses are increasingly recognized to extend 
well beyond caspase-1- and -11- induced pyroptosis, and encompass apoptosis and 
pyronecrosis as discussed in the following paragraphs. 
The canonical inflammasomes 
By definition, the canonical inflammasomes activate caspase-1. Most canonical 
inflammasomes are assembled by PRRs that belong to the nucleotide-binding 
oligomerization domain-like receptor (NLR) family155, but Pyrin143 and HIN200 
protein absent in melanoma 2 (AIM2)156,157 also engage well-defined inflammasomes. 
The roles and signaling mechanisms of the different inflammasomes have been 
reviewed extensively142,158-160, and they will only be briefly discussed here in the 
context of their roles in regulated cell death signaling. 
Akin to other NLRs, NLRP3 possesses a central nucleotide-binding NAIP, CIITA, 
HET-E and TP1 (NACHT) domain and a number of C-terminal leucine-rich repeat 
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(LRR) domains that are thought to regulate NLR activation. NLRP3 is a 
representative member of the NLRP subfamily, which are characterized by a PYD 
domain in the amino-terminus. The NLRP3 inflammasome is activated in response to 
a broad variety of pathogen- and danger-related activators that includes Gram-
negative bacteria, Staphylococcus aureus, RNA viruses, pore-forming toxins, 
ionophores, crystals, etc.161 (Figure 3). As it is unlikely for NLRP3 to physically bind 
such a diverse set of activators, it is commonly thought that these stimuli may 
converge on production of a secondary messenger that is monitored by NLRP3. K+ 
efflux, Ca2+ signaling, mitochondria-derived ROS, cytosolic release of mitochondrial 
DNA and cardiolipin, release of lysosomal cathepsins and microtubule-assisted 
relocation of the NLRP3 inflammasome to mitochondria-ER foci all are mechanisms 
that may possibly contribute to NLRP3 activation162-168, but further research is 
required to fully understand NLRP3 activation mechanisms.  
The human NLRP1 inflammasome has been implicated in Vitiligo-associated 
autoimmune disease169, autoimmune Addison’s disease170, type I diabetes171,172, and 
autoinflammation173. Importantly, humans possess only one Nlrp1 gene, whereas the 
mouse genome contains Nlrp1a, Nlrp1b and Nlrp1c genes. A number of studies have 
shown that NLRP1a and NLRP1b assemble inflammasomes that non-redundantly 
activate caspase-1 in hematopoietic progenitor cells infected with lymphocytic 
choriomeningitis virus (LCMV)174, and in macrophages intoxicated with Bacilllus 
anthracis lethal toxin (LeTx), respectively175. LeTx consists of two subunits: the 
protective antigen (PA) subunit attaches to plasma membrane-bound host receptors 
and assists in cytosolic translocation of the zinc metalloproteinase subunit lethal 
factor (LF). In the cytosol, LF protease activity triggers assembly of the NLRP1b 
inflammasome through mechanisms that are not entirely clear yet176,177 (Figure 3).  
NLRC4 is another NLR protein that assembles a canonical inflammasome178. Unlike 
NLRP3, NLRC4 contains an amino-terminal CARD. The NLRC4 inflammasome 
plays an important role in host defense against Salmonella enterica serovar 
Typhimurium (S. Typhimurium), Legionella pneumophila, Pseudomonas aeruginosa, 
Shigella flexneri and Burkholderia thailandensis161,179,180. Members of the NAIP subfamily 
- which are characterized by amino-terminal BIR motifs - bind flagellin or 
components of bacterial type III secretion systems (T3SS) of pathogenic bacteria that 
gain access to the cytosol (Figure 3)181-183. NAIP5-independent phosphorylation of 
NLRC4 is also required for engagement of flagellin-induced inflammasome 
signaling184,185. Importantly, while rodents encode multiple NAIP genes, humans 
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express different isoforms from a single NAIP gene that detect flagellin and T3SS 
components, respectively186. 
Also the HIN200 family member AIM2 assembles a well-characterized 
inflammasome. Through its dsDNA-binding HIN200 domain, AIM2 detects the 
presence of viral and bacterial pathogens in the cytosolic compartment 187-189 . AIM2 
mediates host defense against cytomegalovirus and influenza virus, but also restricts 
Fancisella tularensis. Guanylate-binding proteins (GBPs) appear dispensable for AIM2 
detection of transfected DNA and cytomegalovirus infection, but they are required 
for responding to AIM2-activating bacterial pathogens190,191. This is explained by the 
notion that these type I IFN-induced GTPases mediate lysis of bacteria-encapsulating 
vacuoles or the bacterial cell wall, thereby exposing F. tularensis DNA to AIM2 
detection.  
 
Figure 3. Schematic representation of the inflammasome pathways resulting in pyroptosis’. Pyroptosis as a 
regulated lytic cell death mode of myeloid cells is induced in response to a wide variety of endogenous, 
environmental and pathogen-derived triggers downstream of inflammasome-associated activation of 
caspases 1 or 11 in mice, or that of the orthologous caspases -1, -4 and -5 in humans. While the PYD-based 
NLRP3, AIM2 and Pyrin platforms require the bipartite adaptor protein ASC to recruit and activate caspase-
1, the CARD-based NLRP1b and NLRC4 inflammasomes trigger caspase-1-dependent pyroptosis 
independently of ASC. Both caspases -1 and -11 engage pyroptosis directly by cleaving its substrate GSDMD. 
The mechanism by which GSDMD triggers pyroptosis is currently unknown.  
Pyrin is the latest addition to the list of pattern recognition receptors (PRRs) that 
engages a canonical inflammasome. Pyrin is mutated in familial Mediterranean Fever 
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(FMF) patients, and the protein was recently shown to respond to bacterial toxins 
that post-translationally modify members of the Rho GTPase family 143,192. Pathogens 
such as Clostridium difficile, Clostridium botulinum, Vibrio parahaemolyticus, Histophilus 
somni, and Burkholderia cenocepacia express such toxins and induce Pyrin-dependent 
caspase-1 activation (Figure 3). In light of the reported association of Pyrin with the 
cell cytoskeleton193, this suggests that Pyrin may guard disrupted Rho signaling 
indirectly, possibly by monitoring remodeling of the cytoskeleton downstream of 
toxin-induced inhibition of the GTPase 143.  
The non-canonical inflammasome 
Akin to the role of caspase-1 in canonical inflammasomes, caspase-11 acts as the 
effector protease of the non-canonical inflammasome 154. Notably, this inflammasome 
pathway has emerged only recently with the unexpected observation that widely 
used caspase-1 knockout mice were also deficient in caspase-11 expression 154. The 
non-canonical inflammasome pathway targets Gram-negative bacteria that gain 
access to the cytosolic compartment (Figure 3). Direct binding of cytosolic LPS was 
shown to promote caspase-11-mediated pyroptosis as a host defense response that is 
thought to be important for disposal of macrophages that are infected with E. coli, 
Citrobacter rodentium, Vibrio cholerae and other Gram-negative pathogens25,154. Akin to 
their role in lysis of F. tularensis-containing vacuoles to license AIM2 inflammasome 
activation, GBP GTPases act upstream of caspase-11 for inducing pyroptosis of 
infected macrophages194,195. Caspase-11 cannot mature IL1β and IL18 directly196, but it 
nevertheless promotes secretion of bioactive IL1β and IL18 indirectly through 
engagement of the NLRP3 inflammasome 154.  
1.3.1.3. Mechanisms of inflammasome-induced pyroptosis 
Caspases are well-known for their chief roles in apoptosis signaling37. Unlike their 
apoptotic counterparts, the inflammatory caspase subset – i.e. human caspases -1, -4 
and -5, and murine caspases -1 and -11 - triggers pyroptosis. Maturation of the 
apoptotic executioner caspases -3 and -7, internucleosomal DNA fragmentation and 
cleavage of PARP1 are considered hallmarks of apoptosis. However, these events 
may not be apoptosis-selective biomarkers as terminal deoxynucleotidyl transferase 
dUTP nick end labeling (TUNEL)-activity is also detected in S. Typhimurium-
infected macrophages197-199, and occurs downstream of caspase-1200 (Figure 4). 
Similarly, inflammasome activation promotes caspase-1- dependent maturation of 
caspase-7, and cleavage of PARP1200-202 (Figure 4). Unlike caspase-1, however, 
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deletion of neither caspase-7 nor PARP1 halted pyroptosis by the NLRP3 and NLRC4 
inflammasomes200,201, suggesting that caspase-7 and PARP1 may contribute to other 
inflammasome-linked events. In this regard, caspase-7 activation by the NLRC4 
inflammasome was shown to promote endolysosomal destruction of Legionella 
pneumophila in infected macrophages203, and caspase-7-mediated PARP1 cleavage 
enhanced transcription of NF-κB-dependent target genes202. Despite these 
overlapping molecular characteristics, apoptotic and pyroptotic cells differ markedly 
in other aspects. Apoptosis features cell body shrinkage (pyknosis) and formation of 
apoptotic body formation, whereas pyroptotic cells undergo cytoplasmic swelling, 
consequently leading to opposing immunological outcomes. While apoptosis is an 
immunologically silent regulated cell death mode in which the plasma membrane 
integrity of the dying cell is not compromised before cells are phagocytosed, 
pyroptosis represents a lytic regulated cell death mode that is characterized by early 
membrane rupture and extracellular release of the intracellular contents. Because 
these hallmarks do not distinguish pyroptosis from other lytic regulated cell death 
modes such as necroptosis99, pyroptosis is better defined as ‘a lytic regulated cell death 
mode that relies on the enzymatic activity of inflammatory caspases’. The term ‘pyroptosis’ 
combines the Greek roots ‘pyros’ and ‘ptosis’ - which respectively stand for ‘fire’ and 
‘falling’ - to highlight the inflammatory nature of this cell death mode204. Although 
the term pyroptosis was coined only in 2001, reports describing caspase-1-mediated 
regulated cell death of S. Typhimurium- and S. flexneri-infected macrophages date 
back to as early as 1996, even though at the time these events were designated as 
apoptotic or necrotic cell death205-209. In contrast, caspase-11 only recently emerged as 
a caspase that shares with caspase-1 the ability to induce pyroptosis in Gram-
negative-infected macrophages154.  
Though still incompletely understood, understanding of the molecular mechanisms 
of pyroptosis has gained significant traction lately. The increasingly detailed 
description of the mechanisms driving caspase-1 and -11 activation in the canonical 
and non-canonical inflammasome pathways have clarified how pyroptosis is 
induced by microbial pathogen-associated molecular patterns (PAMPs) and cellular 
danger signals161. Moreover, the recent discovery that gasdermin D (GSDMD) 
cleavage is critical for both caspase-1- and -11-induced pyroptosis revealed a shared 
pyroptosis execution mechanism in the canonical and non-canonical inflammasome 
arms16,210. Little is currently known about the physiological roles of GSDMD and 
other gasdermin family members, but cleavage of human GSDMD after Asp275 
(corresponding to Asp276 in mouse GSDMD) by caspases-1 and the caspase-11 
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orthologues caspases -4 and -5 releases an amino-terminal fragment that suffices to 
induce pyroptosis when overexpressed (Figure 4). GSDMD is present in humans, 
mouse, rat and genomes of other mammals, but absent in birds, insects, amphibians 
and fish. Notably, the amino-terminal domains of other gasdermin proteins also 
induce cell death when ectopically expressed, but GSDMD appears the sole family 
member in which the regulatory carboxy-terminal domain is physically detached 
from the amino-terminal region by caspase-1/-11 cleavage 16,210. It would therefore be 
interesting to examine whether the cell death-inducing properties of other 
gasdermins may be exposed by alternative post-translation modifications in the 
flexible linker region, and whether this contributes to pyroptosis and/or other lytic 
cell death modes in macrophages and other cell types.  
 
Figure 4. Scheme of the morphological and biochemical features of pyroptosis and apoptosis. These forms 
of cell death represent two very distinct forms of regulated cell death in terms of their final outcome, but 
share some important characteristics related to their signalling events (highlighted in green boxes). 
Remarkably, while hundreds of caspase cleavage events coordinately orchestrate 
apoptotic cell death211-213, caspase-11-mediated pyroptosis appears to rely solely on 
GSDMD cleavage because GSDMD-deficient macrophages are fully protected from 
caspase-11-induced pyroptosis16,210. Because GSDMD deletion conferred only a 
temporal protection from caspase-1-induced pyroptosis210, it is likely that cleavage of 
additional substrates contributes to caspase-1-mediated pyroptosis. This also 
suggests that cleavage events associated with pyroptosis via the canonical and non-
canonical inflammasomes may overlap significantly because caspase-11-mediated 
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GSDMD cleavage indirectly engages caspase-1 downstream of the NLRP3 
inflammasome 16,210.  
A central outstanding question concerns the mechanism(s) by which caspase-1/-11 
cleavage of GSDMD engages pyroptosis1. Given the early plasma membrane rupture 
in pyroptotic cells, the amino-terminal GSDMD domain may oligomerize to form a 
membrane pore akin to how MLKL may act during necroptosis106,214. Alternatively, 
the pyroptotic GSDMD domain may induce cell lysis indirectly by damaging 
intracellular organelles that result in disruption of mitochondrial respiration and 
ATP synthesis. In this regard, activation of the NLRP3 and AIM2 inflammasomes 
was shown to be associated with caspase-1-mediated mitochondrial damage that was 
accompanied by cleavage of the pro-apoptotic Bcl-2 family member Bid and cytosolic 
release of mitochondrial cytochrome c215 (Figure 4). However, transgenic expression 
of Bcl-2 and deletion of apoptosis-associated mitochondrial outer membrane 
permeabilization inducers Bid, Bok, Bax and Bak do not alter the course of 
pyroptosis induced by the NLRP3 or AIM2 inflammasomes215,216, suggesting that 
mitochondrial destabilization in pyroptotic cells may occur through other 
mechanisms. 
Inflammasome-induced GSDMD cleavage may also induce pyroptosis by 
modulating ion fluxes from intracellular stores and/or plasma membrane-bound ion 
channels, which could explain osmosis and the plasma membrane rupture of 
pyroptotic cells. In this regard, pyroptosis was suggested to be accompanied by 
caspase-1-induced formation of transmembrane pores of approximately 1.1-2.4 nm 
prior to cell lysis197 (Figure 4). Unlike caspase-1, caspase-11 was proposed to cleave 
and degrade the plasma membrane-bound cationic channel subunit transient 
receptor potential channel 1 (TRPC1) to stimulate unconventional IL1β secretion 217, 
but how this integrates with the essential role of caspase-11-mediated GSDMD 
cleavage for IL1β secretion in the context of non-canonical inflammasome activation 
requires further investigation (Figure 4). Without doubt, coming years will provide 
important progress in understanding the mechanisms driving pyroptosis 
downstream of caspases -1 and -11, and this is likely to reveal interesting similarities 
and differences by which the canonical and non-canonical inflammasomes 
coordinate pyroptotic cell death. 
                                                                
1 An up to date discussion on GSDMD function is presented in Section 1.3.2. 
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1.3.1.4. Pyroptosis in inflammation and anti-microbial host 
defense  
Inflammasome activation provides protection against bacterial, viral, fungal and 
protozoan pathogens, and pyroptosis induction is thought to contribute importantly 
to anti-microbial host defense149,154,218-221. It is hypothesized that it does so by 
eliminating intracellular replication niches and by externalizing intracellular 
pathogens for immune recognition and clearance. In addition, recent reports suggest 
that pyroptosis may also represent a mechanism for the passive extracellular release 
of bioactive IL1β and IL18. Unlike conventional cytokines, IL1β and the related 
cytokine IL18 are secreted independently of the ER-Golgi secretory pathway, but 
instead are synthesized as cytosolic precursors that await their proteolytic cleavage 
by caspase-1221. IL1β promotes fever and infiltration of inflammatory cells indirectly 
through inflammatory mediators such as prostaglandin E2 (PGE2), nitric oxide 
species (NOS) and adhesion molecules. In addition, it modulates T and B cell 
responses by inducing Th2 and Th17 polarization of naïve CD4 T cells148. IL18 also 
regulates T cell maturation by polarizing the response towards Th1 or Th2 patterns 
in conjunction with IL12148. By monitoring caspase-1 activity using an engineered 
fluorescence resonance energy transfer (FRET) sensor in parallel with extracellular 
IL1β at the single-cell level, secretion of IL1β was shown to correlate fully with 
pyroptosis induction by the NLRP3, NLRC4 and AIM2 inflammasomes222. Moreover, 
although a role for GSDMD in active secretion of these cytokines cannot be ruled out, 
the observation that its deletion delayed pyroptosis induction by the canonical 
inflammasomes along with extracellular release of mature IL1β and IL18 suggests a 
causal link between these inflammasome outcomes 16,210.  
In addition to IL1β and IL18, pyroptosis has been associated with externalization of 
intracellular danger-associated molecular patterns (DAMPs). In particular, release of 
IL1β and high mobility group box 1 (HMGB1) have been linked to pyroptosis 
induction by the canonical and non-canonical inflammasomes154,223. IL1α is a cytokine 
highly related to IL1β, but with the contrasting difference that it does not need to be 
cleaved to be functional148. Therefore, release of bioactive IL1β likely is a common 
feature of lytic cell death modes, and may account for some of their inflammatory 
properties. Also, release of HMGB1 has been documented not only during 
pyroptosis154,223, but also in the context of necroptosis224,225. Intracellular HMGB1 
regulates chromosome architecture in the nucleus, and although its intracellular roles 
confound its analysis as an extracellular DAMP in conditionally-targeted mice226-228, 
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studies using antibody-based HMGB1 neutralization have implicated it in a variety 
of inflammatory disease models. For example, lethality in the caspase-11-dependent 
LPS-induced endotoxemia model154,229 was more effectively prevented by 
neutralization of HMGB1 than by the combined deletion of IL1β and IL18154,223,230. It is 
thought that extracellular HMGB1 may act as a chemokine that engages receptor for 
advanced glycation endproducts (RAGE) and possibly as a TLR ligand in 
conjunction with PAMPs231. 
In addition to these DAMPs, pyroptotic cells have been suggested to release ASC 
specks to increase local inflammatory responses or to amplify inflammasome 
signaling when these aggregates are phagocytosed by neighboring cells232,233. In the 
extracellular space, ASC specks continue to promote caspase-1 proteolysis of pro-
IL1β, and phagocytosed ASC specks serve as a platform for nucleating 
inflammasome activation in bystander cells232,233. Thus, by promoting release of ASC 
specks and DAMPs such as IL1α, IL1β, IL18 and HMGB1, pyroptosis is increasingly 
regarded as a major effector mechanism by which inflammasomes contribute to 
inflammatory and host defense responses.  
1.3.1.5. Inflammasome-induced apoptosis and pyronecrosis  
Although inflammasomes have primarily been linked with induction of pyroptosis, 
mounting evidence suggests that they can elicit additional cell death modes, namely 
apoptosis and pyronecrosis. Similar to pyroptosis, pyronecrosis is a lytic cell death 
mode that relies on inflammasome adaptors, namely NLRP3 and ASC, but unlike 
pyroptosis it proceeds independently of caspase-1 activity234,235. Instead, this 
inflammatory cell death mode possibly relies on the lysosomal cathepsins to induce 
cell lysis and HMGB1 release in the context of Shigella flexneri- and Neisseria 
gonorrhoeae-infected THP1 cells and human peripheral blood mononuclear cell 
(PBMC)-derived monocytes 234,235.  
Current understanding of pyronecrosis is incomplete, but our knowledge on how 
inflammasomes engage apoptosis is gradually increasing. The first description of 
apoptosis induction by inflammasomes emerged from studies with ectopically 
expressed NLRC4 and ASC in HEK293T cells, which lack caspase-1. In this system, 
NLRC4 and ASC formed a complex that recruited endogenous caspase-8 and 
induced apoptosis236. ASC was proposed to engage in direct heterotypic CARD/DED 
interactions with caspase-8 for apoptosis induction236-238, although the possibility of a 
still unidentified component mediating their interaction cannot be ruled out. 
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Caspase-8 is intimately connected with inflammasome responses, as in addition to its 
role in mediating inflammasome-associated apoptosis, it mediates transcriptional 
upregulation of proIL1β in response to TLR4 engagement, thus also serving as a 
checkpoint for efficient inflammasome-induced cytokine responses239. Moreover, 
caspase-8 is recruited to NLRP3 and NLRC4-engaged ASC specks in the context of 
pyroptosis signaling239-241. Additionally, it was shown to promote IL1β maturation 
and secretion from macrophages independently of inflammasomes under conditions 
of ER stress, fungal infection, death receptor engagement and chemotherapy 
treatment242-245.  
Apoptosis induction with endogenous inflammasome components was more 
recently demonstrated in caspase-1 and -11-deficient S. Typhimurium-infected 
mouse macrophages246. Using pharmacological caspase-1 inhibition, caspase-1 
protease activity was suggested to actively suppress apoptosis in S. Typhimurium-
infected macrophages, although the mechanism involved remains unknown246. 
Apoptosis induction in the absence of caspase-1 activity was relayed by the 
inflammasome adaptors Nlrc4 and Nlrp3 in this context246. In a similar manner, 
caspase-1/11-deficient macrophages that have been exposed to canonical NLRP3 and 
AIM2 stimuli also responded with delayed induction of apoptosis237,238. Apoptosis 
was accompanied by caspase-8 recruitment to ASC specks, but caspase-8 could only 
be fully activated in the absence of caspase-1237,238. It is interesting to note in this 
respect that ASC was originally cloned as an aggresome-forming protein in retinoic 
acid- and etoposide-treated apoptotic human promyelocytic leukemia HL-60 cells247, 
and its expression is suppressed in close to half of primary human breast cancers, 
suggesting that it may act as a tumor suppressor that induces apoptosis248.  
However, formation of ASC specks is not confined to apoptotic cells, but also 
observed in the context of inflammasome-induced pyroptosis. ASC deletion prevents 
both pyroptosis and apoptosis induction in the context of the NLRP3 and AIM2 
inflammasomes, but it is difficult to establish whether ASC-dependent apoptosis 
induction emerges from ASC specks or the ASC-containing inflammasome platforms 
because ASC is critical for bridging the interaction between NLRP3 and AIM2 with 
caspase-1 in their respective inflammasomes161. Indeed, the formation of the 1-2 
micrometer-sized ASC aggregates is considered a hallmark of inflammasome 
engagement, and their prion-like physicochemical properties are well-
documented249,250. ASC specks are also formed in the context of the NLRC4 and 
NLRP1b inflammasomes, but as both NLRC4 and NLRP1b have a CARD domain, 
these sensors can directly engage caspase-1 in the absence of ASC utilizing 
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homotypic CARD interactions33,146,147. Consequently, pyroptosis induction by the 
NLRC4 and NLRP1b inflammasomes is unhampered in the absence of ASC, whereas 
ASC is essential for pyroptosis in the context of the PYD-based NLRP3 and AIM2 
inflammasomes33,146,147. The observations described above suggest that 
inflammasome-associated pyroptosis and apoptosis induction may generate 
profoundly different systemic outcomes, and modulation of these cell death 
responses may offer novel approaches for treating inflammasome-associated 
diseases. In conclusion, significant progress was made in recent years in 
characterizing inflammasome-associated apoptosis, but more work is needed to 
examine when and how they contribute to inflammasome signaling in vivo.  
1.3.1.6. Inflammasome-induced cell death in infection and 
autoinflammation 
While understanding the relevance of inflammasome-mediated apoptosis in vivo is 
still in its infancy, a clearer picture on how pyroptosis induction by caspases -1 and -
11 contributes to host defense against microbial pathogens, and detrimental 
inflammation in autoinflammatory diseases is emerging. Pyroptosis has been 
particularly linked to in vivo protection against infection with Bacillus anthracis 
spores, B. thailandensis, B. pseudomalle, S. Typhimurium, Legionella pneumophila and F. 
tularensis219,251,252. In S. Typhimurium infection, the combined absence of IL1β and IL18 
failed to fully recapitulate the more severe phenotype of caspase-1/-11-deficient mice 
in agreement with the notion that pyroptosis not only promotes secretion of IL1β and 
IL18, but also exposes pathogens to extracellular immune recognition219,252.  
However, generalized pyroptosis may also become detrimental to the host. For 
instance, extensive caspase-1-driven pyroptosis was identified as a major cause of 
immunodepletion in HIV patients that targets CD4 T cells that have been 
unproductively infected with the virus253,254. Also, caspase-11-mediated pyroptosis in 
the absence of caspase-1-dependent cytokine production was suggested to be 
disadvantageous to the host in terms of efficiently clearing S. Typhimurium in vivo255. 
Excessive caspase-11-associated pyroptosis may also be pathogenic during LPS-
induced endotoxemia because caspase-11 knockout mice are highly resistant to LPS-
induced lethality, while animals lacking IL1β and IL18 remain largely sensitive154,229. 
Nevertheless, detailed analysis of the in vivo roles of pyroptosis was hampered by the 
absence of specific biomarkers, but the recent identification of GSDMD cleavage as a 
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pyroptosis-selective event offers a potentially suitable biomarker for monitoring 
pyroptosis in vivo. 
Nevertheless, inflammasome-induced cell death is suspected to contribute to 
inflammatory pathology in inflammasomopathies, which are hereditary periodic 
fever syndromes caused by gain-of-function mutations in genes coding for 
inflammasome components151,256. Cryopyrin-associated periodic syndromes (CAPS) 
is frequently caused by mutations in and around the central NACHT domain of the 
inflammasome adaptor NLRP3257. Patients diagnosed with these diseases can be 
distributed across a spectrum of severity of their clinical outcomes, in which Familial 
cold autoinflammatory syndrome (FCAS) patients present the mildest form, Muckle–
Wells syndrome (MWS) correlates with an intermediate phenotype, while Neonatal 
onset multisystem inflammatory disease (NOMID) is very severe. CAPS patients 
exhibit the symptoms of general inflammation, suffering with rash, fever, headache 
and fatigue that can be triggered by cold exposure, stress or, in its most serious form, 
even be present in a chronic manner. Severe presentations of CAPS can progress to 
hearing impairment or even neurological sequelae due to aseptic meningitis257. Some 
Nlrp3 SNPs that are associated with CAPS have been shown to render NLRP3 
constitutively active, which explains the high levels of inflammation experienced by 
the patients256. CAPS patients highly benefit from IL1 inhibitors that are already 
prescribed in the clinic257. However, in mouse models of CAPS, combined blockade 
of IL1R/IL18R signaling provided less protection from postnatal lethality than 
caspase-1 deletion, reinforcing the notion that pyroptosis-related DAMPs may 
contribute to pathology in this autoinflammatory model150. 
Inflammasome-associated cell death may also be an important driver of pathology in 
recently described autoinflammatory diseases that are caused by activating 
mutations in NLRC4151-153. In all studied cases, recurrent fever began early in life, but 
the other symptoms were variable, including rash and intestinal-commitment. High 
levels of IL18 in the serum of patients, together with other inflammatory markers, 
confirmed the correlation of NLRC4-activating mutations with disease onset. In 
accordance with the clinical presentation, these diseases were termed NLCR4-MAS, 
SCAN4 and NLRC4-FCAS, respectively151-153. IL1β neutralization improved a subset 
of symptoms in NLCR4-MAS patients and in a mouse model of NLRC4-FCAS, but 
could not rescue the high levels of circulating IL18. The latter suggests that excessive 
NLRC4-induced cell death linked with IL18 secretion and macrophage activation 
syndrome may be an important cause of pathology in NLRC4-associated 
autoinflammation151-153. These findings undoubtedly warrant a thorough 
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investigation of inflammasome-induced cell death responses and its roles in CAPS 
and NLRC4-associated autoinflammation. 
1.3.1.7. Concluding remarks: inflammasomes as polyvalent 
cell death controllers 
We illustrated throughout this review that inflammasomes may regulate several cell 
death modes and inflammatory mechanisms (Figure 5). That a signaling platform 
would control a variety of downstream cell death pathways is not unprecedented. 
The death receptor family member TNFR1 can engage at least three different 
complexes, termed complex I, II and IIb, with each complex promoting a distinct 
cellular response. Complex I induces NF-κB- and AP-1-dependent transcription of 
pro-inflammatory cytokines and the apoptosis inhibitor cFLIP, therefore constituting 
a pro-survival signal. When complex I-dependent responses are impaired, assembly 
of complex II activates caspase-8 for induction of apoptosis. When caspase-8 
activation fails, complex IIb leads to induction of necroptosis through RIPK1 and 3. 
Therefore, signaling through TNFR1 is highly regulated, thereby skewing cellular 
responses to TNF stimulation depending on the cellular context225. Similarly, 
inflammasome responses appear to be regulated by an exquisite range of regulatory 
mechanisms. Although induction of pyroptosis downstream of caspase-1 may be an 
all–or–none response222, inflammasome activation itself is tightly controlled at both 
the transcriptional and post-translational levels. A prime example of transcriptional 
control is presented by the NF-κB-dependent induction of NLRP3, proIL1β and 
caspase-11 levels in order to license inflammasome assembly, pyroptosis, and the 
release of mature IL1β161. Inflammasome activation is also regulated directly through 
post-translational modifications, as illustrated by the necessity for NLRP1b 
autocleavage258, and NLRC4 phosphorylation 184,185 for inflammasome activation. 
Primate-specific CARD-only and Pyrin-only proteins represent yet another level of 
inflammasome regulation259. Overall, tight regulation of inflammasome activation 
may serve to ensure that cells respond adequately to intracellular pathogen invasion 
while minimizing as much as possible the collateral damage induced by excessive 
cell death and inflammatory responses.  
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Figure 5. Representation of inflammasomes as cell death switches. While engagement of NLRP3, AIM2 and 
NLRC4 leads to pyroptosis in the presence of caspase-1, lack of this inflammatory caspase deviates the 
response towards caspase-8-dependent apoptosis. Importantly, NLRC4 is able to activate caspase-1 in the 
absence of the adaptor ASC, but the apoptotic phenotype is highly dependent on the adaptor protein. 
Considering the downstream effects of pyroptosis and apoptosis, inflammasome engagement could 






1.3.2. GSDMD as the pore mediator of pyroptosis 
The plasma membrane alterations of pyroptosis have remained so far the most 
studied feature of this cell death, for its potential to release DAMPs and to cause an 
immune response in neighboring cells. Through studies with osmoprotectant 
solutions, caspase-1 was suggested to induce pores between 1.1 to 2.4nm in size at 
the plasma membrane, with osmotic pressure accounting for total cell lysis197. 
Accordingly, further attempts to characterize the pyroptotic pore formation 
demonstrated that in the presence of glycine as an osmoprotectant, propidium iodide 
(PI) – a nuclear dye impermeable to intact membranes – can be detected in pyroptotic 
cells while bigger contents – tracked by lactate dehydrogenase (LDH) – are still 
retained in the cytoplasm260. However, advance in understanding the pyroptotic lysis 
only gained traction with the identification of GSDMD as the executor of pyroptosis.  
Cleavage of GSDMD by either caspase-1, mouse caspase-11 or human caspase-4 and 
-5 releases the pore-forming N-terminal domain (GSDMDN) from its inhibitory C-
terminal fragment16,261. GSDMDN then oligomerizes through intramolecular disulfide 
bonds and integrates into membranes262-265. In overexpression systems, the GSDMDN 
pore has variable sizes, ranging from 10 to 20nm in internal diameter263-265. This pore 
assembly could potentially allow even large proteins to flux through, which lead to 
the suggestion that pyroptotic cells do not undergo osmotic pressure during lysis266. 
However, further physiological characterizations of the GSDMD pore would aid in 
the understanding of the pyroptotic cell lysis.  
While GSDMDN demonstrates specificity for phospholipids of the cytoplasmic leaflet 
of the plasma membrane (i.e. Phosphatidylinositol 4-phosphate, Phosphatidylinositol 
(4,5)-biphosphate and Phosphatidylserine), it can also be found across practically any 
membrane-bound organelle262-265. This suggests that GSDMDN mediated killing is 
programmed to happen from the “inside-out” of cells and might involve pore 
formation in other organelles besides the plasma membrane. 
Interestingly, the toxic activity of the N-terminal fragment of GSDMD is a common 
feature between the gasdermin family members263. The gasdermin family had 
previously been identified in the skin and gastrointestinal tract, hence its naming267. 
The founder member of the family, GSDMA1, was described as the causative gene of 
skin anomalies in mice. There are four gasdermin proteins in humans, named 
gasdermin A (GSDMA), gasdermin B (GSDMB), gasdermin C (GSDMC) and 
GSDMD268. Mice do not have a homologue for GSDMB, but both GSDMA and 
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GSDMC are represented by three and four paralogues, respectively. All gasdermin 
proteins are highly homologous and contain several leucine-rich motifs throughout 
their structure268. Resolution of the structure of GSDMA3 demonstrated that the 
previously called Gasdermin-domain is in fact composed by two globular domains, 
linked by an unstructured loop263. Three-D structures of the other gasdermin family 
members are not available yet, though given their high homology, it is assumed that 
all gasdermin proteins are organized in the same way. 
While in one hand the gasdermins gene are highly homologous, they present 
different spectra of tissue expression. GSDMA1, GSDMA2, GSDMD and GSDMC1-4 
have high expression level in the gastrointestinal tract of mice, while absent or low 
expressed in heart, brain, liver, skeletal muscles and lungs268. Interestingly, 
throughout the gastrointestinal tract, high mRNA level of each gasdermin family 
member is found confined to specific locations. GSDMA1 and GSDMA2 are more 
expressed in the stomach, while GSDMD has higher expression in small intestine and 
GSDMC’s are mostly present in the colon268. In all cases, these GSDMs are expressed 
in differentiated cells of the epithelial layer269. In contrast to them, human GSDMB 
shows higher mRNA levels in stem cells of esophagus and stomach269. Considering 
the gasdermins intrinsic ability to cause cell death, validation of this data on the 
protein level and further characterization in specific cell types could shed light into 
which cell death signaling plays a role in the maintenance or immune response of the 
different tissues. 
The gasdermin family members have close proximity of domain to their distant 
relative deafness associated tumor suppressor (DFNA5)268, initially identified as the 
gene bearing a mutation causative of nonsyndromic hearing impairment270. In fact, 
DFNA5 also shares the ability to induce a lytic form of cell death through its N-
terminal fragment263, and a gain of function mutation might be at the foundation of 
its role in deafness. Despite DFNA5 being initially described as a separate branch in 
the gasdermin phylogenetic tree268, given its shared ability to induce cell death it was 
recently proposed that DNFA5 is renamed to gasdermin E (GSDME)271. 
While the activation of GSDMD is through caspase-1 and -11/-4/-5-mediated cleavage 
in Aspartate 276/27516,261, it is still unknown how the other gasdermins are activated. 
Remarkably, the GSDMD cleavage site lies in its unstructured loop, where all 
gasdermins have lower level of homology268. This suggests that each gasdermin 
protein is potentially activated by a different mechanism. Indeed, DFNA5/GSDME is 
cleaved in this same region by caspase-3271,272. Cleavage of DFNA5/GSDME by 
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caspase-3 has been suggested to lead to secondary necrosis of cells triggered by 
apoptotic stimuli272. In some systems, however, secondary necrosis was shown to 
occur normally even in the absence of DFNA5/GSDME273. This suggests that there 
might be a stimuli-dependency for DFNA5/GSDME function. Interestingly, cells 
bearing a high expression level of DFNA5/GSDME were shown to skip the normal 
features of apoptosis, such as cell shrinkage and blebbing, and to undergo direct lytic 
cell death after signaling of the apoptotic program271. Particularly, the 
DFNA5/GSDME–mediated lytic cell death would be behind the inflammatory side 
effects in lungs and intestines after treatment with chemotherapy drugs271. An 
extensive characterization of what constitutes the threshold of DFNA5/GSDME 
expression level to allow apoptotic blebbing or lysis of the plasma membrane to 
occur could help understand when homeostatic and pathological cell death follows. 
Furthermore, understanding tissue and cell type-associated expression of 
DFNA5/GSDME might shed light into the local roles of this protein in cell death. 
In conclusion, despite great recent advance in understanding the function of 
gasdermins, the field is still left with major fundamental questions. Most of the 
characterizations done so far have relied on overexpression systems, which might 
overlook fine-tuned regulations and functions of the gasdermins. Therefore, there 
should be a focus in establishing in vivo physiological roles of gasdermins. Further 
studies on the regulation and activation mechanisms of the gasdermins will allow a 
better understanding of cell death regulation and its potential contribution to 




 2. Aims 
Pyroptosis is a lytic form of regulated cell death happening in myeloid and epithelial 
cells. Cell death by pyroptosis releases DAMPs such as HMGB1 and IL1α but is also 
regarded as a secretion mechanism for the leaderless cytokines IL1β and IL18. 
Furthermore, the pyroptotic cell corpse has been shown to contain pathogens to 
facilitate their clearance by infiltrating immune cells. While pyroptosis aids in innate 
immunity signaling and clearance in response to bacterial, fungal and viral 
pathogens, extensive cell death and cytokine release might participate in the 
pathology of autoinflammatory disorders. 
Caspase-1 is a cysteine protease responsible for pyroptotic cell death induction. 
Further, caspase-1 cleaves and activates the pro-cytokines IL1β and IL18. While 
activation of caspase-1 is controlled by the macromolecular structures called 
canonical inflammasomes, pyroptosis can also be initiated by caspase-11, in a non-
canonical inflammasome activation. Caspase-1 and caspase-11 signaling for 
pyroptosis converge on cleavage of GSDMD. The newly formed N-terminal fragment 
of GSDMD translocates to the plasma membrane and oligomerizes, forming a pore 
responsible for cell lysis. To this date, the intracellular mechanisms happening 
during pyroptosis are not fully understood. In terms of organellar changes, most of 
the focus on pyroptosis execution has been placed in understanding the alterations at 
the plasma membrane. However, whether other organelles participate on cell death 
execution is currently unknown. Furthermore, in addition to GSDMD, IL1β and IL18, 
caspase-1 has been shown to cleave several other substrates, whose functions for 
pyroptosis execution have not been described yet. In fact, lack of GSDMD merely 
delays cell death after caspase-1 activation. Thus, we hypothesized that cell death on 
the GSDMD-/- cells after inflammasome trigger could be reminiscent of a more 
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complex biochemical program already present in the wild type condition, and that an 
underlying complex pyroptotic program could be happening in addition to the 
GSDMD pore during cell death execution.  
In order to first address the issue of defining the organellar features of pyroptosis, we 
undertook a live imaging-based analysis to morphologically describe cell death 
execution. We addressed NLRC4 and NLRP1b-triggered cell death side by side, with 
the assumption that organellar events happening downstream of caspase-1 activation 
would be shared between the two inflammasomes. Furthermore, since macrophage 
cell death after canonical inflammasome triggering could not be rescued by GSDMD 
ablation, we studied the non-canonical inflammasome, dependent on caspase-11, for 
questioning the roles of GSDMD in organellar changes observed. In a second stage, 
we aimed at characterizing the biochemical aspects of pyroptosis execution 
downstream, utilizing again the NLRC4 and NLRP1b inflammasomes. Particularly 
for the biochemical studies, these inflammasomes has an extra potential as these 
receptors contain a CARD domain and engage caspase-1 even in the absence of ASC. 
Thus, this allowed us to segregate the biochemical events which are ASC-dependent 
or -independent. Finally, we characterized the ability of inhibitors targeting serine 
proteases of the prolyl dipeptidase extended family to promote inflammasome 




 3. Results 
The goal of this doctoral project was to characterize pyroptotic cell death at the 
morphological and biochemical level. For this end, the canonical inflammasomes 
NLRP1b and NLRC4 were selected as models for studying downstream cell death 
induction. 
Transgene expression of an NLRP1b allele derived from 129 mice confers 
macrophages of C57/BL6 mice susceptibility to toxicity by LeTx from Bacillus 
anthracis175. LeTx is composed of two subunits: PA, which forms a pore for shuttling 
the metalloprotease, LF, to the cytosol. Cytosolic presence of catalytically active LF 
triggers the NLRP1b inflammasome274, though through a still undefined mechanism. 
Furthermore, it is known that proteasomal activity is a requirement for NLRP1b 
activation274, and that the receptor can promote caspase-1 activation even in the 
absence of ASC146,147. 
The NAIP5/NLRC4 system senses presence of flagellin in the cytosol182. To 
accomplish cytosolic delivery of flagellin, a system based on the B. anthracis toxin has 
been devised in which the N-terminal fragment of LF (LFn) was fused at the N-
terminal side of flagellin of Legionella pneumophila, allowing PA recognition of the 
chimeric protein (LFn-FlaA) and its shuttling to the cytosol275. Co-treatment of 
macrophages with PA and LFn-FlaA (called FlaTox) triggers NAIP5, which engages 
NLRC4 oligomerization and downstream ASC-caspase-1 activation. NLRC4 is also 
able to directly activate caspase-1 in the absence of ASC through CARD/CARD 
interactions33. 
To define which intracellular events could be happening before plasma membrane 
rupture during pyroptotic cell demise, as initial steps we focused on analyzing 
organellar morphological changes after activation of the NLRP1b and NLRC4 
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inflammasomes. Given our observation during these studies that GSDMD-/- 
macrophages die with same kinetics as wild type cells after canonical inflammasome 
activation, in this section we also studied caspase-11-driven pyroptosis to 
differentiate GSDMD-dependent and -independent mechanisms. The single cell 
analyzes used for this purpose are described in Section 3.1 of Results. 
While focused on the first part of the project, we observed caspase-3/-7 activity on 
pyroptotic cells, based on DEVDase reporter, suggestive of a signaling pathway 
happening in parallel to the GSDMD pore formation. Thus, Section 3.2 of Results 
comprises the characterization of the molecular events happening in pyroptosis 
independently of the GSDMD-mediated plasma membrane damage.  
Finally, we addressed the role of small compounds targeting the extended dipeptidyl 
peptidase(DPP)-4 family members on their ability to promote cell death and 
inflammasome activation. For clarity, these results were separated in two sub-
sections: the results on lysosomal Pro-X carboxypeptidase (PRCP) inhibition by 
Compound 8o are described in Section 3.3.1 of Results; the other DPP inhibitors are 
combined in Section 3.3.2 of Results.  
Each section is in the form of a manuscript, thus containing a specific introduction, 
description of results and discussion. A combined discussion of all results presented 
in the thesis is provided in Section 4. 
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3.1. A morphological, single cell-based, 
analysis of pyroptosis 
Section 3.1. is modified from the research paper: de Vasconcelos, N.M., 
Van Opdenbosch, N.; Van Gorp, H; Parthoens, E.; Lamkanfi, M.; 
Single-cell analysis of pyroptosis dynamics reveals conserved GSDMD-
mediated subcellular events that precede plasma membrane rupture. 
Cell Death and Differentiation, 2018. 
 
3.1.1. Abstract 
Pyroptosis is rapidly emerging as a mechanism of anti-microbial host defense, and of 
extracellular release of the inflammasome-dependent cytokines IL1β and IL-18, 
which contributes to autoinflammatory pathology. Caspases 1, 4, 5 and 11 trigger this 
regulated form of necrosis by cleaving the pyroptosis effector GSDMD, causing its 
pore-forming amino-terminal domain to oligomerize and perforate the plasma 
membrane. However, the subcellular events that precede pyroptotic cell lysis are ill 
defined. In this study, we triggered primary macrophages to undergo pyroptosis 
from three inflammasome types and recorded their dynamics and morphology using 
high-resolution live-cell spinning disk confocal laser microscopy. Based on 
quantitative analysis of single-cell subcellular events, we propose a model of 
pyroptotic cell disintegration that is initiated by opening of GSDMD-dependent ion 
channels or pores that are more restrictive than recently proposed GSDMD pores, 
followed by osmotic cell swelling, commitment of mitochondria and other 
membrane-bound organelles prior to sudden rupture of the plasma membrane and 
full permeability to intracellular proteins. This study provides a dynamic framework 
for understanding cellular changes that occur during pyroptosis, and charts a 
chronological sequence of GSDMD-mediated subcellular events that define 




Pyroptosis is a lytic form of regulated cell death that is induced by inflammatory 
caspases -1, -4, -5 and -11 1,2. Various infectious agents, cellular stress conditions and 
environmental cues may trigger assembly of cytosolic multiprotein platforms termed 
inflammasomes that recruit caspase-1 and facilitate its proximity-induced 
autoactivation3. Murine caspase-11 and its human orthologs caspases -4 and -5 are 
activated by cytosolic LPS, and indirectly promote activation of caspase-1 through 
the non-canonical inflammasome pathway 4. Caspase-1 cleaves the biologically inert 
precursor proteins IL1β and IL-18 into the mature, secreted inflammatory cytokines3. 
Unlike for IL-1β and IL-18, each of the aforementioned inflammatory caspases can 
induce pyroptosis directly by cleaving GSDMD at the central linker peptide, which 
separates the pore-forming amino-terminal domain (GSDMDN) from the inhibitory 
carboxy-terminal (GSDMDC) domain5-8. This cleavage event causes GSDMDN to 
oligomerize and insert in the plasma membrane, giving rise to rapid cell lysis. 
Pyroptosis deprives intracellular pathogens from their replicative niches, and is 
thought to trap infectious agents in the cellular debris in order to facilitate bacterial 
clearance by recruited neutrophils9. In addition, it is considered an inflammatory 
form of regulated necrosis because cell rupture promotes the extracellular release of 
cytosolic proteins such as the leaderless cytokines IL-1β and IL-18 and the nuclear 
alarmin HMGB1 that may attract and stimulate secondary innate immune cells5,8,10,11. 
Pyroptosis as a cell biological phenomenon was first reported in the context of 
macrophages that had been infected with the Gram-negative bacterial pathogens S. 
flexneri and S. Typhimurium, respectively12-14. However, the term pyroptosis was 
coined only in 2001 to distinguish this inflammatory form of caspase-1-regulated 
necrosis from accidental necrosis and apoptosis15. Notably, pyroptosis is thought to 
share features with both apoptosis and necroptosis, another form of regulated 
necrosis that relies on RIPK3 and its substrate MLKL for cell death execution16-18. 
Akin to apoptosis, pyroptosis is controlled by caspases, and both are thought to be 
accompanied by fragmentation of nuclear DNA12,13,19,20. Similar to necroptosis, 
however, pyroptosis is associated with cytosolic swelling, cell rounding, absence of 
chromatin condensation and early plasma membrane rupture associated with spill 
out of the cytosolic contents21. To the best of our knowledge, there has been no 
detailed characterization of the morphology and subcellular dynamics that precede 
pyroptotic cell lysis. Here, we triggered primary macrophages to undergo pyroptosis 
from two inflammasome types and recorded their dynamics and morphology using 
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high-resolution live-cell spinning disk confocal laser microscopy. Our findings show 
that pyroptosis differs from necroptosis, and that it proceeds by a determined 
sequence of subcellular events for cellular disintegration irrespective of the engaged 
inflammasome pathway. 
3.1.3. Results 
Myosin II-independent blebbing and differential cell detachment during pyroptosis and 
necroptosis  
Pyroptosis and necroptosis both are lytic forms of regulated cell death, but it is 
unclear whether they differ in particular features. C57BL/6J mouse bone marrow-
derived macrophages (BMDMs) that express a functional Nlrp1b allele (B6NLRP1b+) can 
be induced to undergo caspase-1-dependent pyroptosis when stimulated with B. 
anthracis LeTx22. Stimulation with TNF+BV6+zVAD-fmk (TBz) induces necroptosis in 
macrophages and other cell types23. We used these cytotoxic agents to compare the 
morphological features of B6NLRP1b+ BMDMs undergoing necroptosis and pyroptosis. 
As previously reported in necroptotic L929sAhFas cells24, TBz-treated B6NLRP1b+ 
macrophages readily detached from the adherent surface and rounded up prior to 
losing plasma membrane integrity and becoming Sytox Green-positive (Fig. 1a and 
Supplemental Movie 1). The membrane appeared smooth during this process, and 
formation of balloon-like protrusions of the plasma membrane that were reminiscent 
of blebs were seen concomitant with the loss of plasma membrane integrity (Fig. 1a). 
Unlike necroptotic cells, pyroptotic macrophages remained attached to the adherent 
surface until they became Sytox Green-positive (Fig. 1b and Supplemental Movie 2). 
As during necroptosis, however, plasma membrane rupture was accompanied by the 
formation of blebs (Fig. 1b). The ROCK-I inhibitor Y27632 and the selective inhibitor 
of non-muscle myosin II ATPases (-)-blebbistatin inhibited blebbing in apoptotic cells 
(data not shown). However, inhibition of ROCK-I and myosin-II had no effect on 
pyroptotic and necroptotic blebbing (Fig. 1c, d). 
Phosphatidylserine exposure is closely associated with plasma membrane rupture during 
pyroptosis 
Early PS exposure is a hallmark of apoptosis that attracts engulfing cells25. Recent 
studies showed that also mammalian cell lines undergoing necroptosis, as well as 
necrotic cells in the nematode Caenorhabditis elegans actively present PS on their outer 
surfaces prior to cell lysis in order to recruit phagocytes26,27. To study the kinetics of 
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PS exposure relative to plasma membrane rupture during pyroptosis, LeTx-treated 
B6NLRP1b+ BMDMs were quantified for Annexin-V-FITC and PI positivity over time. 
 Figure 1. Cell detachment and blebbing during necroptosis and pyroptosis. a, BMDMs were stimulated 
with TNF+BV6+zVAD-fmk (TBz) and imaged in culture media containing Sytox Green. b, rCTB stained 
BMDMs were stimulated with LeTx and imaged as in (a). a, b, Confocal images were acquired every three 
minutes. c, d, BMDMs pretreated with Y27632 (10 μM) (c) or (-)-blebbistatin (10 μM) (d) were stimulated with 
LeTx or TBz and imaged. Fluorescent micrographs show the maximum intensity projection (Sytox Green) or 
the single plane (rCTB) of a representative cell from three independent experiments (TBz n=30; LeTx n=30; 
LeTx+Y27632 n=25; TBz+Y27632 n=23; LeTx+(-)-blebbistatin n=19; TBz+(-)-blebbistatin n=20). In all panels time 
point zero indicates the first detection of Sytox Green. All scale bars, 10 µm. 
This analysis indicated that Annexin-V positivity preceded plasma membrane 
rupture with approximately 9-12 minutes during LeTx-induced pyroptosis (Fig. 2a, 










































B6NLRP1b+ BMDMs failed to yield signals for Annexin-V and PI during this time 
interval, demonstrating specificity of these findings (Supplemental Movie 4). 
 Figure 2. PS exposure happens during pyroptosis. a-d, BMDMs were stimulated with LeTx (a, b) or FlaTox 
(c, d) and imaged in culture media containing Annexin-V-FITC and PI. Confocal images were acquired every 
3 minutes. Graphs show the percentage of mean fluorescence intensity (MFI) calculated as described in Online 
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experiments (LeTx n=18; FlaTox n=21). Single cell plots are shown in Supplemental Figure 1. Fluorescent 
micrographs show the maximum intensity projection of a representative. In all panels time point zero 
indicates the first detection of PI. All scale bars, 10 µm. 
To understand whether Annexin-V staining prior to cell lysis is a shared feature of 
pyroptosis when routed through other inflammasomes, we repeated the analysis for 
LFn-FlaA-treated B6NLRP1b+ BMDMs. LFn-FlaA selectively triggers NAIP5/NLRC4 
inflammasome-dependent pyroptosis and consists of Legionella pneumophila flagellin 
(FlaA) fused to the N-terminal domain of B. anthracis lethal factor (LFn) to enable B. 
anthracis protective antigen (PA)-assisted cytosolic delivery of the fusion protein28. 
Quantification of data from 21 cells from several independent experiments showed 
that Annexin-V staining was observed in B6NLRP1b+ BMDMs treated with PA + LFn-
FlaA (here called FlaTox) approximately 3 minutes before cells became PI-positive 
(Fig. 2c, d, Supplemental Figure 1b and Supplemental Movie 5). Future studies will 
need to confirm that this corresponds to active PS exposure to the outer leaflet of the 
plasma membrane, given that the confocal micrographs do not allow enough 
resolution to differentiate between inner or outer staining of PS. However, we favour 
the latter hypothesis given that Annexin-V staining could be observed while the 
plasma membrane was still impermeable to PI (Fig. 2b, d). We conclude from these 
studies that PS exposure happens in pyroptosis, and is closely associated with 
plasma membrane rupture. 
Mitochondrial commitment independently of the apoptotic Bax/Bak pore 
Mitochondria play a central role during apoptosis with the release of cytochrome c 
and other molecules that reside in the mitochondrial intermembrane space 
promoting assembly of the apoptosome and caspase-mediated cellular dismantling29. 
In contrast, the role of mitochondria in inflammasome signalling is contentious. 
Mitochondrial damage has been proposed to occur downstream of the NLRP3 and 
AIM2 inflammasomes, with caspase-1 activation and IL-1β secretion proceeding 
independently of the Bcl2-regulated Bax/Bak pore, Parkin-mediated mitophagy, and 
the Cyclophilin D-dependent mitochondrial permeability transition pore30. 
Mitochondrial damage and dismantling of the organelle have also been suggested to 
occur upstream of the NLRP3 inflammasome because blockade of mitochondrial 
voltage-dependent anion channels (VDAC) and Bcl2 overexpression in macrophages 
selectively inhibited caspase-1 activation and IL-1β secretion by the NLRP3 
inflammasome31. We performed a longitudinal live cell analysis of mitochondrial 
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 Figure 3. Mitochondria are damaged during pyroptosis. a, BMDMs were preloaded with Mitotracker Red 
CMXRos and stimulated with LeTx in culture media containing Sytox Green (n=50). Confocal images were 
acquired every 3 minutes. b-e, BMDMs were preloaded with TMRM and stimulated with either LeTx (b, c) or 
FlaTox (d, e) and imaged as in (a). Graphs show the percentage of mean fluorescence intensity (MFI) 
calculated as described in Online Methods, and values represent the mean ± SD of all individual cells that were 
imaged in five independent experiments (LeTx, n=28; FlaTox n=28). Single cell plots are shown in 
Supplemental Figure 3. Fluorescent micrographs show the maximum intensity projection (TMRM and Sytox 
Green) or the single plane (Mitotracker) of a representative cell. In all panels time point zero indicates the first 
detection of Sytox Green. All scale bars, 10 µm. 
dynamics to better understand the role of this organelle in pyroptosis. Active 
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(ΔΨm)-insensitive dye MitoTracker Red CMXRos. Consistent with mitochondrial 
commitment during pyroptosis, the tubular mitochondrial network seen in mock-
treated cells (Supplemental Fig. 2) was lost following LeTx challenge (Fig. 3a and 
Supplemental Movie 6). Notably, mitochondria appeared rounded and fragmented 
before cell rupture, marked by Sytox Green internalization, was evident (Fig. 3a). A 
quantitative analysis of TMRM fluorescence, a mitochondrial membrane potential 
(ΔΨm)-sensitive dye, confirmed that LeTx-induced mitochondrial membrane 
depolarization occurred approximately 18-21 minutes before plasma membrane 
rupture (Fig. 3b, c, Supplemental Figure 3a and Supplemental Movie 7). As 
reported for the AIM2 and NLRP3 inflammasomes32, the pro-apoptotic Bcl2 family 
member BID was cleaved when pyroptosis was induced in LeTx-intoxicated B6NLRP1b+ 
macrophages (Supplemental Fig. 4a). However, LeTx-induced caspase-1 maturation 
and LDH release were unaffected in BMDMs from transgenic mice that overexpress 
the Bax/Bak pore antagonist Bcl2 under control of the H2K promoter (Supplemental 
Fig. 4b, c).  
Bcl2-transgenic BMDMs were also shown to induce normal caspase-1 activation and 
IL-1β secretion in response to NLRP3-activating stimuli30. Moreover, we found that 
the kinetics of LeTx-induced TMRM signal decay in Bcl2-overexpressing B6NLRP1b+ 
macrophages was comparable to that of B6NLRP1b+ macrophages, consistent with 
mitochondrial outer membrane permeabilization during pyroptosis occurring 
independently of the Bax/Bak pore (Supplemental Fig. 4d, e). Notably, the kinetics of 
mitochondrial decay induced by the NLRC4 inflammasome was remarkably 
consistent with that of LeTx-treated macrophages, both featuring a loss of TMRM 
signal approximately 20 minutes before plasma membrane rupture (Fig. 3d, e, 
Supplemental Figure 3b and Supplemental Movie 8). Thus, Bcl2-insensitive 
mitochondrial damage is a conserved feature of pyroptotic cell dismantling. 
Lysosome decay precedes pyroptotic plasma membrane rupture  
To document the fate of lysosomes during pyroptosis, we stained B6NLRP1b+ 
macrophages with LysoTracker, a fluorescent probe that is highly selective for acidic 
organelles, and imaged the lysosomal fluorescence over time. Lysosome staining 
remained relatively stable following LeTx stimulation until LysoTracker fluorescence 
declined gradually 6-9 minutes before the plasma membrane ruptured (Fig. 4a, b, 
Supplemental Figure 5a and Supplemental Movie 9). These results are in line with a 
previous report demonstrating that LeTx induced a loss of lysosomal acidity which 
depended on expression of a LeTx-responsive NLRP1b allele33. Lysosome decay was 
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not restricted to LeTx because we also observed a decrease in LysoTracker staining 
when pyroptosis was induced through the NLRC4 inflammasome (Fig. 4c, d, 
Supplemental Figure 5b and Supplemental Movie 10). The kinetics of lysosome 
destabilization in FlaTox-treated macrophages was closely aligned with that of LeTx-
intoxicated cells, with LysoTracker signal decay occurring around 6-9 minutes before 
cells became Sytox Green-positive (Fig. 4c, d). Together, these results demonstrate 
that lysosome decay is a conserved feature of pyroptosis that precedes plasma 
membrane damage by about 10 minutes.  
 Figure 4. Lysosomes decay prior to pyroptotic cell lysis. a-d, BMDMs preloaded with Lysotracker and 
stimulated with LeTx (a, b) or FlaTox (c, d) were imaged throughout cell death in culture media containing 
Sytox Green. Confocal images were taken every 3 minutes. Graphs show the percentage of mean fluorescence 
intensity (MFI) calculated as described in Online Methods, and values represent the mean ± SD of all 
individual cells that were imaged in three independent experiments (LeTx, n=27; FlaTox n=19). Single cell 
plots are shown in Supplemental Figure 5. Fluorescent micrographs show the maximum intensity projection 
of a representative cell out of at least 19 imaged cells. In all panels time point zero indicates the first detection 
of Sytox Green. All scale bars, 10 µm. 


















































L e T x  (L y so tra c k e r)
L e T x  (S y to x  G re e n )

























F la T o x  (L y so tra c k e r)
F la T o x  (S y to x  G re e n )
M o c k  (L y so tra c k e r)
 50 
 
Nuclear condensation and internucleosomal DNA fragmentation are hallmark 
features of apoptosis. Early studies of pyroptosis suggested that caspase-1 activation 
in S. Typhimurium-infected macrophages triggers a diffuse pattern of DNA 
fragmentation in the absence of nuclear condensation12,19. In agreement, several 
reports documented terminal deoxynucleotidyl transferase-mediated dUTP-biotin 
nick end-label (TUNEL) activity in S. Typhimurium-infected macrophages12,19,20,34. 
However, little is known about the dynamics of early and late-stage nuclear events 
during pyroptosis.  
We stained nuclear DNA of B6NLRP1b+ macrophages with Hoechst 33342 (Hoechst) 
stain, and imaged cells to track the shape and size of the nucleus following LeTx 
challenge. Pyroptotic macrophages retained an ellipsoid-shaped nucleus until they 
became Sytox Green-positive (Fig. 5a and Supplemental Movie 11). In agreement, 
examination of sphericity – a measure of how close the shape of an object is to a 
perfect sphere – using the Imaris microscopy image analysis platform confirmed that 
the macrophage nucleus rounded up concurrently to the loss of plasma membrane 
integrity (Fig. 5b and Supplemental Figure 6a). From these analyses, we also noted 
that the nucleus appeared more condensed following plasma membrane rupture.  
Consistently, a kinetic analysis of the nucleus’ Feret diameter - a measure of an object 
size along a specified direction – showed that nuclear condensation is a late-stage 
pyroptotic event that occurs together with plasma membrane rupture (Fig. 5c and 
Supplemental Figure 6b). Similarly, pyroptosis induction in FlaTox-treated  
macrophages was accompanied by nuclear rounding and condensation around the 
time when cells turned Sytox Green-positive (Fig 5d-f, Supplemental Figure 6c, d 
and Supplemental Movie 12). These results demonstrate that nuclear rounding and 
condensation are late-stage pyroptotic events. 
 Cell swelling during pyroptosis  
Cell volume depends on the osmotic movement of water across the plasma 
membrane, which is fundamentally regulated by ion and voltage gradients and 
balanced by active ion transport across membranes35. Dissipation of cellular ionic 
gradients increases intracellular osmotic pressure, leading to water influx, cell 
swelling and sudden bursting of the cell membrane. Pyroptotic cells have long been 
recognized to swell20, but the current model that pyroptosis is induced by the 
insertion in the plasma membrane of large pre-assembled non-selective GSDMD 
pores suggests that simultaneous exchange of ions and proteins across the plasma 
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membrane should maintain osmolarity during pyroptosis36. To gain more insight in 
this process, we studied the cell volume dynamics of primary macrophages 
undergoing pyroptotic cell death. 
Figure 5. Nuclei round up and condense during pyroptosis. a-e, BMDMs were preloaded with Hoechst dye 
and stimulated with LeTx (a, b, c) or FlaTox (c, d, e) before imaging in culture media containing Sytox Green. 
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(MFI) of Sytox Green and nuclear sphericity or the Feret’s diameter based on Hoechst staining, all calculated 
as described in Online Methods. Values represent the mean ± SD of individual cells imaged in three 
independent experiments (LeTx: Sphericity n=24, Feret’s diameter n= 18; FlaTox: Sphericity n=26, Feret’s 
diameter n=20). Single cell plots are shown in Supplemental Figure 6. Fluorescent micrographs show the 
maximum intensity projection of a representative cell. In all panels time point zero indicates the first 
detection of Sytox Green. All scale bars, 10 µm. 
The plasma membrane of B6NLRP1b+ macrophages was stained with Cholera Toxin 
Subunit B (rCTB) coupled to the fluorescent dye Alexa594. Cells were subsequently 
stimulated with LeTx to induce pyroptosis by the NLRP1b inflammasome, and we 
recorded single-cell volume changes in real-time until cell lysis was evident by Sytox 
Green staining. Contrary to mock-treated macrophages, LeTx induced a gradual 
increase in cell volume starting approximately 13 minutes before cell rupture (Fig. 6a, 
b, Supplemental Fig. 7a and Supplemental Movie 13). The cell volume increased by 
up to 50% before contracting again after cell lysis (Fig. 6a, b). Pyroptosis following 
FlaTox-induced activation of the NLRC4 inflammasome also was associated with cell 
swelling before cellular internalization of Sytox Green was observed (Fig. 6c, d, 
Supplemental Fig. 7b and Supplemental Movie 14). Under these conditions, cells 
swelled up to 30% (Fig. 6d). A recent study proposed the pomegranate-derived 
polyphenolic compound punicalagin to inhibit NLRP3 and AIM2 inflammasome-
induced IL-1β secretion by preventing plasma membrane permeability downstream 
of inflammasome activation37. Punicalagin inhibited release of LDH in the culture 
medium and PI internalization by LeTx-intoxicated B6NLRP1b+ macrophages 
(Supplemental Fig. 8a, f), but in our hands was associated with upstream blockade 
of caspase-1 maturation, calcium influx and cell swelling (Supplemental Fig. 8). 
Punicalagin also interfered with FlaTox-induced caspase-1 maturation and LDH 
release in a dose-dependent manner (Supplemental Fig. 9a-e), suggesting that this 
compound interferes with pyroptosis and IL-1β secretion by upstream blockage of 
inflammasome activation. Although these findings undermined punicalagin’s further 
use for probing pyroptosis execution mechanisms, our results demonstrate that 
osmotic swelling occurs in advance of cell lysis. 
Pyroptosis features ion fluxing prior to cell lysis  
An early report estimated pyroptotic membrane pores in S. Typhimurium-infected 
macrophages to be 1.1-2.4 nm in diameter based on the size range of osmoprotectant 
molecules that prevented cell lysis20. More recent studies showed that GSDMDN 
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Figure 6. Cell swelling precedes pyroptotic cell rupture. a-d, BMDMs stained with Cholera Toxin subunit B-
Alexa 594 (rCTB) were stimulated with LeTx (a, b) or FlaTox (c, d) and imaged in culture media containing 
Sytox Green. Confocal images were acquired every 1.5 minutes. Graphs show the percentage of mean 
fluorescence intensity (MFI) of Sytox Green and cell volume quantifications based on rCTB-Alexa 594 
staining, both calculated as described in Online Methods. Values represent the mean ± SD of individual cells 
imaged in three independent experiments (LeTx, n=26; FlaTox n=16). Fluorescent micrographs show the 
maximum intensity projection (Sytox Green) or the single plane (rCTB) of a representative cell. Single cell 
plots are shown in Supplemental Figure 7. In all panels time point zero indicates the first detection of Sytox 
Green. All scale bars, 10 µm. 
pores with inner diameters of 10-20 nm formed in liposomes, suggesting that 
pyroptosis may be associated with assembly of pyroptotic pores that are sufficiently 
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Figure 7. Ca2+ influx occurs prior to total membrane permeabilization in pyroptosis.  a-d, BMDMs 
preloaded with the cell-permeant Ca2+ indicator Fluo4 were imaged after stimulation with LeTx (a, b) or 
FlaTox (c, d) in culture media containing PI. Confocal images were acquired every 1.5 minutes. Graphs show 
the percentage of mean fluorescence intensity (MFI) calculated as described in Online Methods, and values 
represent the mean ± SD of individual cells imaged in four independent experiments (LeTx, n=24; FlaTox 
n=23). Single cell plots are shown in Supplemental Figure 10. Fluorescent micrographs show the maximum 
intensity projection of a representative cell. In all panels time point zero indicates the first detection of PI. All 
scale bars, 10 µm. 
However, GSDMDN oligomers formed in 293T cells overexpressing GSDMDN 
appeared more heterogeneous in size39. Our observation that pyroptotic cells 
undergo cell volume increase up to 10 minutes before total lysis (Fig. 6), suggested 
pyroptotic cells have permeability of their plasma membrane prior to total lysis, as 
marked by Sytox Green. We therefore hypothesized that pyroptosis may proceed in a 
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assembly of large, non-selective GSDMDN pores that lead to catastrophic cell lysis. To 
probe the size dynamics of pyroptotic pores under physiological conditions, LeTx-
stimulated B6NLRP1b+ macrophages were pre-loaded with Fluo4, a cell-permeant 
fluorogenic probe that fluoresces strongly upon Ca2+ binding, and tracked for 
internalization of Ca2+ (Mw = 40 Da; van der waals radius = 0,23 nm) relative to uptake 
of the DNA intercalating agent PI (Mw = 668 Da). In agreement with our hypothesis, 
we observed an increase in Fluo4 staining that preceded PI incorporation by 
approximately 12-15 minutes (Fig. 7a, b, Supplemental Fig. 10a and Supplemental 
Movie 15). Echoing these results, induction of pyroptosis through the NLRC4 
inflammasome in FlaTox-treated BMDMs also was associated with Ca2+ entry prior to 
PI-positivity. Under these conditions, an increased Fluo4 signal was noted 6-9 
minutes before cells became PI-positive (Fig. 7c, d, Supplemental Fig. 10b and 
Supplemental Movie 16), in line with FlaTox-induced cell volume increase being 
slightly delayed relative to LeTx-treated cells (Fig. 6). Notably, internalization of the 
DNA-intercalating agent ethidium bromide (Mw = 394 Da) occurred only slightly 
ahead of Sytox Green (Mw = 609 Da) uptake (Supplemental Fig. 11 and 
Supplemental Movie 17), suggesting that pyroptotic ion fluxing was mediated by a 
channel or pore that excludes molecules sized 400 Da and more, and that DNA-
intercalating dyes enter pyroptotic cells sequentially according to their molecular 
weight.  
GSDMD mediates early ionic flux and mitochondrial decay in pyroptotic cells 
GSDMDN pores were recently reported to have inner diameters of 10-20 nm when 
assembled in vitro in liposomes6,7,38,39. However, our observations demonstrate that 
pyroptotic Ca2+ influx precedes plasma membrane rupture and involves a pore or 
channel that excludes entry of DNA-intercalating agents with Mw of 394-609 Da. We 
hypothesized that early ionic flux and cell swelling during pyroptosis is mediated by 
GSDMD pores of lower stoichiometry while the larger structures that form in 
liposomes may represent a terminal steady-state phase of GSDMD pore assembly 
associated with catastrophic cell lysis. Empirical analysis of the hypothesis that 
GSDMD pores mediated early pyroptotic Ca2+ influx was vitiated by the observation 
that LeTx and FlaTox treatment of GSDMD-/- macrophages induced apoptosis with 
kinetics matching those of pyroptosis induction in GSDMD-sufficient B6NLRP1b+ and 
C57BL/6J (B6) macrophages, respectively (Supplemental Fig. 12a, b). Apoptosis has 
previously also been documented in GSDMD-/- macrophages following stimulation 
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Figure 8. GSDMD-deficiency prevents LPS transfection-induced early Ca2+ influx and mitochondrial 
decay. a, c, Pam3csk4-primed BMDMs of the indicated genotypes were preloaded with the cell-permeant Ca2+ 
indicator Fluo4 and imaged after transfection with LPS (Fugene+LPS), treated with Fugene alone, or “mock”-
treated in culture media containing PI. Confocal images were acquired every 2 minutes. Fluorescent 
micrographs show the maximum intensity projection of a representative cell. b, e, BMDMs of the indicated 
genotypes were preloaded with TMRM and imaged after transfection with LPS (Fugene+LPS), treated with 
ba
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Fugene alone, or “mock”-treated in culture media containing Sytox Green. Confocal images were acquired 
every 3 minutes. Fluorescent micrographs show the maximum intensity projection of a representative cell. d, 
f, Graphs show the percentage of mean fluorescence intensity (MFI) calculated as described in Online 
Methods, and values represent the mean ± SD of individual cells imaged in three or four independent 
experiments (Fluo4: WT n=18, GSDMD-/- n=28; TMRM: WT n=18, GSDMD-/- n=29). Single cell plots are shown 
in Supplemental Figure 14. In all panels time point zero indicates the first detection of PI/Sytox Green. All 
scale bars, 10 µm. 
with LPS + nigericin and upon infection with S. Typhimurium40. Therefore, the 
kinetics of apoptosis induction in GSDMD-/- macrophages that align with pyroptosis 
timelines impeded examination of the role of GSDMD pores in early pyroptotic ion 
fluxing following treatment with the above canonical inflammasome agonists. 
LPS transfection is a non-canonical inflammasome stimulus that triggers caspase-11- 
and GSDMD-mediated pyroptosis5,8. LPS transfection-induced pyroptosis was 
associated with a robust Fluo4 signal in wildtype macrophages, indicating that early 
Ca2+ influx is a shared commonality of pyroptosis induction by the non-canonical and 
canonical inflammasome pathways (Fig. 8a). LPS transfection also resulted in a loss 
of TMRM signal and mitochondrial decay prior to cell lysis (Fig. 8b), akin to our 
observations with the canonical inflammasome agonists LeTx and FlaTox (Fig. 3). 
Having established that pyroptosis induction by the non-canonical inflammasome 
shares Ca2+ influx and mitochondrial decay as early features with pyroptosis induced 
through canonical inflammasome pathways, we next addressed the role of GSDMD 
in these processes. Contrary to canonical inflammasome agonists (LeTx and FlaTox) 
that triggered fast induction of apoptosis in GSDMD-/- macrophages (Supplemental 
Fig. 12), incorporation of PI by LPS-transfected GSDMD-/- macrophages was delayed 
by approximately 5 hours relative to pyroptotic wildtype macrophages 
(Supplemental Fig. 13), thus providing a suitable time window for examining the 
potential role of GSDMD in pyroptosis-associated early Ca2+ influx and 
mitochondrial decay. Notably, GSDMD-deficiency not only protected against 
pyroptotic plasma membrane rupture during the timeframe of imaging, but also 
abolished the early Ca2+ influx seen in LPS-transfected wildtype macrophages (Fig. 
8a, c, d, Supplemental Fig. 14a and Supplemental Movie 18). LPS-transfected 
GSDMD-/- macrophages also maintained their mitochondrial polarization during the 
imaging timeframe, unlike LPS-transfected wildtype macrophages that lost their 
mitochondrial membrane potential during pyroptosis induction (Fig. 8b, e, f, 
Supplemental Fig. 14b and Supplemental Movie 19). To conclude, we show that 
both early Ca2+ influx and mitochondrial decay are conserved mechanisms of 
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pyroptotic cell demise that are mediated by GSDMD and precede plasma membrane 
rupture.  
Pyroptosis causes non-selective extracellular release of cytosolic and organellar proteins  
The extracellular release of host-derived DAMPs that are normally kept in the 
intracellular milieu is considered a major mechanism by which necrotic cell death 
promotes inflammation. In addition to IL1β and IL18, pyroptotic cells are known to 
release the cytosolic protein LDH – the enzymatic activity of which in culture media 
is often used as a surrogate marker of plasma membrane rupture – and the nuclear 
DAMPs HMGB1 and IL1α4,10. Pyroptotic cells were recently shown to contain 
organelles and microbial pathogens inside the ‘pore-induced intracellular trap’9, but 
whether proteins that reside in membrane-bound organelles are spilled 
extracellularly is unclear. To address this question, we stimulated macrophages with 
LeTx or FlaTox for the indicated durations (Fig. 9a, b) before the extracellular 
medium and total cell lysates were analysed by Western blotting for a suite of 
organellar proteins. In parallel, the extracellular medium was analysed for LDH 
 
Figure 9. Pyroptosis triggers non-selective release of cytosolic and organellar proteins. Culture 
supernatants and cell lysates of BMDMs stimulated with LeTx (a) or FlaTox (b) for the depicted durations 
were analysed by Western blotting for the indicated proteins. (c, d) Culture supernatants used in (a, b) were 
assayed for LDH activity. Data are representative of three independent experiments. 
activity, near-maximal values of which were reached 120 and 90 minutes post-








































































































































extracellular levels of procaspase-3 raised concurrent herewith, whereas the cellular 
pool of this cytosolic protein diminished accordingly over time (Fig. 9c, d). β-actin 
and the nuclear DAMP HMGB1 were also retrieved in supernatants of both LeTx- 
and FlaTox-stimulated cells. Moreover, mitochondrial cytochrome c and lysosomal 
cathepsin B were spilled with comparable kinetics in the extracellular space (Fig. 9a, 
b), consistent with our observation that both mitochondria and lysosomes are 
damaged during pyroptosis. Together, these results highlight that a broad set of 
proteins and potential DAMPs originating from damaged organelles and the cytosol 
alike are targeted for non-selective extracellular release during pyroptosis. 
3.1.4. Discussion 
The requirement for the proteolytic activity of inflammatory caspases fundamentally 
distinguishes pyroptosis from apoptosis, necroptosis and accidental necrosis. It has 
long been recognized that the induction of pyroptosis in parallel to caspase-1-
mediated maturation of IL-1β and IL-18 may constitute a powerful defense 
mechanism of the host against microbial pathogens15. Pyroptosis is now thought to 
not only remove the replicative niche of intracellular pathogens, but was also shown 
to promote the passive release of IL-1β, IL-18 and DAMP molecules that attract 
neutrophils and contribute to a pro-inflammatory environment that contribute to 
pathogen clearance5,11,40. In addition, engulfed bacteria were recently demonstrated to 
get trapped in the pyroptotic cell corpse, which has been coined the ‘pyroptotic 
intracellular trap’, as a mechanism to counter pathogen spreading and to facilitate 
efferocytosis by infiltrating neutrophils9.  
Despite its evident role in anti-microbial host defense and the recent identification of 
GSDMD as a key pyroptosis effector molecule, the distinguishing features and 
subcellular dynamics of pyroptotic cells have remained largely unmapped. 
Comparing necroptotic and pyroptotic macrophage cell death, we found that 
contrary to necroptosis, cells that undergo pyroptosis remain attached to the 
adherent surface throughout the entire cell death process. This suggests that cell 
adhesion molecules such as integrins, selectins, syndecans and cadherins may be 
disrupted during necroptosis, but not in pyroptosis. It would also be interesting in 
this respect to investigate whether this differential feature of pyroptotic and 
necroptotic cell death leads to distinct consequences to the surrounding tissue in an 
in vivo context.  We also showed that myosin-II and ROCK-I activity are dispensable 
for pyroptotic and necroptotic blebbing, whereas they are known to be essential for 
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blebbing during apoptosis. Future studies should explore whether pyroptotic and 
necroptotic blebbing are passively induced by osmotic pressure, or actively regulated 
processes that involve specific enzymes.  
Our single-cell analysis of pyroptosis kinetics revealed that pyroptosis is 
characterized by ionic fluxing and cell swelling that is accompanied by 
mitochondrial depolarization and lysosome leakage well before cells ultimately lost 
their plasma membrane integrity concomitant with evidence of late-stage nuclear 
condensation. We thus observed a conserved sequence of subcellular events that 
preceded plasma membrane rupture by up to 20 minutes, challenging the current 
model that pyroptosis is induced by the insertion in the plasma membrane of pre-
assembled large non-selective GSDMD pores with inner diameters of 10-20 nm. Pores 
of this size would likely maintain osmolarity by allowing the simultaneous passage 
of ions, small molecules and proteins, and thus would not be able to account for the 
early cell swelling we observed. Important in this regard is our demonstration that 
Ca2+ influx could precede the uptake of cell-impermeant fluorescent dye molecules 
(sized 400 Da or more) and plasma membrane rupture by 12-15 minutes, arguing that 
pyroptosis is executed by an increasing permeability of the plasma membrane and 
that formation of large non-selective GSDMD pores is a late-stage pyroptotic event 
that is associated with the breakdown of the plasma membrane. Consistently, an 
early estimate of the pyroptotic membrane pore diameter in S. Typhimurium-
infected macrophages suggested it to be 1.1-2.4 nm in diameter, although the identity 
of such pores have not been defined20. Considering our demonstration that GSDMD 
is required for early Ca2+ influx and mitochondrial membrane depolarization of LPS-
transfected macrophages, it is tempting to speculate that GSDMDN monomers insert 
in membranes individually or as small oligomers that further assemble into higher 
order oligomers, reminiscent of the mechanism used by Bax in the mitochondrial 
outer membrane and cation-selective actinoporin pores41. Such ‘non-concerted’ 
membrane insertion model for GSDMDN pore assembly would account for both early 
ion-selective fluxing and late-stage non-selective GSDMDN pore formation. 
Moreover, GSDMDN oligomers formed in GSDMDN-overexpressing 293T cells were 
reported to be heterogeneous in size39.  
We further observed that pyroptotic plasma membrane rupture is kinetically closely 
associated with Annexin-V-positivity. Considering that phosphatidylserine is an ‘eat-
me’ signal for phagocytes, it will be interesting to determine the timeframe by which 
extracellular release of IL1β and IL18 precedes efferocytosis of the pyroptotic corpse, 
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and to study the role of PS in this process. We also showed that pyroptosis is 
associated with an apparently non-discriminatory extracellular spilling of proteins 
from both the cytosolic and organellar compartments. The latter suggests that 
enzymes and DAMPs that normally reside in membrane-bound organelles such as 
the nucleus, mitochondria and lysosomes might potentially exert specific roles and 
contribute to an inflammatory milieu following their release from pyroptotic cells.  In 
conclusion, this study charted a chronological sequence of subcellular events that 
define pyroptotic cell death at the single-cell level, and provides a dynamic 
framework for understanding cellular changes that occur during pyroptosis. 
3.1.5. Methods 
Mice. B6NLRP1b+ 22, H2K-Bcl2Tg 42 and GSDMD-/- 5 mice have been reported. C57BL/6J 
mice were originally bought from the Jackson Laboratories and bred in-house. Mice 
were housed in individually ventilated cages and kept under pathogen-free 
conditions at the animal facilities of Ghent University. All animal experiments were 
conducted with permission of the ethics committee on laboratory animal welfare of 
Ghent University. 
Reagents. Recombinant expression and purification of LFn-FlaA was performed as 
described28. B. anthracis protective antigen (PA) and lethal factor (LF) were acquired 
from List Biologicals. Tetramethylrhodamine (TMRM, T668), Lysotracker (L7528), 
Sytox Green (S7020), Mitotracker (M7512), Fluo4 (F14217), Pluronic F-127 (P6867), 
Hoechst 33342 Trihydrochloride Trihydrate (H1399), Propidium Iodide (P3566) and 
Cholera Toxin Subunit B (CTB) coupled to Alexa 594 (C22842) or 647 (C34778) were 
purchased from Thermo Scientific. Propidium Iodide (PI) solution (556463) and 
Annexin-V-FITC (556419) were from BD Biosciences. The antibodies used in the 
study were anti-caspase-1 (AG-20B-0042-C10, Adipogen), anti-Cathepsin B (31718S, 
Cell Signaling Technology), anti-Cytochrome c (11940S, Cell Signaling Technology), 
anti-HMGB1 (ab18256, Abcam), anti-caspase-3 (9662S, Cell Signaling Technology), 
anti-β-Actin-HRP (sc-47778, Santa Cruz Biotechnology), anti-BID (AF860, R&D 
systems). HRP-conjugated secondary antibodies were acquired from Jackson 
Immunoresearch Laboratories and enhanced chemiluminescence solution was from 
Thermo Scientific. Punicalagin (P0023) was from Sigma Aldrich and the CytoTox 96 
Non-Radioactive Cytotoxicity Assay (G1780) and FugeneHD Transfection Reagent 
were purchased from Promega. Y27632 and (-)-blebbistatin were acquired from 
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Selleckchem. Pam3-csk4 (tlrl-pms) and LPS-SM (tlrl-smlps) were acquired from 
Invivogen.  
Macrophage differentiation and stimulation. Macrophages were differentiated by 
culturing bone marrow progenitor cells in Iscove’s modified Dulbecco’s medium 
(IMDM; Lonza) containing 10% (v/v) heat-inactivated FBS, 30% (v/v) L929 cell-
conditioned medium, 1% (v/v) non-essential amino acids (Lonza), 100 U/ml penicillin 
and 100 mg/ml streptomycin at 37 °C in a humidified atmosphere containing 5% CO2 
for six days. Bone marrow-derived macrophages (BMDMs) were then seeded into 8-
well µ-slides (Ibidi) or in multiple wells plates as needed, in IMDM containing 10% 
FBS, 1% non-essential amino acids and antibiotics. For NLRP1b inflammasome 
activation, cells were stimulated with LeTx (1 µg/ml PA combined with 0,5 or 1 
µg/ml LF). The NLRC4 inflammasome was activated in BMDMs treated with FlaTox 
(1 µg/ml PA combined with 1 µg/ml LFn-FlaA). Necroptosis was induced with 
mTNFα (20 ng/ml), BV6 (2 µM) and zVAD-fmk (50 µM). In some experiments, 
BMDMs were treated with Y27632 (10µM), (-)-blebbistatin (10µM) or punicalagin (25 
or 50 µM) before inflammasome stimuli. For the non-canonical inflammasome 
activation, BMDMs were primed with Pam3-csk4 (1ug/ml) for 6h in Opti-MEM 
medium. Then, cells were either mock treated or stimulated with 0,25% (v/v) Fugene 
with or without LPS (2ug/ml). 
Live cell imaging. BMDMs were incubated with TMRM (400 nM), Lysotracker (50 
nM), Mitotracker (25 nM) and Hoechst (20 ng/ml) for 30 min at 37°C, after which 
they were washed to fresh culture media. For plasma membrane labelling, cells were 
incubated with CTB Alexa 594 or CTB Alexa 647 (10 µg/ml) for 30 min at 4°C and 
then washed with fresh media. In other experiments, Fluo4 (5 µM) was mixed in a 1:1 
(v/v) ratio with Pluronic F-127 (20% w/v in DMSO) before adding the mixture to cells 
in HBSS. Cells were incubated with Fluo4 solution for 30 min at room temperature 
and washed to fresh media containing Fluo4 (2.5 µM). Imaging was performed in 
culture media containing Sytox Green (10 nM) or PI (0.5 µg/ml). 
Image acquisition and processing. In each experiment, 2-3 fields/condition were 
selected for time-lapse imaging using an observer Z.1 spinning disk microscope 
(Zeiss, Zaventem, Belgium) equipped with a Yokogawa disk CSU-X1. Cells were 
incubated in a chamber with a 5% CO2 atmosphere at 37°C throughout the 
experiment. DIC and fluorescence images were acquired at regular intervals ranging 
from 1 to 10 minutes apart, with the use of a pln Apo 40x/1.4 oil DIC III objective and 
a Rolera em-c2 camera. Image acquisition started at the moment of stimulation with 
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LeTx, FlaTox and TBz; and after 2h of LPS transfection for pyroptosis induction by 
the non-canonical inflammasome pathway. Cells were imaged at least until they 
became positive for Sytox Green or PI. Z-stacks consisted of 5 or 8 planes with a Z-
interval of 2µm. Mock-treated cells were imaged in parallel to ensure that imaging 
and staining procedures were not cytotoxic. 
Representative images and movies were extracted and edited in Fiji software. Image 
quantifications were performed on the 3D images through voxel-based quantification 
of the mean fluorescence intensity (MFI), volume and sphericity in Imaris x64 7.7.2 
(Bitplane) software package. Obtained fluorescence data were normalized for 
bleaching against the corresponding time points of mock-treated cells that were 
imaged in parallel. Cell volume and MFI percentages were plotted relative to each 
cell’s initial value, except for Annexin-V, Sytox Green and PI percentages, which 
were plotted against the maximum noted values. The Feret diameter of Hoechst-
stained nuclei was determined for each Z-slice using Fiji software, and the highest 
value obtained for each time point was retained and shown. All graph data on main 
figures depict the mean of multiple cells that were quantified in each independent 
experiment ± SD. All graph data on supplementary figures depict the individual 
values obtained for each cell after normalization. The time indication in presented 
graphs and image panels is relative to the moment when cells became positive for 
Sytox Green or PI. Time zero in movie stills refers to the start of imaging. 
Western Blotting. Unless otherwise stated, cell lysates and culture supernatants were 
combined for Western blotting. Protein samples were denatured in Laemmli buffer, 
boiled at 95 °C for 10 min, separated by SDS-PAGE and transferred to PVDF 
membranes. PBS supplemented with 0.05% Tween-20 (v/v) and 3% nonfat dry milk 
(w/v) was used for blocking and washing of membranes. Immunoblots were 
incubated overnight with primary antibodies against cathepsin B and cytochrome c 
(1:1000 in TBS, 0,1% Tween-20, 5% BSA), HMGB1 or caspase-3 (1:1000 in PBS, 0,1% 
Tween-20, 5% nonfat dry milk), caspase-1 or BID (1:1000 in PBS, 0,05% Tween-20, 3% 
nonfat dry milk), followed by HRP-conjugated secondary antibodies raised against 
mouse, goat or rabbit (1:5000). The β-Actin-HRP antibody was used at 1:5000 in PBS 
0,1% Tween-20, 5% nonfat dry milk. All proteins were detected by enhanced 
chemiluminescence. 
Kinetic of LDH release. The supernatant of cells stimulated at various time points 
was collected and centrifuged at 300xg for 5min to remove cellular debris. LDH 
measurement was performed with the CytoTox 96 Non-Radioactive Cytotoxicity 
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Assay kit according to the manufacturers’ instructions, in samples diluted 1:5 in PBS. 
Data was plotted considering the O.D. value obtained in a well treated with Triton-
x100 as 100%. 
Cell permeabilization kinetics (Incucyte). BMDMs were plated and stimulated in a 
96-well plate in media containing PI (0,1 ug/ml) and data was acquired with a 10x 
objective using the Incucyte Zoom system (Essen BioScience) in a CO2 and 
temperature controlled environment. Each condition was run in (technical) 
duplicates. The number of fluorescent objects was counted with Incucyte ZOOM 
(Essen BioScience) software and was plotted considering as 100% the highest value 
obtained in a well treated with Triton-x100.  
3.1.6. Suplementary data 
 
Supplemental Figure 1. PS exposure during pyroptosis. a, b B6Nlrp1b+ BMDMs were stimulated with LeTx (a) 
or FlaTox (b) and imaged in culture media containing Annexin-V-FITC and PI. Confocal images were 
acquired every 3 minutes. Graphs show the percentage of mean fluorescence intensity (MFI) of single cells 
(LeTx n=18; FlaTox n=21), calculated as described in Methods, of Annexin-V (upper panel) or PI (lower panel) 
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Supplemental Figure 2. Mitochondrial morphology of mock-treated BMDMs. B6Nlrp1b+ BMDMs preloaded 
with Mitotracker Red CMXRos were imaged in culture media containing Sytox Green (n=50). A single plane 
of a representative cell is shown. Scale bars, 10 µm. 
 
 
Supplemental Figure 3. Mitochondrial damage during pyroptosis. a, b B6Nlrp1b+ BMDMs were preloaded 
with TMRM and stimulated with either LeTx (a) or FlaTox (b) and imaged in culture media containing Sytox 
Green. Confocal images were acquired every 3 minutes. Graphs show the percentage of mean fluorescence 
intensity (MFI) of single cells (LeTx, n=28; FlaTox n=28), calculated as described in Methods, of TMRM (upper 
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unstimulated cells, imaged in parallel. In all panels time point zero indicates the first detection of Sytox Green. 
Relates to Figure 3c, e. 
 
Supplemental Figure 4. Bax/Bak pores are dispensable for pyroptosis-associated mitochondrial damage. a 
Protein lysates of B6Nlrp1b+ BMDMs stimulated with LeTx for 60, 120 or 180 minutes were analysed by Western 
blotting for BID. a-c, Protein lysate of B6Nlrp1b+ and B6Nlrp1b+H2K-Bcl2Tg BMDMs that have been stimulated with 
LeTx for 90 or 180 minutes were assayed by Western blotting for caspase-1 maturation (b), and their culture 
supernatants were assayed for LDH activity (c). d, e B6Nlrp1b+ and B6Nlrp1b+H2K-Bcl2Tg BMDMs were loaded 
with TMRM and stimulated with LeTx in culture media containing Sytox Green. Confocal images were 
acquired every 3 minutes. Graphs show the percentage of mean fluorescence intensity (MFI) calculated as 
described in Methods, and values represent the mean ± SD of individual cells imaged in 3 independent 
experiments (B6Nlrp1b+ n=26; B6Nlrp1b+H2K-Bcl2Tg n=21). Fluorescent micrographs show the maximum intensity 
projection of a representative cell. In panels d, e time point zero indicates the first detection of Sytox Green. 
All scale bars, 10 µm. 
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Supplemental Figure 5. Lysosomes decay prior to pyroptotic cell lysis. a, b B6Nlrp1b+ or B6 BMDMs preloaded 
with Lysotracker and stimulated with LeTx (a) or FlaTox (b), respectively, were imaged throughout cell death 
in culture media containing Sytox Green. Confocal images were taken every 3 minutes. Graphs show the 
percentage of mean fluorescence intensity (MFI) of single cells (LeTx, n=27; FlaTox n=19), calculated as 
described in Methods, of Lysotracker (upper panel) or Sytox Green (lower panel) signals. “Mock” lines represent 
the average of the values obtained in unstimulated cells, imaged in parallel. In all panels time point zero indicates 
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Supplemental Figure 6. Nuclei round up and condense during pyroptosis. a-d B6Nlrp1b+ BMDMs were 
preloaded with Hoechst dye and stimulated with LeTx (a, b) or FlaTox (c, d) before imaging in culture media 
containing Sytox Green. Confocal images were acquired every 10 minutes. Graphs show values for nuclear 
sphericity (a, c, upper panels) or Feret’s diameter (b, d, upper panels) based on Hoechst staining or the 
percentage of mean fluorescence intensity (MFI) of Sytox Green signal (lower panels) of single cells (LeTx: 
Sphericity n=24, Feret’s diameter n= 18; FlaTox: Sphericity n=26, Feret’s diameter n=20), calculated as 
described in Methods. “Mock” lines represent the average of the values obtained in unstimulated cells, imaged in 
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Supplemental Figure 7. Cell swelling precedes pyroptotic cell rupture. a, b B6Nlrp1b+ or B6 BMDMs stained 
with Cholera Toxin subunit B-Alexa 594 (rCTB) were stimulated with LeTx (a) or FlaTox (b), respectively, and 
imaged in culture media containing Sytox Green. Confocal images were acquired every 1.5 minutes. Graphs 
show the percentage of cell volume quantifications based on rCTB-Alexa 594 staining (upper panel) or the 
mean fluorescence intensity (MFI) of Sytox Green signal (lower panels) of single cells (LeTx, n=26; FlaTox 
n=16), calculated as described in Methods. “Mock” lines represent the average of the values obtained in 
unstimulated cells, imaged in parallel. In all panels time point zero indicates the first detection of Sytox Green. 
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Supplemental Figure 8. Punicalagin inhibits LeTx-induced pyroptosis caspase-1 activation. a, b B6Nlrp1b+ 
BMDMs were pretreated with Punicalagin at the indicated concentrations (µM) and stimulated with LeTx for 
90 min. Culture supernatants were assayed for LDH (a), and protein lysates for caspase-1 by Western blotting 
(b). (c, d) BMDMs were pretreated with Punicalagin (50 µM) and stimulated with LeTx for 90 or 180 minutes. 
Culture supernatants were assayed for LDH (c), and protein lysates for caspase-1 by Western blotting (d). (e, 
f) B6Nlrp1b+ BMDMs that had been preloaded with the Ca2+ indicator Fluo4 and stained with CTB-Alexa 647 
(rCTB) were incubated with Punicalagin (50 µM) or vehicle control before cells were stimulated with LeTx 
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the percentage of mean fluorescence intensity (MFI) of PI (upper panel, left axis) and Fluo4 (lower panel) and 
cell volume quantifications based on rCTB-Alexa 647 staining (upper panel, right axis), all calculated as 
described in Methods. Values represent the mean ± SD of 2 independent experiments (LeTx n=11; 
Punicalagin+LeTx n=9). Fluorescent micrographs show the maximum intensity projection (PI and Fluo4) or 
the single plane (rCTB) of a representative cell. All scale bars, 10 µm. 
 
Supplemental Figure 9. Punicalagin inhibits FlaTox-induced caspase-1 activation. a, b B6Nlrp1b+ BMDMs 
were pretreated with Punicalagin at the indicated concentrations (µM) and stimulated with FlaTox for 30 
min. Culture supernatants were assayed for LDH (a), and protein lysates for caspase-1 by Western blotting 
(b). BMDMs were pretreated with Punicalagin (50 µM) and stimulated with FlaTox for 30 or 60 minutes. 
Culture supernatants were assayed for LDH (c), and protein lysates for caspase-1 by Western blotting (d). 
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Supplemental Figure 10. Pyroptotic Ca2+ influx occurs prior to total membrane permeabilization.  a-d 
B6Nlrp1b+ BMDMs preloaded with the cell-permeant Ca2+ indicator Fluo4 were imaged after stimulation with 
LeTx (a) or FlaTox (b) in culture media containing PI. Confocal images were acquired every 1.5 minutes. 
Graphs show the percentage of mean fluorescence intensity (MFI) of single cells (LeTx, n=24; FlaTox n=23), 
calculated as described in Methods, of Fluo4 (upper panel) or PI (lower panel) signals. “Mock” lines represent 
the average of the values obtained in unstimulated cells, imaged in parallel. In all panels time point zero indicates 
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Supplemental Figure 11. Pyroptotic cells provide sequential permeability to Ethidium Bromide and Sytox 
Green. a, b B6Nlrp1b+ BMDMs were stimulated with LeTx and imaged in culture media containing Ethidium 
Bromide and Sytox Green. Confocal images were acquired every 1 minute. Graph shows the percentage of 
mean fluorescence intensity (MFI) calculated as described in Methods, and values represent the mean ± SD of 
individual cells imaged in 3 independent experiments (n=50). Fluorescent micrographs show the maximum 
intensity projection of a representative cell. In all panels time point zero indicates the first detection of Sytox 
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Supplemental Figure 12. Canonical inflammasome stimuli induce apoptosis in GSDMD-deficient 
macrophages with kinetics similar to pyroptosis induction in WT cells. a, b BMDMs of indicated genotypes 
were stimulated with LeTx (a) or FlaTox (b). Images show the bright field of representative cells (LeTx n=20; 




Supplemental Figure 13. Delayed membrane permeabilization following non-canonical inflammasome 
activation in GSDMD-deficient macrophages. Pam3csk4-primed GSDMD-deficient and –sufficient B6 
BMDMs were transfected with LPS (2 µg/ml, Fugene+LPS), treated with Fugene alone or kept without 
treatment and imaged in media containing PI. The number of positive cells was quantified relative to a 
Triton-x100-treated well (considered 100%) of each genotype. Values represent mean ± SD of technical 
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Supplemental Figure 14. GSDMD deficiency recues Ca2+ influx and mitochondrial decay associated with 
activation of the non-canonical inflammasome. a, b Pam3csk4-primed BMDMs of WT (a) and GSDMD-/- (b) 
mice were preloaded with the cell-permeant Ca2+ indicator Fluo4 and imaged after transfection with LPS (2 
µg/ml, Fugene+LPS), Fugene alone or mock-treated in culture media containing PI. Confocal images were 
acquired every 2 minutes. c, d BMDMs of WT (c) and GSDMD-/- (d) mice were preloaded with TMRM and 
imaged after transfection with LPS (2 µg/ml, Fugene+LPS), Fugene alone or mock-treated in culture media 
containing Sytox Green. Confocal images were acquired every 3 minutes. Graphs show the percentage of 
mean fluorescence intensity (MFI) of single cells (Fluo4: WT n=18, GSDMD-/- n=28; TMRM: WT n=18, GSDMD-
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panels) signals. “Mock” lines represent the average of the values obtained in unstimulated cells that were 
imaged in parallel. In all panels time point zero indicates the first detection of PI. Relates to Figure 8d, f. 
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3.2. A biochemical perspective of pyroptosis 
Section 3.2. is structured as the manuscript: de Vasconcelos, N.M.* and 
Van Opdenbosch, N.*; Van Gorp, H; Lamkanfi, M. Caspase-1-
dependent pyroptosis comprises an apoptotic program. In preparation. 
*contributed equally to the work 
 
3.2.1. Abstract 
Inflammasomes are key elements of the innate immune response to bacterial and 
viral pathogens1. However, uncontrolled inflammasome activation can also be the 
causing mechanism of hereditary inflammatory disorders2. Canonical 
inflammasome-activated cells still undergo cell death in the absence of GSDMD3, and 
previous studies have shown caspase-7 to be a substrate of caspase-14. Here we show 
that caspase-1 activates a caspase-3 and -7-mediated apoptotic program during the 
execution of pyroptosis downstream of the NLRC4 and NLRP1b inflammasomes. 
DEVDase activity, considered a hallmark of apoptosis, was present in pyroptotic 
bone marrow-derived macrophages, and pyroptosis was accompanied by cleavage of 
typical apoptotic markers ROCKI, p23, PARP1 and Bid. Absence of GSDMD revealed 
an apoptotic phenotype, which was insensitive to the ablation of ASC or to TLR-
priming. Double deficiency for caspase-3 and -7 rescued the observed DEVDase 
activity and delayed plasma membrane permeabilization for 4h. Overall, we 
conclude that both caspase-1 and caspase-8 can mediate an apoptotic program 
downstream of the inflammasome. We propose a model in which inflammasome 
activation leads to several parallel death programs: caspase-8 and -1-mediated 
apoptosis and caspase-1-induced pore formation through GSDMD. All these 
pathways act in a concerted manner in WT macrophages, and therefore are key 
molecular constituents of pyroptosis. The existence of these parallel cell death 
pathways suggests redundancy in cell death induction mechanisms of an infected 




3.2.2. Main text 
Anthrax lethal toxin (LeTx) elicits NLRP1b inflammasome activation and pyroptosis 
in B6 BMDMs containing the LeTx-sensitive Nlrp1b allele of 129 mice5. Analysis of 
the caspase maturation profile in B6Nlrp1b+ BMDMs treated for 2h with LeTx 
demonstrated caspase-1 conversion into its mature p20 form (Fig. 1a). Confirming 
what has been observed with NLRP3 and NLRC4 inflammasomes4, caspase-3 and -7 
were cleaved to their active form after LeTx triggering of B6Nlrp1b+ macrophages. 
Activation of the NLRC4 inflammasome can be accomplished by a system employing 
the N-terminal fragment of B. anthracis Lethal Factor fused to Flagellin from 
Legionella pneumophila for its cytoplasmic delivery through combination with 
Protective Antigen (FlaTox)8. After 2h of FlaTox treatment, we could detect caspase-1 
maturation in BMDMs (Fig. 1a). Interestingly, in the context of NLRC4 activation, the 
p43 and p18 forms of caspase-8 was detected 2h post treatment. Further confirming 
the published data, caspase-3 and caspase-7 were matured after FlaTox treatment. 
To probe whether caspase-3 and -7 cleavages in pyroptotic macrophages correlated 
to their activation, we employed a time-kinetics analysis with a fluorogenic probe 
containing the caspase-3 and caspase-7-target substrate sequence, DEVD, using the 
imaging-based Incucyte system. Treatment of B6Nlrp1b+ BMDMs with LeTx led to PI 
staining, indicative of the pyroptosis-induced permeabilization of the plasma 
membrane, after only 1h30 (Fig. 1b). The DEVD-based probe stained LeTx-triggered 
cells with similar kinetics and at comparable level as PI. Similarly, intoxication of 
BMDMs with FlaTox lead to DEVDase activity, which was concomitant to membrane 
permeabilization, detected through PI staining. Both the extrinsic and intrinsic 
apoptotic pathways converge into activation of caspase-3 and -7, and therefore 
DEVDase activity is considered a hallmark of apoptosis. NLRP1b and NLRC4-
induced pyroptosis generated DEVD-activity at comparable levels to the well 
described apoptotic trigger, Staurosporine (Fig. 1b). DEVD activity was specific for 
downstream activation of inflammasomes, because triggering BMDMs lacking the 
Nlrp1b transgene with LeTx did not induce any DEVD signal in the cells (Fig. 1c). 
Similarly, NLRC4-/- BMDMs were unable to induce DEVD signal after FlaTox 
treatment (Fig. 1d). During the extrinsic apoptotic pathway, activation of caspase-8 at 
the death receptor complex leads to downstream activation of caspase-3 and -7 and 
apoptotic dismantling of the cell. Ablation of ASC has been shown to impair caspase-
8 activation in the speck downstream of NLRP1b and NLRC4 inflammasomes, while 
caspase-1 continued to induce pyroptosis6,7. Indeed, B6Nlrp1b+ASC-/- BMDMs 
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Figure 1. NRLP1b and NLRC4-induced pyroptosis is associates to a Caspase-3/-7 signature. a, f, B6Nlrp1b+ or 
B6 macrophages were treated with LeTx and FlaTox, respectively, for 2h and lysates run on WB for detection 
of the indicated proteins. b, B6Nlrp1b+ macrophages treated with either LeTx, FlaTox or Staurosporine in media 
containing DEVD-probe and PI were imaged on an Incucyte platform. c, B6Nlrp1b+ and B6 macrophages were 
treated with LeTx and assayed as in (b). d, B6 and NLRC4-/- macrophages were treated with FlaTox and 
assayed as in (b). e, B6Nlrp1b+ and B6Nlrp1bASC-/- macrophages were treated with LeTx or FlaTox and assayed as 
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treated well (considered 100%). Values represent mean ± SD of technical duplicates of a representative 
experiment from three biological repeats. 
underwent plasma membrane permeabilization with same kinetics as B6Nlrp1b+ after 
LeTx or FlaTox triggering (Fig. 1e). Similarly, ablation of ASC in BMDMs did not 
hamper DEVDase activity or its kinetics after both NLRP1b and NLRC4 
inflammasomes, suggesting this event is not mediated by caspase-8 activation at the 
ASC speck (Fig. 1e). 
To confirm the DEVDase activity in pyroptotic cells was not an off-target effect of 
other active caspases, we analyzed lysates of either LeTx of FlaTox-triggered cells for 
substrates normally cleaved during the execution phase of apoptosis. ROCKI, p23 
and Bid were cleaved in BMDMs triggered with LeTx and FlaTox (Fig. 1f) into 
similar cleavage fragments than reported during apoptosis. These data establish that 
caspase-3 and -7 are activated during pyroptosis in an ASC-independent manner and 
contribute to biochemical aspects of this form of cell death. 
We hypothesized that the rapid lysis of the plasma membrane mediated by GSDMD 
would stop intracellular signaling and decided to use GSDMD-/- BMDMs to examine 
the caspase-3 and -7 cleavage events in more detail. B6Nlrp1b+GSDMD-/- BMDMs were 
hampered in LDH release after stimulation of the NLRP1b inflammasome with LeTx 
(Fig. 2a). However, further microscopic evaluation of B6Nlrp1b+GSDMD-/- macrophages 
demonstrated these not to be protected from cell death, as the cells appeared 
shrunken and displayed blebbing, consistent with apoptosis induction (Fig. 2b). 
Previous reports have shown that lack of GSDMD after engagement of a caspase-1-
dependent inflammasome does not protect from cell death, as macrophages undergo 
apoptosis3,9. Flow cytometry of B6Nlrp1b+GSDMD-/- macrophages triggered with LeTx 
demonstrated a population positive for Annexin-V while impermeable to PI 
(AnnenV+/PI-) (Fig. 2c), consistent with apoptosis. Activation of the NLRP1b 
inflammasome was not altered by lack of GSDMD, and the total populations of dead 
cells were comparable between GSDMD-deficient and sufficient cells. NLRC4 
engagement in the absence of GSDMD lead to a similar pattern, with lack of LDH 
being associated to an apoptotic phenotype and cells staining as AnnenV+/PI- (Fig. 
2d-f).  
Analysis of the profile of caspase maturation in GSDMD-/- cells demonstrated that 
caspase-8 is strongly matured into its p18 forms in the presence of LeTx or FlaTox 
(Fig. 2g). Similarly, caspase-3 was robustly matured into the active p17 fragment. 
Interestingly, the level of caspase-7 maturation in apoptotic cells was comparable to 
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those of pyroptotic cells. We had previously shown that morphological changes in 
GSDMD-/- BMDMs proceed with a kinetic similar to pyroptotic changes. Analysis of 
Figure 2. Lack of GSDMD reveals an apoptotic phenotype after NRLP1b and NLRC4 inflammasome 
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respectively, for 2h and their supernatants probed for LDH activity (a, d), imaged under a confocal 
microscope (b, e), cells collected for FACS analysis of Annexin V/PI positivity (c, f), and lysates run on WB for 
detection of the indicated proteins (g). h, B6Nlrp1b+ or B6 macrophages with or without GSDMD were treated 
with either LeTx or FlaTox, respectively, in media containing DEVD-probe and PI were imaged on an 
Incucyte platform. i, GSDMDI105N knock-in homozygous (GSDMDI105Nki/ki) or WT (GSDMDI105N+/+) 
macrophages were treated with FlaTox in media containing DEVD-probe and PI were imaged on an Incucyte 
platform. The number of positive cells was quantified relative to a PI stained, Triton-x100-treated well 
(considered 100%) for each genotype. Values represent mean ± SD of technical duplicates of a representative 
experiment from three biological repeats. 
DEVDase activity on GSDMD-/- macrophages showed similar levels to their WT 
counterparts when stimulated with either LeTx or FlaTox, though GSDMD-/- BMDMs 
had a delay in comparison to GSDMD sufficient cells (Fig. 2h). Kinetics of DEVDase 
activity on GSDMD-/- macrophages followed the same as PI internalization, an 
indication of secondary necrosis in this case. A possible explanation for the delayed 
DEVDase activity versus the observation of comparable caspase-7 maturation levels 
is that the substrate is not efficient in entering cells with an intact plasma membrane. 
Therefore, the rapid lysis of pyroptotic cells causes a faster accumulation of the dye 
than in apoptotic ones. However, together with the ROCK1, PARP1 and Bid 
cleavage, we conclude that the probe displays specificity for caspase-3 and -7 
activities. 
In order to understand whether it was the lack of GSDMD or of its function that 
allowed the apoptotic phenotype to appear in GSDMD-/- cells, we have made use of 
the ENU-generated mouse knockin GSDMDI105N, in which GSDMD is expressed but 
unable to cause cell lysis3. Activation of GSDMDki/ki BMDMs with FlaTox led to 
apoptosis with similar kinetics than GSDMD-/- BMDMs (Fig. 2i), establishing that the 
lack of function of GSDMD is sufficient to reveal the apoptotic phenotype. Of note, 
also on the GSDMD-/- background, inflammasome signaling through NLRP1b was 
essential for activation of caspase-1, -3, -7 and -8 plus the detection of DEVDase 
activity, after LeTx stimulation (Sup. Fig. 1). 
Caspase-8 activation during inflammasome triggering of caspase-1-deficient 
macrophages has been shown to occur in the ASC speck7. Given that cells lacking 
GSDMD contained active caspase-1, we analyzed whether the apoptotic phenotype 
observed in the absence of GSDMD expression was related to the described caspase-8 
arm. Surprisingly, lack of ASC could also not protect from LeTx or FlaTox induced 
apoptosis, and allowed blebbing and cell shrinkage, concomitant to the appearance 
of an AnnenV+/PI- population similar to B6Nlrp1b+GSDMD-/- dying macrophages (Fig. 
3a, b). Kinetics of DEVDase activity and PI incorporation of B6Nlrp1b+ASC-/-GSDMD-/- 
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triggered with LeTx led, however, to a 20% decay in the maximum number of 
stained cells (Fig. 3d). FlaTox-intoxicated BMDMs showed a 50% reduction in their 
 Figure 3. Lack of ASC does not impair apoptosis in the GSDMD-deficient genotype after NRLP1b and 
NLRC4inflammasome activation. a-c, B6Nlrp1b+GSDMD-/- or B6Nlrp1b+GSDMD-/-ASC-/- macrophages were treated 
with either LeTx or FlaTox for 2h and imaged under a confocal microscope (a), cells collected for FACS 
analysis of Annexin V/PI positivity (b), and lysates run on WB for detection of the indicated proteins (c). d, e, 
B6Nlrp1b+GSDMD-/- or B6Nlrp1b+GSDMD-/-ASC-/- macrophages were treated with either LeTx (d) or FlaTox (b) in 
media containing DEVD-probe and PI were imaged on an Incucyte platform. The number of positive cells 
was quantified relative to a PI stained, Triton-x100-treated well (considered 100%) for each genotype. Values 
represent mean ± SD of technical duplicates of a representative experiment from three biological repeats.  
DEVDase maximum activity and PI incorporation (Fig. 3e). While caspase-1 is 
activated in the absence of ASC after NLRP1b and NLRC4 inflammasomes, its p20 
form is no longer detectable5,10. However, ablation of ASC in the GSDMD-/- 
background restored the maturation of caspase-1 into its p20 (Fig. 3c). Further, while 
ed
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caspase-8 was still processed in B6Nlrp1b+ASC-/-GSDMD-/- triggered for NLRP1b 
inflammasome activation, lack of ASC lead to a significant reduction of caspase-8 
maturation after FlaTox triggering (Fig. 3c), confirming the more pronounced need of 
the NLRC4 inflammasome for ASC. Interestingly, we could not detect any reduction 
on the cleavage pattern of caspase-3 and caspase-7 in the absence of ASC. Overall, 
the data indicate that in the GSDMD-deficient background, caspase-8 can be 
activated outside of the ASC speck after inflammasome triggers. 
To address the role for caspase-3 and -7 in the apoptotic phenotype observed, we 
made immortalized B6Nlrp1b+GSDMD-/-Casp3flox/floxCasp7flox/floxLysM-Cre+ myeloid 
progenitor cells and differentiated them to BMDMs (iBMDMs). DEVDase activity 
was abolished and the signal was diminished below threshold levels in 
B6Nlrp1b+GSDMD-/-Casp3flox/floxCasp7flox/floxLysM-Cre+ immortalized macrophages 
stimulated with LeTx, while control B6Nlrp1b+GSDMD-/- showed DEVDase staining 
when undergoing pyroptosis, further proving the specificity of the probe in our 
system (Fig. 4a). Remarkably, there was a delay of 4h in PI incorporation by these 
cells when compared to B6Nlrp1b+GSDMD-/-. FlaTox-intoxication of iBMDMs showed a 
similar pattern, demonstrating the importance of caspase-3 and -7 for the apoptotic 
phenotype in GSDMD-deficient macrophages (Fig. 4b). Despite a significant 
reduction of DEVDase activity, Western blot analysis demonstrated that caspase-3 
and -7 excisions were not complete in LysM-Cre+ cells (Fig. 4c). Interestingly, 
caspase-1 and caspase-8 were activated at similar levels in caspase-3 and -7-defficient 
and sufficient cells, following treatment with LeTx and FlaTox.  
Figure 4. Caspase-3/-7 control apoptosis downstream of NRLP1b and NLRC4 inflammasomes in the 
GSDMD-deficient genotype. a, B6Nlrp1b+GSDMD-/- or B6Nlrp1b+GSDMD-/-Casp3Flox/FloxCasp7Flox/FloxLysM-Cre+ 
a b c
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immortalized macrophages were treated with either LeTx or FlaTox for 2h and lysates run on WB for 
detection of the indicated proteins. b, c, B6Nlrp1b+GSDMD-/- or B6Nlrp1b+GSDMD-/-Casp3Flox/FloxCasp7Flox/FloxLysM-
Cre+ immortalized macrophages were treated with either LeTx (b) or FlaTox (c) in media containing DEVD-
probe and PI were imaged on an Incucyte platform. The number of positive cells was quantified relative to a 
PI stained, Triton-x100-treated well (considered 100%) for each genotype. Values represent mean ± SD of 
technical duplicates of a representative experiment from three biological repeats. 
In conclusion, in this work we have shown that NLRP1b and NLRC4 inflammasome 
activation leads to a signature of caspase-3 and -7 activity in pyroptotic cells, and lack 
of GSDMD reveals this apoptotic program. In the GSDMD-/- background, caspase-8 
maturation was not prevented by lack of ASC, suggesting a caspase feedback loop 
could be responsible for activating caspase-8. Thus, inflammasome-dependent 
apoptosis in GSDMD deficient cells is a distinct mechanism than apoptosis 
happening in the absence of caspase-1 (Figure 5). The data presented here 
demonstrates that pyroptosis comprises a concerted coordination of a caspase 
cascade, in parallel to the pore formation by GSDMD. Defining the role of this 
apoptotic cascade happening during inflammasome activation may highlight 
alternative targets for treatment of inflammasome-mediated diseases. 
 
Figure 5. A model for the molecular pathways downstream of the inflammasome. Engagement of the 
inflammasome by cytosolic recognition of PAMPs or DAMPs activates caspase-1. Caspase-1 cleaves GSDMD 
for pore membrane formation, but also activates executioner caspases downstream, mainly caspase-7, 
accounting for an apoptotic substrate signature. The contribution of each executioner caspase to the DEVDase 
profile in WT cells remains to be determined, but given the high levels of caspase-7 activation it is tempting to 



























unimpaired by absence of ASC, suggesting caspase-8 activation at the ASC speck is not the driver of 
apoptosis. However, both caspase-3 and caspase-7 participate on the apoptotic phenotype of GSDMD-
deficient cells. 
3.2.3. Methods 
Mice. B6Nlrp1b+ 11, GSDMD-/- 12 and ASC-/- 13 mice have been described before. C57BL/6J 
mice were originally purchased from Charles River, and bred in-house. Animals 
were housed in individually ventilated cages under specific pathogen-free 
conditions, and studies were conducted under protocols approved by Ghent 
University Committee on Use and Care of Animals. 
Macrophage differentiation and stimulation. BMDMs were generated by culturing 
mouse bone marrow cells in L-cell-conditioned IMDM supplemented with 10% FBS, 
1% non-essential amino acids and 1% penicillin-streptomycin for 6 days in a 
humidified atmosphere containing 5% CO2. BMDMs were seeded in 12-well plates, 
and the next day either left untreated or stimulated with anthrax protective antigen 
(PA, 1 µg/ml, Quadratech) and lethal factor (LF, 500 ng/ml, Quadratech) or LFn-
Flag14 (1 µg/ml). Alternatively, BMDMs were treated with the proteasome inhibitor 
MG132 (10 µM, Calbiochem) for 30 minutes prior to LeTx incubation.  
Western blotting. Cell lysates were incubated with cell lysis buffer (20 mM Tris HCl 
pH 7.4, 200 mM NaCl, 1% NP-40) and denatured in laemmli buffer. For detection of 
caspase-1, ASC, caspase-3 and caspase-7, p23, ROCKI and Bid a part of the 
supernatant was kept with the cell lysates. Subsequently the protein samples were 
boiled at 95°C for 10 min and separated by SDS-PAGE. Separated proteins were 
transferred to nitrocellulose membranes. Blocking, incubation with antibody and 
washing of the membrane were done in PBS supplemented with 0.05% or 0.2% 
Tween-20 (v/v) and 3% non-fat dry milk. Immunoblots were incubated overnight 
with primary antibodies against caspase-1 (AG-20B-0042-C100, Adipogen), caspase-8 
(ALX-804-447-C100, 1G12, Enzo Life Sciences; 8592S, D5B2, Cell signaling), caspase-3 
(9662, Cell Signaling; 9664S, 5A1E, Cell signaling), ASC (AG-25B-0006, Adipogen), 
caspase-7 (9491, Cell Signaling; 9492, Cell Signaling), ROCKI (ab45171, Abcam), p23 
(MA3-414, Thermo Scientific) and Bid (AF860, R&D systems). Horseradish 
peroxidase-conjugated goat anti-mouse (115-035-146, Jackson Immunoresearch 
Laboratories), anti–rabbit (111-035-144, Jackson Immunoresearch Laboratories) or 
anti-rat (112-035-143, Jackson Immunoresearch Laboratories) secondary antibodies 
were used to detect proteins by enhanced chemiluminescence (Thermo Scientific). 
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Cell death kinetic measurements. A plate-based fluorescent assay (Incucyte, 
Essenbio) was used to quantify cell permeabilization with PI incorporation 
(Propidium Iodide, Thermo Scientifc, final concentration 0,1 µg/ml) and caspase-3/7 
activation (CellEvent Caspase3/7 Green substrate, Invitrogen) according to the 
manufacturers’ instructions. Data were acquired and analyzed using the Incucyte 
Zoom system (Essenbio). Briefly, cells were stimulated in a 96-well plate and 
incubated in a CO2 and temperature-controlled environment that allowed 
measurement of fluorescent signals over a time span of 10 hrs. 
FACS Annexin V measurements 
Annexin V (BD Pharmingen) staining on cells was performed according to the 
manufacturer’s instructions. Flow cytometry was used to measure stained cells and 
data were analyzed with FlowJo Software.  
3.2.4. Supplementary data 
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of GSDMD-deficient BMDMs. a-c, B6Nlrp1b+GSDMD-/- or GSDMD-/- macrophages were treated with either 
LeTx for 2h and imaged under a confocal microscope (a), cells collected for FACS analysis of Annexin V/PI 
positivity (b), and lysates run on WB for detection of the indicated proteins (c). d, B6Nlrp1b+ or B6 macrophages 
treated with LeTx in media containing DEVD-probe and PI were imaged on an Incucyte platform. e, B6Nlrp1b+ 
macrophages pretreated or not with MG132 were triggered with LeTx in media containing DEVD-probe and 
PI and imaged on an Incucyte platform. The number of positive cells was quantified relative to a PI stained, 
Triton-x100-treated well (considered 100%) for each genotype. Values represent mean ± SD of technical 
duplicates of a representative experiment from three biological repeats. 
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3.3. Effects of the inhibition of serine 
proteases on cell death induction and 
inflammasome activation 
3.3.1. PRCP inhibitor Compound 8o activates the 
NLRP3 inflammasome 
Section 3.3.1. is structured as the manuscript: de Vasconcelos, N.M.; 
Van Opdenbosch, N.; Vliegen, G.; Van Der Veken, P.; De Meester, I.; 
Lamkanfi, M. Lysosomal Prolyl carboxypeptidase antagonist 
Compound 8o induces macrophage cell death and NLRP3 
inflammasome-dependent IL1β release. In preparation.  
3.3.1.1. Abstract 
Despite the suggested role for Prolyl carboxypeptidase (PRCP) in inflammation, its 
function in macrophage biology has not been addressed yet. Here we made use of a 
PRCP antagonist, Compound 8o, to profile the response of bone marrow-derived 
macrophages. We found that Compound 8o induced high toxicity of macrophages 
and IL1β secretion. Cell death occurred independently of necroptosis, extrinsic 
apoptosis and pyroptosis, while IL1β release was rescued in the absence of the 
NLRP3 inflammasome components. Thus, inhibition of PRCP by Compound 8o 




3.3.1.2. Main text 
Prolyl carboxypeptidase (PRCP) is a lysosomal serine protease that cleaves off the 
most carboxy-terminal amino acid of its substrates (proteins and peptides) when this 
is preceded by Proline residue1. Angiotensin II and III and prekallikrein are 
established substrates of PRCP, linking this carboxypeptidase to regulation of blood 
pressure and cardiovascular functions2. Notably, polymorphisms in the gene 
encoding PRCP were shown to significantly increase the risk for preeclampsia in 
patients with a history of hypertension3. Furthermore, PRCP has been detected in the 
synovial fluids of atherosclerotic lesions, although its impact on the disease has not 
been fully elucidated4. Because of its clinical association with cardiovascular disease, 
understanding of PRCP biology has focused primarily on its roles in endothelial 
cells. However, PRCP-like protease activity has also been reported in macrophages4,5. 
Considering that PRCP has been implicated in initiation of inflammatory responses, 
and given the central role macrophages play in inflammatory responses, we set out 
to investigate the role of PRCP in macrophage biology using pharmacological tool 
agents.  
To inhibit the carboxypeptidase activity of PRCP in macrophages, we took advantage 
of Compound 8o, a previously discovered small molecule that reversibly antagonizes 
PRCP protease activity with high specificity and efficacy6. BMDMs were treated with 
Compound 8o and then analyzed microscopically to observe morphological changes. 
Interestingly, we found that BMDMs treated with Compound 8o displayed 
extensively swollen cytoplasmic vacuoles within 3h post-treatment (Fig. 1a). To 
probe whether inhibition of PRCP in macrophages lead to cytotoxicity, we tracked 
the incorporation of Sytox Green over time using the IncuCyte platform. Sytox Green 
is a cell-impermeant dye that enters cells and stains nuclear DNA only when the 
plasma membrane is permeabilized, a defining feature of necrotic cell death. 
Notably, treatment of BMDMs with Compound 8o led to a rapid cell death response 
that proceeded in a concentration-dependent manner. Compound 8o killed close to 
100% of BMDMs after 6h of incubation with 25 µM, while 10 μM of Compound 8o 
triggered about 50% of BMDMs to undergo cell death by 24h (Fig. 1b). A component 
of the extracellular wall of bacteria, LPS, can act as a survival signal in macrophages 
by signaling through TLR4 to induce expression of NF-κB-dependent anti-apoptotic 
proteins. However, priming BMDMs for 2h with LPS prior to Compound 8o 
stimulation did not alter the level or kinetics of cell death induction by Compound 8o 
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at neither 25 μM and 10 μM of the inhibitor (Fig. 1c), suggesting that Compound 8o 
induces a cell death pathway that is insensitive to TLR4-induced survival signaling. 
Several forms of regulated lytic cell death have recently been uncovered, with 
different effects on immune stimulation. Necroptosis is regulated by two members of 
the RIP kinase family, RIPK1 and RIPK3. Activation of these kinases downstream of 
death receptors and intracellular sensor proteins leads to phosphorylation of 
pseudokinase MLKL, the translocation of which to the plasma membrane triggers 
lysis of the cell7. To address whether PRCP inhibition with Compound 8o was 
mediated by the necroptosis machinery, we treated macrophages from RIPK1 D138N 
(RIPK1 KD) mutant macrophages, which lack RIPK1 kinase activity, with Compound 
8o. Abrogation of the kinase activity of RIPK1 has been demonstrated to impair its 
functions for necroptosis induction, while allowing NF-κB signaling to occur8. 
Interestingly, RIPK1 kinase deficiency was unable to stop cell death from LPS-
primed BMDMs treated with Compound 8o (Fig. 2a), suggesting that necroptosis is 
dispensable for Compound 8o-induced cytotoxicity. Consistent herewith, we found 
that MLKL-deficient BMDMs underwent plasma membrane permeabilization with 
unchanged kinetics relative to wildtype macrophages that had been treated with 
Compound 8o (Fig. 2a). 
Figure 1. Compound 8o leads to toxicity of bone marrow-derived macrophages. a, BMDMs were treated 
with 10uM of Compound 8o or kept without treatment. DIC images were acquired at the beginning of the 
experiment and after 3h. b, BMDMs were treated with 10 µM or 25 µM of Compound 8o or mock-treated and 
imaged on an INCUCYTE in media containing Sytox Green. c, BMDMs were initially primed with LPS 












































1 0 u M












































M o c k
1 0 u M










x100-treated well (considered 100%). Values represent mean ± SD of technical duplicates of a representative 
experiment from three biological repeats. 
Activation of death receptors can also lead to caspase-8-dependent apoptosis9. 
Apoptotic cells typically pack their contents into apoptotic bodies and undergo cell 
death without spill out of cytoplasmic material. Nonetheless, failure in clearance of 
apoptotic cells, as occurs in cell culture models and patients with functional defects 
in the phagocytic machinery, eventually leads to a process called secondary necrosis, 
in which the plasma membrane of the apoptotic cell is compromised, and its 
intracellular cargo is released10. To examine the role of extrinsic apoptosis in the 
plasma membrane permeabilization observed after Compound 8o treatment, we 
studied whether caspase-8 deletion interferes with Compound 8o-induced cell death 
in macrophages. Importantly, lack of caspase-8 is perinatally lethal, but mice are 
rescued from lethality by a RIPK3-deficient background11. However, we found that 
combined deficiency in caspase-8 and RIPK3 failed to protect BMDMs from 
Compound 8o-induced cytotoxicity (Fig. 2b), indicating that simultaneous blockade 
of both extrinsic apoptosis as well as necroptosis did not prevent cell death induction 
downstream of PRCP inhibition.  
Figure 2. Compound 8o toxicity is not mediated by necroptosis. a, b, WT, RIPK1 D138N (RIPK1 KD), MLKL-
/- (a), RIPK3-/- and RIPK3/Casp8-/- (b) BMDMs were initially primed with LPS (100ng/ml) and treated with 25 
µM of Compound 8o or kept without treatment and imaged on an INCUCYTE in media containing Sytox 
Green. The number of positive cells was quantified relative to a Triton-x100-treated well (considered 100%) 
for each genotype. Values represent mean ± SD of technical duplicates of a representative experiment from 
three biological repeats. 
Pyroptosis is a distinct mechanism of lytic cell death that proceeds downstream of 
inflammasome activation. Inflammasomes are a set of cytosolic protein complexes 
that induce activation of caspase-1 in myeloid cells and epithelial cells. Caspase-1 
subsequently cleaves its high affinity substrate, GSDMD12,13. The free N-terminal 
GSDMDN fragment then translocates to the plasma membrane and its 
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lysis of the cell14-17. Active caspase-1 also cleaves the inactive precursor forms of 
cytokines pro-IL1β and pro-IL18.  Both cytokines lack an ER-Golgi targeting 
sequence, and therefore are not secreted through the classical ER-Golgi secretory 
system18. Instead, several reports suggest a role for cell death in secretion of these 
active cytokines13,19,20. To understand whether Compound 8o triggers inflammasome 
activation in macrophages, we analyzed supernatants of Compound 8o-treated 
BMDMs for IL1β release. Notably, IL1β was readily detected in the supernatants of 
BMDMs that had been stimulated with Compound 8o for 4h (Fig. 3a). Longer 
treatments of 8h and 24h with Compound 8o did not increase the level of IL1β 
release, consistent with the high toxicity of the compound. Considering these results, 
we next addressed whether pyroptosis plays a role in the cell lysis observed with 
Compound 8o. We made use of Caspase-1-/-/Caspase-11-/- BMDMs to prevent 
downstream inflammasome activation. Following treatment with Compound 8o, 
however, these cells underwent cell death with similar kinetics and at similar levels 
relative to wildtype macrophages (Fig. 3b). Yet, lack of caspase-1 and caspase-11 
completely abrogated IL1β release, demonstrating that PRCP inhibition with 
Compound 8o induces inflammasome-dependent IL1β release parallelly to 
inflammasome-independent cell death (Fig. 3c). 
Figure 3. Compound 8o activates the NLRP3 inflammasome in macrophages. a, BMDMs were initially 
primed with LPS (100ng/ml) for 3h, then treated with 10 µM or 40 µM Compound 8o for either 4h, 8h and 
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BMDMs were initially primed with LPS (100ng/ml) and treated with 25 µM of Compound 8o or kept without 
treatment and imaged on an INCUCYTE in media containing Sytox Green. The number of positive cells was 
quantified relative to a Triton-x100-treated well (considered 100%) for each genotype. c, d, WT, Caspase1/11-/- 
(c), NLRP3-/- and ASC-/- (d) BMDMs were initially primed with LPS (100ng/ml) for 3h, then treated with 40uM 
Compound 8o for 4h, and their supernatants were assayed for IL1β release. Values represent mean ± SD of 
technical duplicates of a representative experiment from three biological repeats. 
Caspase-1 activation can be elicited from several intracellular inflammasome 
receptors, with NLRP3 sensing a diverse variety of stimuli, including pore forming 
toxins, ATP, particulate matter and lysosomal damage18. NLRP3 associates with the 
bipartite protein ASC to form a cytosolic speck to which caspase-1 is recruited. 
NLRP3 activation has been shown to also occur downstream of lytic forms of cell 
death, such as caspase-11-triggered pyroptosis21 and MLKL-mediated necroptosis20. 
In these systems, abrogation of either NLRP3, its binding partner ASC or caspase-1 
stops IL1β release but does not influence the cell death program elicited. To 
understand if NLRP3 could be responsible for the IL1β release after PRCP inhibition, 
we probed WT, ASC-/- and NLRP3-/- BMDMs with Compound 8o. Interestingly, in the 
absence of ASC or NLRP3 we could no longer detect IL1β in the supernatant of 
Compound 8o-treated BMDMs (Fig. 3d), establishing that the NLRP3 inflammasome 
is responsible for IL1β release in Compound 8o-treated macrophages. However, 
NLRP3 deletion did not alter toxicity of Compound 8o in macrophages supporting 
the notion that inflammasome activation is not responsible for the cell death elicited 
by this PRCP antagonist (Fig. 3d). 
In conclusion, we have shown that use of a PRCP inhibitor, Compound 8o, leads to a 
fast and lytic form of cell death in macrophages. This cell death was independent of 
RIPK1 kinase function, MLKL and RIPK3, discarding necroptosis as its mechanism. 
Furthermore, lack of caspase-8 and caspase-1/caspase-11 could not rescue BMDMs 
from Compound 8o-induced cytotoxicity, demonstrating that extrinsic apoptosis and 
pyroptosis are dispensable for the cell death observed. Importantly, in the context of 
inflammasome signaling, lack of caspase-1 has been demonstrated to allow a shift to 
a caspase-8-dependent pathway, merely delaying death of triggered 
macrophages22,23. However, in this scenario, caspase-8 and the cell death induced are 
under control of NF-kB signaling for survival, and thus can be prevented by TLR 
stimulation23,24. In our experimental settings, macrophages were primed with LPS 
before triggering cell death with Compound 8o. Therefore, we believe the lack of 
effect is not due to a rapid cell death switch, but rather reflects that caspase-1 is not 
essential for the cell death program triggered by PRCP inhibition. 
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Interestingly, macrophages treated with Compound 8o matured and secreted IL1β in 
a NLRP3, ASC and caspase-1/-11-dependent manner. In vivo, IL1β has been shown to 
be able to promote neutrophilia in the context of a bacterial infection in order to 
promote pathogen clearance but can also contribute to overt local inflammation18. 
Our finding that IL1β is released from macrophages treated with Compound 8o 
suggests that PRCP inhibition can have inflammatory effects in vivo. Furthermore, 
the NLRP3 response observed after PRCP inhibition occurred either downstream or 
independently of the cell death program. Further understanding of the cell death 
mechanism triggered after PRCP inhibition could answer its relationship to NLRP3 
activation. Overall, to our knowledge, our research for the first time investigated the 
role of PRCP inhibition in macrophages and interrogated the contribution of the well 
described cell death pathways (i.e. necroptosis, pyroptosis and extrinsic apoptosis) to 
its toxicity. The high toxicity observed suggests that PRCP may regulate important 
physiological pathways, and its inhibition might have detrimental effects in vivo. 
Indeed, previous reports have suggested that downregulation of PRCP is related to 
reduction in cell proliferation and increased cell death, though this was considered to 
be independent on PRCP activity25. Future research into PRCP targeting for clinical 
applications should take into consideration the possible toxic effects of Compound 8o 
in macrophages. 
3.3.1.3. Methods 
Mice. Casp8/RIPK3-/- 26, RIPK1 D138N (RIPK1 KD)27, RIPK3-/- 28, MLKL-/- 29, NLRP3-/- 30, 
ASC-/- 31, Casp1/11-/- 32 mice have been reported. C57BL/6J mice were originally bought 
from the Jackson Laboratories and bred in-house. Mice were housed in individually 
ventilated cages and kept under pathogen-free conditions at the animal facilities of 
Ghent University. All animal experiments were conducted with permission of the 
ethics committee on laboratory animal welfare of Ghent University. 
Primary macrophage differentiation and stimulation. Macrophages were 
differentiated by culturing bone marrow progenitor cells in Iscove’s modified 
Dulbecco’s medium (IMDM; Lonza) containing 10% (v/v) heat-inactivated FBS, 30% 
(v/v) L929 cell-conditioned medium, 1% (v/v) non-essential amino acids (Lonza), 100 
U/ml penicillin and 100 mg/ml streptomycin at 37 °C in a humidified atmosphere 
containing 5% CO2 for six days. Bone marrow-derived macrophages (BMDMs) were 
then seeded into 96 or 24 well plates as needed, in IMDM containing 10% FBS, 1% 
non-essential amino acids and antibiotics. On the next day, cells were changed to 
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fresh media and either primed or not with LPS (100ng/ml) for 3h prior to treatment 
with Compound 8o (water) at either 10, 25 or 40 µM. 
Imaging of macrophages. BMDMs grown on 8-well µ-slide chambers (Ibidi) were 
either left untreated or received 10 µM of Compound 8o. DIC images were acquired 
using an observer Z.1 spinning disk microscope (Zeiss, Zaventem, Belgium) 
equipped with a Yokogawa disk CSU-X1. 
Cell death kinetics (Incucyte). Analysis of cell death was performed through 
incorporation of 500 nM of Sytox Green dye (S7020, Thermo Scientific) in a 96-well 
format assay. Data was acquired with a 10x objective using the IncuCyte Zoom 
system (Essen BioScience) in a CO2 and temperature-controlled environment. Each 
condition was run in (technical) duplicates. The number of fluorescent objects was 
counted with Incucyte ZOOM (Essen BioScience) software and was plotted 
considering as 100% the highest value obtained in a well treated with Triton-x100. 
Cytokine analysis. Unless otherwise stated, cell supernatant was collected after 4h of 
stimulation, and the culture medium was measured by magnetic bead-based 
multiplex assay using Luminex technology (Bio-Rad) according to the 
manufacturer’s instructions. 
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3.3.2. DPP8/DPP9 inhibitors as activators of 
NLRP1b 
Section 3.3.2. is structured as the manuscript: de Vasconcelos, N.M.; 
Van Opdenbosch, N.; Vliegen, G.; Van Der Veken, P.; De Meester, I.; 
Lamkanfi, M. Inhibition of DPP8/DPP9 elicits an NLRP1b-dependent 
inflammasome activation. In preparation. 
 
3.3.2.1. Abstract 
The dipeptidases DPP8 and DPP9 have been implicated in a number of inflammatory 
pathologies, but their role remains elusive. Recently, pharmacological inhibition of 
DPP8/DPP9 was suggested to trigger inflammasome-dependent cytokine release, 
although the mechanism involved is ill-defined. Here we demonstrate that transgenic 
expression of the 129S-allele of Nlrp1b in C57/BL6 (B6Nlrp1b+) sensitizes mouse 
macrophages to cell death after inhibition of DPP8/DPP9 by Val-boroPro or 1G244. 
The cytotoxic effects observed are accompanied by enhanced IL1β and IL18 release, 
consistent with an inflammasome-dependent response. 1G244 triggered cell death 
and cytokine release in B6Nlrp1b1+ macrophages were partially hampered by pre-
treatment with the proteasomal inhibitor, MG132. Further, ablation of ASC in a 
B6Nlrp1b1+ background still allowed cell death to proceed after either Val-boroPro or 
1G244 treatments, while lack of caspase-1 delayed cell death and prevented IL1β and 






Serine proteases from the prolyl oligopeptidases family cleave dipeptides after a 
Proline located, mostly, at the N-terminal site of a protein sequence. DPPIV, FAP, 
DPP8, DPP9, DPP2 and PREP can be broadly considered within the same family, 
given their shared substrate specificity and high level of homology1. These proteases 
have been shown to play distinct roles in inflammation and immune responses, 
acting in the regulation of T cell activation, bioavailability of chemokines and tissue 
remodelling2. Inhibition of prolyl oligopeptidases are a promising target given their 
roles in disease pathologies with inflammatory components such as atherosclerosis. 
Nevertheless, inhibitor specificity within the family has been a challenging issue1. 
While the substrates and roles of DPP2 and PREP are still elusive1, the prototypical 
member of the family DPPIV is used as a target in the clinic for control of type 2 
diabetes3,4. FAP, on the other hand, has collagenase activity and plays roles in wound 
healing and tumorigenesis2. Clinical trials have been undertaken with a FAP 
inhibitor, Val-boroPro (VBP), for therapy of advanced non-small cell lung carcinoma 
and melanoma5,6. While there was a therapeutic response with VBP administration, 
concerns on its safety lead to termination of the study2. Indeed, VBP is also a potent 
inhibitor of DPP8, DPP9 and DPP4. 
DPP8 and DPP9 are the most homologous proteases in the family. Control of protein 
turnover, antigen presentation and inflammation are some of the functions 
associated to DPP9 activity7,8. However defining DPP8/DPP9 roles in physiological 
conditions is a challenging endeavour2.  
Inflammasomes play important roles during inflammatory responses against 
pathogenic invasion9. These cytosolic platforms rely on the sensing of a variety of 
intracellular danger or pathogen associated molecules by pattern recognition 
receptors of the Nod-like receptors and AIM2-like receptors families and Pyrin10. 
Once triggered, they assemble with the bipartite molecule ASC to form the 
inflammasome platform. Caspase-1 is a serine protease produced as a zymogen in 
the cytosol and relies on the recruitment to inflammasomes for proximity-induced 
autoactivation9. Active caspase-1 cleaves and activates the pro-form cytokines pro-
IL1β and pro-IL189. Further, caspase-1 cleaves GSDMD11,12, releasing an N-terminal 
fragment which translocates to the plasma membrane and perforates it during 
pyroptotic cell death13-16. Therefore, caspase-1 acts to both activate IL1β and IL18 and 
to promote their release through GSDMD-mediated pyroptotic cell death. 
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Remarkably, Val-boroPro (VBP) and its activity in DPP8 and DPP9 inhibition has 
been suggested to induce procaspase-1-dependent cell death in the human 
monocytic-like cell THP1, seemingly in the absence of an upstream inflammasome 
receptor17. While caspase-1 can be activated in the absence of cleavage, this 
mechanistically is associated to the lack of ASC after engagement of CARD-
containing receptors18-20. Therefore, it remained unclear how VBP engaged caspase-1 
independently of inflammasome sensors and how it activates caspase-1 without 
induced autocleavage in THP1 cells. 
A further publication suggested a role for the NLRP1b inflammasome in VBP 
activity21. Most of the data on VBP activity is done in RAW cells, a macrophage cell 
line originated from Balb/c mice. However, in vivo studies and analysis of primary 
macrophages are in cells derived from C57BL/6J mice, which express a Nlrp1b allele 
that is considered inactive22. While humans only have one Nlrp1 gene, mice have 
three orthologues: Nlrp1a, Nlrp1b and Nlrp1c. Nlrp1c is regarded as a pseudogene, 
whereas an activating mutation on Nlrp1a has been shown to be linked to 
inflammasome assembly and pyroptosis in hematopoietic progenitor cells23. The best 
characterized mouse Nlrp1 orthologue is Nlrp1b, whose activation and 
inflammasome assembly have been shown to occur after Bacillus anthracis derived 
LeTx triggering22,24. Furthermore, five different alleles of Nlrp1b are encoded in 
various mice strains22. Allele 1, found in 129S and Balb/c mice, and allele 5, found in 
the CAST/EiJ line, promote susceptibility of their macrophages to LeTx intoxication. 
On the other hand, allele 2, found in A/J and C57BL/6J mice together with alleles 3 
and 4 in other inbred strains, confer resistance of macrophages from these mouse 
strains to LeTx. 
Cleavage of the allele 1 of NLRP1b (for clarity, here called NLRP1b1) at its FIIND 
domain, LeTx catalytic activity and proteasome function are the determinants of 
NLRP1b1 inflammasome activation25,26, though it is still not understood how these 
events relate to one another. Therefore, the current work aimed at clarifying the 
ability of DPP8/DPP9 inhibition to activate an inflammasome, to determine the 
inflammasome receptor responsible for the IL1β and IL18 release and the mechanism 
of cell death induction. 
3.3.2.3. Results 
DPP8/DPP9 inhibitors induce macrophage cell death and IL1β and IL18 release 
Results 104 
 
To validate the ability of VBP to induce toxicity in murine primary macrophages, 
bone marrow-derived macrophages (BMDMs) were treated with increasing 
concentrations of VBP, and the kinetics of cell death was tracked on an Incucyte 
platform. Staining by Sytox Green, a membrane-impermeable dye, was used as a 
marker for lytic cell death. When analysed for 24h for incorporation of Sytox Green, 
VBP induced a low, but consistent levels of BMDM cell death, accounting for at most 
30% of toxicity at 24h at all concentrations tested (Fig. 1a). A modification at the n-
terminal end of VBP has been shown to hamper its inhibitory activity. Interestingly, 
N-acetyl-VBP (NacVBP) failed to induce toxicity in BMDMs (Fig. 1b), suggesting 
VBP toxic effects are due to its inhibition of the catalytic activity of DPP proteases. 
However, an alteration to a cyclic form shown to improve VBP (CyclicVBP) stability 
also failed to induce BMDM toxicity up to 24h (Fig. 1c).  
VBP has been shown to not specifically inhibit DPP8 and DPP9, also acting on DPP4 
and FAP with similar affinity. To understand whether the effect we observed was 
specific to any of these dipeptidases, we made use of inhibitors with a more confined 
selectivity profile and analysed BMDM cell death. Sitagliptin, UAMC0039, 
UAMC01110, KYP-2047/UAMC0714 have been shown to specifically inhibit DPP4, 
DPP2, FAP and PREP, respectively. However, none of these inhibitors were able to 
induce BMDM cell death when used in similar concentrations than VBP (Fig. 1d-g). 
This suggests that the toxicity observed with VBP treatment is related to its inhibition 
of DPP8/DPP9. Confirming this hypothesis, 1G244, which is regarded as a specific 
DPP8/DPP9 inhibitor, induced cell death in BMDMs more efficiently than VBP (Fig. 
1h). Therefore, DPP8/DPP9 inhibition is toxic to BMDMs. 
Inhibition of DPP8 and DPP9 leads to IL1β release in NLRP1b1-dependent and independent 
pathways 
Macrophage cell death is often regarded as a mechanism of cytokine secretion, 
particularly for IL1β and IL18 through activation of inflammasomes. Furthermore, 
VBP has been shown to induce IL1β and IL18 secretion in human macrophages, 
though through a still ill-defined mechanism. Therefore, to validate VBP activities in 
BMDMs, we primed macrophages with LPS and subsequently treated them with 
VBP. VBP treatment led to a low, but consistent secretion of IL1β and IL18 in the 
supernatant of BMDMs, particularly at 24h post stimulation (Fig. 2a, b). NacVBP was 
unable to induce IL1β secretion up to 24h post-treatment (Fig. 2c), suggesting VBP 
needs to inhibit a catalytic activity to activate an inflammasome. Correlating with our 
previous cell death data, CyclicVBP also did not induce any IL1β release, but IL1β 
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Figure 1. Inhibition of DPP8/DPP9 by Val-boroPro and 1G244 is toxic to primary BMDMs. a-h, B6 BMDMs 
were treated with 10, 25 or 40 µM of Val-boroPro (a), N-acetyl-Val-boroPro (b), Cyclic-Val-boroPro (c), 
Sitagliptin (d), UAMC0039 (e), UAMC01110 (f), KYP-2047/UAMC0714 (g) or 1G244 (h) or mock-treated and 
imaged on an INCUCYTE platform in media containing Sytox Green. The number of positive cells was 
quantified relative to a Triton-x100-treated well (considered 100%). Values represent mean ± SD of technical 
duplicates of a representative experiment from three biological repeats. 
could be readily detected in the supernatant of 1G244-treated macrophages from 8h 
post-stimulation (Fig. 2d, e). IL18 could not be detected in the supernatant of 
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Figure 2. BMDMs treated with Val-boroPro or 1G244 release IL1β and IL18. a, c-e, B6 BMDMs were initially 
primed with LPS (100ng/ml) for 3h, then treated with 10 µM or 40 µM of Val-boroPro (a, b), N-acetyl-Val-
boroPro (c), Cyclic-Val-boroPro (d) or 1G244 (e). Collected supernatants after 4h, 8h and 24h were assayed for 
IL1β (a, c-e) or IL18 (b). Values represent mean ± SD of technical duplicates of a representative experiment 
from three biological repeats. 
While we could detect low levels of IL1β after VBP treatment, these were not in line 
with previous reports of DPP8/DPP9 inhibition on THP1 human cells. All 
inflammasome receptors are similarly represented in human and mouse 
macrophages, except for the NLRP1 family members. Humans have only one Nlrp1 
gene, but mice have three orthologues Nlrp1a, Nlrp1b and Nlrp1c. Furthermore, from 
the five Nlrp1b alleles existing throughout mice strains, the allele 1 found in 129S 
mice confers susceptibility to B. anthracis-derived LeTx, while allele 2 present in 
C57BL/6J hinders their response to LeTx. To compare the role of NLRP1b in C57BL/6J 
macrophages, we made use of transgene expression of the 129S-derived Nlrp1b allele 
(Nlrp1b1) in B6 macrophages which has been shown to render these sensitive to LeTx 
intoxication. Similarly, B6Nlrp1b1+ macrophages were sensitized to DPP8/DPP9 
inhibition by VBP, CyclicVBP and 1G244 (Fig. 3a, c, d). Furthermore, NacVBP still 
had no effects on B6Nlrp1b1+ BMDMs (Fig. 3b), confirming that the effects observed are 
due to catalytic inhibition of DPP8/DPP9. Cytokine analysis detected IL1β and IL18 
on supernatant of B6Nlrp1b1+ BMDMs 4h after treatment by VBP and 1G244 (Fig. 3 e, f, 
j, k), which accumulated up to 24h. Furthermore, CyclicVBP induced IL1β and IL18 























































































































































































































































Figure 3. Presence of 129-derived allele of Nlrp1b sensitises macrophages to DPP8/DPP9 inhibition. a-d, 
B6Nlrp1b1+ BMDMs were treated with 10, 25 or 40 µM of Val-boroPro (a), N-acetyl-Val-boroPro (b), Cyclic-Val-
boroPro (c) or 1G244 (d) or mock-treated and imaged on an INCUCYTE platform in media containing Sytox 
Green. The number of positive cells was quantified relative to a Triton-x100-treated well (considered 100%). 
Values represent mean ± SD of technical duplicates of a representative experiment from three biological 
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µM of Val-boroPro (e, f), N-acetyl-Val-boroPro (g), Cyclic-Val-boroPro (h, i) or 1G244 (j, k). Supernatants 
collected after 4h, 8h and 24h were assayed for IL1β (e, g, h, j) or IL18 (f, i, k). Values represent mean ± SD of 
technical duplicates of a representative experiment from three biological repeats. 
inhibition of DPP8/DPP9 by VBP or 1G244 leads to NLRP1b inflammasome 
activation, when in presence of Nlrp1b allele 1. 
DPP8/DPP9-mediated Nlrp1b1 activation is not hampered by absence of ASC but partially 
requires proteasomal activity for activation 
Inhibition of the proteasome by MG132 hampers activation of the NLRP1b 
inflammasome by its canonical trigger LeTx. To understand if the proteasome 
requirement was a shared event after DPP8/DPP9 inhibition, we pre-treated B6Nlrp1b1+ 
BMDMs with MG132 prior to 1G244 stimulation. Interestingly, MG132 delayed cell 
death after 1G244 treatment in B6Nlrp1b1+ BMDMs, but was unable to fully protect cells 
(Fig. 4a). Release of IL1β and IL18 cytokines, on the other hand, was reduced to 
background levels when cells were treated with MG132 prior to 1G244 (Fig. 4b, c), 
suggesting a conserved upstream pathway of the NLRP1b inflammasome activation. 
NLRP1b and NLRC4 proteins contain CARD domains. Therefore, these receptors are 
unique as they do not fully depend on the adaptor molecule ASC to bridge their 
interaction with caspase-1. As it was shown after LeTx-triggering, B6Nlrp1b1+ASC-/- 
BMDMs still underwent cell death after both VBP and 1G244 stimulation, though at 
diminished levels (Fig. 4d, e). Thus, our results so far established that the upstream 
requirements for NLRP1b activation, namely the need for proteasomal activity but 
not ASC, are shared between LeTx intoxication and DPP8/DPP9 inhibition.  
DPP8/DPP9 inhibition leads to pyroptosis in Nlrp1b1 sufficient cells 
Inflammasomes act as platforms for caspase-1 activation, which cleave its high 
affinity substrate GSDMD for pyroptotic cell death. Treatment with VBP and 1G244 
led to a lytic form of cell death which was mostly NLRP1b-dependent (Fig. 1 and Fig. 
2). Therefore, we hypothesized that DPP8/DPP9 inhibition could promote caspase-1-
dependent pyroptosis. Indeed, B6Nlrp1b1+ BMDMs deficient for caspase-1/-11 were 
protected from cell death after both VBP and 1G244 treatments (Fig. 4d, e). Lack of 
caspase-1/-11 in the B6Nlrp1b1+ background also prevented release of IL1β and IL18 in 
the supernatant of BMDMs treated with 1G244 (Fig. 4f, g). Interestingly, triggering 
NLRP1b inflammasome with LeTx in the absence of caspase-1/-11 has been shown to 
only delay cell death, promoting a switch to a caspase-8-dependent apoptosis. In this 
scenario, either lack of both ASC and caspase-1/-11 or TLR-stimulation abrogates cell 
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death by impairing caspase-8 activation. However, after VBP and 1G244 treatment, 
ablation of caspase-1/-11 was sufficient to protect BMDMs from cell death during the 
time analysed, demonstrating a toxicity curve similar to the ASC/Caspase-1/Caspase-
11-/- cells (Fig. 4d, e). Therefore, DPP8/DPP9 inhibition by VBP and 1G244 represents 
a canonical NLRP1b inflammasome trigger, causing downstream caspase-1-
dependent pyroptosis and IL1β and IL18 release. 
 
Figure 4. DPP8/DPP9 inhibition leads to MG-132-mediated, ASC independent and caspase-1/11-dependent 
activation of the NLRP1b inflammasome. a, B6Nlrp1b1+ BMDMs were triggered with 10 µM 1G244 or mock-
treated in presence or absence of MG132 and imaged on an INCUCYTE platform in media containing Sytox 
Green. The number of positive cells was quantified relative to a Triton-x100-treated well (considered 100%). 
Values represent mean ± SD of technical duplicates of a representative experiment from two biological 
repeats. b, c, LPS-primed B6Nlrp1b1+ BMDMs were treated as in (a) and supernatants collected after 4h for IL1β 
(b) or IL18 (c) measurement in the supernatant. Values represent mean ± SD of technical duplicates of a 
representative experiment from two biological repeats. d, e, B6Nlrp1b1+, B6Nlrp1b1+ASC-/-, B6Nlrp1b1+Caspase-1/-11-/-, 
B6Nlrp1b1+ASC-/-Caspase-1/-11-/- BMDMs were treated with 10 µM of either 1G244 (d) or Val-boroPro (e) or 
mock-treated and imaged on an INCUCYTE platform in media containing Sytox Green. The number of 
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Values represent mean ± SD of technical duplicates of one biological repeat. f, g, LPS-primed B6Nlrp1b1+ and 
B6Nlrp1b1+Caspase-1/-11-/-  BMDMs were treated as in (d) and supernatants collected after 24h for IL1β (f) or 
IL18 (g) measurement in the supernatant. Values represent mean ± SD of technical triplicates of one biological 
repeat. 
3.3.2.4. Discussion 
In the current study, we have demonstrated that DPP8 and DPP9 inhibition is a 
trigger for inflammasome activation. In NLRP1b1+ cells, containing the 129 allele 1, 
treatment with VBP and 1G244 led to fast cell death and IL1β and IL18 release, both 
events being controlled by caspase-1. Furthermore, ASC deficiency was unable to 
hamper cell death after 1G244 and VBP treatment, while proteasome inhibition by 
MG132 partially impaired cell death and cytokine release. Therefore, in NLRP1b 
competent cells, inhibition of DPP8 and DPP9 leads to a canonical NLRP1b 
inflammasome activation and pyroptosis, sharing conserved regulatory mechanisms 
with the LeTx trigger. These results suggest that the NLRP1b inflammasome is a 
sensor of DPP8/DPP9 activity. Whether the activity of DPP8/DPP9 in the NLRP1b 
protein is direct or indirect is still to be determined. Our results also demonstrated 
that absence of NLRP1b delayed cell death and cytokine production, but both effects 
were still present at 24h post treatment. Further studies will be needed to delineate 
the contribution of other inflammasome receptors in B6 cells after DPP8/DPP9 
inhibition. 
While DPP8 function is still elusive, DPP9 activity has been implicated in cell 
viability of T lymphocytes and human skin cells27,28. In line with our results in which 
primary macrophages derived from either B6Nlrp1b1+ or pure B6 have differential 
responses after DPP8/DPP9 inhibition, toxicity of DPP8/DPP9 inhibition has been 
demonstrated to be more prominent in the J774.A macrophage cell line, originated 
from Balb/c mice, than in C57BL/6J primary macrophages29. Furthermore, a S739A 
point mutation hampers DPP9 proteolytic activity and prevents mice from 
developing passed neonatal stage30. Remarkably, DPP9S739A/S739A mice were developed 
in C57BL/6J background. Our observation that B6 macrophages die upon DPP8/DPP9 
inhibition and release IL1β suggests that the lethality observed in DPP9S739A/S739A mice 
might be related to an overt cell death and immune overactivation. A more in-depth 
analysis of the immune compartments of DPP9S739A/S739A mutant mice would be 
needed to understand the physiological functions for DPP9 activity. 
In conclusion, DPP8/DPP9 proteases control inflammasome-dependent responses, 
which are enhanced in an NLRP1b-dependent manner. Characterization of 
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pathogens able to inhibit DPP8/DPP9 could shed light on the physiological roles of 
the NLRP1b inflammasome. Further studies on the role of DPP8/DPP9 in the B6 
background could aid in understanding its developmental role. 
3.3.2.5. Methods 
Mice. ASC-/- 31, Casp1/11-/- 32 and B6Nlrp1b1+ 33 mice have been reported, and the 
genotypes thereof obtained by breeding. C57BL/6J mice were originally bought from 
the Jackson Laboratories and bred in-house. Mice were housed in individually 
ventilated cages and kept under pathogen-free conditions at the animal facilities of 
Ghent University. All animal experiments were conducted with permission of the 
ethics committee on laboratory animal welfare of Ghent University. 
Reagents. Recombinant expression and purification of B. anthracis protective antigen 
(PA) was performed as described. B. anthracis lethal factor (LF) was acquired from 
List Biologicals. Sytox Green (S7020) was purchased from Thermo Scientific. The 
antibody for caspase-1 (AG-20B-0042-C10) was acquired from Adipogen. HRP-
conjugated secondary antibody was acquired from Jackson Immunoresearch 
Laboratories and enhanced chemiluminescence solution was from Thermo Scientific. 
LPS-SM (tlrl-smlps) was acquired from Invivogen.  
Primary macrophage differentiation and stimulation. Macrophages were 
differentiated by culturing bone marrow progenitor cells in Iscove’s modified 
Dulbecco’s medium (IMDM; Lonza) containing 10% (v/v) heat-inactivated FBS, 30% 
(v/v) L929 cell-conditioned medium, 1% (v/v) non-essential amino acids (Lonza), 100 
U/ml penicillin and 100 mg/ml streptomycin at 37 °C in a humidified atmosphere 
containing 5% CO2 for six days. Bone marrow-derived macrophages (BMDMs) were 
then seeded into 96 or 24 well plates as needed, in IMDM containing 10% FBS, 1% 
non-essential amino acids and antibiotics. On the next day, cells were changed to 
fresh media and either primed or not with LPS (100ng/ml) for 3h prior to treatment 
with Sitagliptin (water), 1G244 (DMSO), UAMC0039 (water), UAMC01110 (DMSO), 
Val-boroPro (0,1%TFA in DMSO), N-acetyl Val-boroPro (DMSO), Cyclic Val-boroPro 
(0,1%TFA in DMSO) or KYP-2047/UAMC0714 (DMSO) at either 10, 25 or 40uM 
(Table 1). For NLRP1b inflammasome activation, cells were stimulated with LeTx (1 
µg/ml PA combined with 0,5 µg/ml LF). 
Table 1. Summary of the inhibitors used in the study and their IC50 values for 
DPPIV family members. Values represent IC50 (nM). 
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 DPP-IV DPP8 DPP9 FAP PREP DPP-II Ref 
Val-boroPro 4 11 560 390 >100,000 n/a 34 
1G244 >100,000 14 53 >100,000 n/a n/a 35 
Sitagliptin 10 48000 >100000 >100000 n/a n/a 36 
UAMC01110 >100000 >100000 >100000 11 >50000 n/a 37 
UAMC00039 165000 142 000 78600 n/a n/a 0.48 38 
KYP-2047 >100000 n/a >100000 >100000 6 >100000 39 
 
Cell death kinetics (Incucyte). Analysis of cell death was performed through 
incorporation of 500 nM of Sytox Green dye in a 96-well format assay. Data was 
acquired with a 10x objective using the Incucyte Zoom system (Essen BioScience) in a 
CO2 and temperature-controlled environment. Each condition was run in (technical) 
duplicates. The number of fluorescent objects was counted with Incucyte ZOOM 
(Essen BioScience) software and was plotted considering as 100% the highest value 
obtained in a well treated with Triton-x100. 
Cytokine analysis. Cell culture supernatant was collected after 4h, 8h and 24h of 
stimulation, and the culture medium was measured by magnetic bead-based 
multiplex assay using Luminex technology (Bio-Rad) according to the 
manufacturer’s instructions. 
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 4. Discussion and 
Perspectives 
Pyroptosis is a form of regulated cell death happening in macrophages and epithelial 
cells linked to inflammasome activation276. Cytosolic receptors belonging to the 
families of the Nod-like receptors, AIM2-like receptors and Pyrin sense intracellular 
damage or pathogen associated patterns. Their activation and assembly to the 
bipartite protein ASC forms the inflammasome platform. Procaspase-1 is recruited to 
this platform for proximity-induced autoactivation161. Furthermore, a non-canonical 
inflammasome directed by caspase-11 can independently execute pyroptotic cell 
death154. Remarkably, both caspase-1 and caspase-11 converge on activation of the 
same substrate, GSDMD, to mediate plasma membrane rupture during 
pyroptosis16,261. While in the last 15 years there has been much advance in 
understanding the upstream inflammasome players, the mechanisms governing cell 
death are still elusive.  
In the presented organellar analysis of pyroptosis (Section 3.1), we defined a 
conserved set of organellar changes associated to pyroptotic cell death execution. 
Ionic fluxing, cellular swelling, mitochondrial depolarization and lysosomal leakage 
all preceded final plasma membrane lysis, as reported by Sytox Green or PI uptake. 
These events anticipated membrane rupture after both NLRP1b and NLRC4 
inflammasome activation. Furthermore, non-canonical inflammasome activation 
directed a similar demise program, with mitochondrial depolarization and ionic 
fluxes happening prior to membrane commitment, in a GSDMD-dependent way. 
Hence, these represent pyroptotic shared events. 
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In combining these data, we propose a model in which pyroptosis undergoes 
through a gradual increase in plasma membrane permeability in a GSDMD-
dependent manner. This effect could be accomplished by insertion of GSDMDN in 
the plasma membrane as either single molecules or oligomers of low orders of 
magnitude, which would account for early alterations in cellular permeability 
(Figure 1). Further oligomerization of GSDMDN at the plasma membrane and 
formation of the highly organized pore of 10-20 nm in diameter262-265 would account 
for final stages of pyroptotic permeability and release of intracellular contents. 
 
Figure 1. A schematic overview of the morphological changes associated to pyroptosis induction after 
NLRP1b and NLRC4 inflammasome activation. Caspase-1 activation after canonical triggers leads to 
pyroptosis compassing mitochondrial depolarization and fragmentation, lysosomal decay and nuclear 
rounding. At the plasma membrane, cell death downstream of the inflammasome is accompanied by a 
gradual increase in permeability, demonstrated by ionic fluxing and cellular swelling which preceded 
incorporation of nuclear dyes PI or Sytox Green. Furthermore, caspase-11 and the non-canonical 
inflammasome activation converge at the level of GSDMD cleavage. Non-canonical inflammasome-mediated 
cell death was similarly accompanied by ionic fluxing and mitochondrial decay, which were dependent on 
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The close temporal associations between phosphatidylserine exposure in pyroptotic 
cells and plasma membrane rupture could guarantee rapid and efficient uptake of 
the cell corpse, avoiding pathogen spread. Pyroptotic cell corpses have been shown 
to contain intracellular pathogens to facilitate removal by infiltrating neutrophils in 
structures called PITs277. It is tempting to speculate that PS exposure on the 
pyroptotic cell corpse helps in the uptake of the PITs and pathogen removal, and it 
would be interesting to address what are the potential pathological consequences of 
lack of PS exposure in pyroptotic cells during an infection in vivo. On our analysis of 
intracellular components that are released after NLRP1b and NLRC4 inflammasome 
activation, we found that there is no selectivity towards which intracellular proteins 
are released during pyroptotic cell rupture. This reinforces the concept that the 
maintenance of pathogens in the PITs is probably a reflection of their size, as 
organelles are also maintained in the cellular corpse. However, it suggests that 
pathogen-derived proteins could also be released in the extracellular milieu and 
activate neighboring cells. 
Presence of cathepsin B, cytochrome c and HMGB1 in the supernatants of pyroptotic 
macrophages suggests that organellar damage is a marked feature of pyroptosis, and 
accounts for release of proteins without selectivity during cell death. Interestingly, 
GSDMDN has been found to be present across most intracellular membranes262,263,265, 
consistent with our observed dependency for GSDMDN in mitochondrial damage. 
However, GSDMDN damage of the plasma membrane could also account for damage 
on mitochondria and lysosomes, by unbalancing electrochemical gradients imposed 
by the plasma membrane. A temporal analysis of intracellular localization of 
GSDMDN during cell death could aid in answering whether pyroptotic organellar 
damage is directly mediated by GSDMDN or reflects the plasma membrane damage 
cause by GSDMDN. 
Further, through our analysis of biochemical events downstream of NLRC4 and 
NLRP1b inflammasome activation, we demonstrated that DEVDase activity can be 
detected in pyroptotic cells, which is accompanied by cleavage of substrates typically 
associated to apoptosis, namely ROCK1, Bid and p23 (Section 3.2). This suggests that 
pyroptotic cell death happening downstream of the canonical inflammasome is a 
combination of an apoptotic signature (DEVDase) and pore formation at the plasma 
membrane, executed by GSDMD. Interestingly, caspase-7 was chiefly activated in 
pyroptotic cells, as it has previously been reported200. Thus, it is tempting to 
speculate that caspase-7 is the executioner caspase responsible for the pyroptotic 
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DEVDase signature. GSDMD-/- cells triggered for the NLRC4 and NRLP1b 
inflammasomes undergo apoptosis with same kinetics as WT cells undergo 
pyroptosis (Section 3.1). Furthermore, GSDMD-/- macrophages triggered with FlaTox 
and LeTx demonstrated similar levels of DEVDase activity than WT cells. This 
suggests that the apoptotic phenotype observed in GSDMD-/- cells relies on caspase-1 
and represents the program of executioner caspases happening in WT cells during 
pyroptosis. Indeed, ablation of ASC, known to mediate caspase-8 recruitment to the 
inflammasome and its activation in conditions of lack of caspase-1278,279, could not 
rescue GSDMD-/- macrophages from apoptosis after LeTx and FlaTox. Of note, 
caspase-3 was found to be weakly activated in NLRP1b and NLRC4-triggered 
pyroptotic cells, but was markedly maturated in GSDMD-/- cells after the same 
stimuli. This suggests that caspase-3 and caspase-7 are either matured at different 
moments or by a different mechanism upstream, which would be more markedly 
present in GSDMD-/--triggered macrophages. It remains to be determined whether 
each of the executioner caspases has a prominent role in the DEVDase activity of 
NLRP1b and NLRC4-triggered pyroptotic cells and whether both executioner 
caspases are needed for the apoptotic phenotype in NLRP1b and NLRC4-triggered 
GSDMD-/- macrophages. 
In conclusion, activation of the inflammasome leads to a complex network of caspase 
activation downstream. Activation of caspase-1 at the ASC speck, leads to processing 
of several substrates such as IL1β, IL18, GSDMD and executioner caspases, in either a 
direct or indirect way. Caspase-8 recruitment to the ASC speck also happens, though 
in a slower manner, being more obvious in conditions of delayed cell rupture, as in 
absence of caspase-1 or its catalytic activity278,279. Therefore, engagement of a 
canonical inflammasome would account for three parallel signaling pathways to cell 
death: a caspase-1-dependent membrane rupture by GSDMD; a caspase-1-dependent 
apoptotic program, through cleavage of executioner caspases; and a slower ASC-
dependent recruitment of caspase-8 and apoptosis.  
Interestingly, some of the morphological events observed in pyroptosis are 
reminiscent of apoptosis (Table 1), namely mitochondrial fragmentation and 
depolarization, phosphatidylserine exposure on the outer leaflet of the plasma 
membrane and DNA degradation. We have shown that, during non-canonical 
inflammasome activation, mitochondrial depolarization depends on GSDMD 
(Section 3.1). Considering caspase-11 also activates NLRP3 and caspase-1 
downstream, and that lack of GSDMD after caspase-11 activation not only impairs 
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pyroptosis, but also prevents caspase-1 activation downstream of NLRP3261, it 
remains unclear whether the mitochondrial depolarization is dependent on caspase-
11 or caspase-1. Next steps on pyroptosis research could address which of the 
pyroptotic morphological events which are shared with apoptosis are dependent on 
caspase-7 and caspase-3 activation downstream of the canonical inflammasome. 
Table 1. Comparison of morphological alterations in pyroptotic and apoptotic 
cells. 











Yes, as a diffuse TUNEL 
staining207 
Yes, condensed TUNEL 
staining207 
Nuclear morphology Condensation (late onset) 
Condensation and 
fragmentation20 
Annexin-V staining Yes (late onset) Yes20 
Cellular morphology 
Swelling and rupture, 
while attached 





To be determined Apoptotic bodies20 
Release of intracellular 
contents 




Contrary to pyroptosis, apoptosis is regarded as a silent form of cell death, not 
accounting for the induction of an inflammatory signaling in the local tissue73. 
Interestingly, mutations in genes of inflammasome receptors can cause genetic 
autoinflammatory diseases, commonly named as inflammasomopathies, due to an 
overt inflammasome activation. One of the most common presentations of 
inflammasomopathies are recurrent fever attacks, and patients normally experience a 
health improve when treated with IL1 antagonists257. This suggests that IL1β, and 
potentially IL1α, signaling is one of the most detrimental effects of the excessive 
inflammasome activation in these patients. For example, mutations in MEFV, the 
gene encoding the inflammasome receptor Pyrin, is the causative agent of FMF, and 
patients also benefit from IL1 inhibition281. An FMF-knock-in mouse engineered to 
contain a human domain of the MEFV gene and its autoactivation mutation is 
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completely protected when in an IL1β-null background282. Remarkably, lack of 
GSDMD in these MEFV mice also completely protects from pathology283. This 
suggests that targeting GSDMD in the clinic might be an efficient alternative 
approach for treating patients with inflammasomopathies. However, given our 
knowledge that GSDMD-/- macrophages still undergo cell death after inflammasome 
activation, it would be interesting to address the long-term effects of absence of 
GSDMD in inflammasomopathies models. 
While inflammasome-mediated responses have been shown to be protective to a 
number of bacterial infections142, it is still unclear how absence of GSDMD in 
macrophages could alter their response to infections in vivo. Furthermore, future 
research could address whether pathogens could differentially regulate each of the 
cell death pathways downstream of inflammasome activation. 
Finally, in the last part of the current thesis, we characterized how inhibition of two 
proteases from the extended prolyl dipeptidases family could cause inflammasome 
activation (Section 3.3). PRCP inhibition by Compound 8o led to a lytic form of cell 
death with fast kinetics, independently from the major cell death players of 
necroptosis, extrinsic apoptosis and pyroptosis. In addition, Compound 8o elicited 
NLRP3 inflammasome activation and release of IL1β in treated BMDMs. Description 
of the cell death mediator could elucidate whether NLRP3 activation is downstream 
of parallel to PRCP inhibition. 
DPP8/DPP9 inhibition also led to cell death induction and IL1β release, more 
pronounced in BMDMs containing the 129-associated allele of Nlrp1b. NLRP1b-
sufficient cells relied on caspase-1 for cell death and IL1β released, establishing Val-
boroPro and 1G244 as NLRP1b inflammasome activators and pyroptosis inducing 
agents. It remains to be analyzed how human cells, which possess only one Nlrp1 
locus, behave as. Overall, these results demonstrate that use of PRCP or DPP8/DPP9 
inhibitors can in fact have inflammatory roles in vivo. This should be taken into 
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Citrobacter rodentium. 
 Basic work flows for flow cytometry detecting cell death, 
cell cycle, proliferation and transfection efficiency. 
Biochemistry  Western blotting, cytokine measurements (ELISA, 
Luminex) 
Microscopy Experimental setup, acquisition and analysis of live cell 
imaging assays or immunocytochemistry; confocal 
microscopy on ZEISS and LEICA-based platforms. 
 Image analysis and quantification with ImageJ, Volocity 
and Imaris.  
Molecular Biology Restriction enzyme-based cloning, genomic PCR. 
Others  Graph Pad Prism, Microsoft Word, Excel and Power Point. 




Mass spectrometry – Shotgun and COFRADIC analysis 
(sample preparation and data analysis) 
Recombinant protein production (inducing bacterial 
expression, His-tag-based purification) 
Maintenance of mice (managing breeding) 
Laboratory supervision One 1st year Master student (2016) 
Presentations in Conferences  
2017 25th Euroconference on Apoptosis – European Cell Death 
Organization 
 Leuven, Belgium 
Curriculum Vitae 148 
 
 Flash Talk: High-Resolution Time-Lapse Analysis of 
Organelle Dynamics During Pyroptosis 
2016 IMMUNO 2016, XLI Congress of the Brazilian Society of 
Immunology 2016 
 Campos do Jordão, Brazil 
 10 min-Express Presentation: High-Resolution Time-Lapse 
Analysis of Organelle Dynamics During Pyroptosis. 
2016 10th EWCD – Death never Dies 
 Fiuggi, Italy 
 Poster: High-Resolution Time-Lapse Analysis of 
Subcellular Organelle Dynamics During Pyroptosis 
Awards 
2017 Best Flash Talk presentation on the 25th Euroconference 
on Apoptosis – European Cell Death Organization 
2013 PhD Scholarship – CAPES, Brazil 
2012 Masters’ Scholarship – CNPq, Brazil 
2011 Scientific Initiation Scholarship – CNPq, Brazil 
2009 Scientific Initiation Scholarship – CNPq, Brazil 
2008  Scientific Initiation Scholarship – CNPq, Brazil 
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